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Contributions of receptors to N. meningitidis interactions with 
human macrophages 
Abstract 
N. meningitidis is a gram-negative human pathogen that invades human cells, 
evades immune responses and goes on to cause meningococcal disease, sepsis 
and death. Serogroups B and C are most prevalent in industrialised countries, 
with over 50% of cases due to serogroup B, which as yet, has no effective 
vaccine. The work described involved developing methods and adapting 
effective model systems used throughout this study, and examination of which 
possible opsonic receptors may be involved in bacterial interactions in the 
presence of serum. The study revealed the involvement of CD 14 in 
meningococcal recognition was examined using a number of approaches, 
including glycosylphosphatidylinositol- (GPI) cleaving enzyme, 
phosphatidylinositol phospholipase C (PIPLC), appropriate anti-CD14 blocking 
antibody and CD14 transfectants. Class A scavenger receptor (SR-A) were also 
found to contribute significantly to meningococcal recognition by human 
macrophages. This observation was supported by the use of THP-1 monocytic 
cells; PMA-differentiation resulted in recovery of phagocytosis that could be 
inhibited with SR-A blocking reagent, Poly I. Immune serum-mediated 
interactions implicated CR3 and Fcy receptor involvement as well as that of 
cholesterol-rich lipid rafts. I also examine the role of non-opsonic receptors by 
using the first viable LPS-deficient strain of N. meningitidis, and note that the 
lpxA mutant adheres to primary human macrophages more effectively than its 
parent strain, but internalisation, LAMP-1 incorporation and TNF production 
were all severely reduced. 
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Chapter 1 
Introduction 
1.1 Innate Immunity 
Innate immunity is essential for the recognition and destruction of pathogens in 
the absence of acquired immunity using a limited number of pattern recognition 
receptors, including phagocytic receptors. Mononuclear phagocytes, neutrophils, 
mast cells, complement system and anti-microbial peptides are all included in the 
armoury of innate immunity. Two hypotheses that complement one another are 
used to illustrate how the innate immune system responds to a specific antigenic 
attack, and describe how the body is able to distinguish between "self" and "non- 
self". 
Janeway (Janeway 1992) proposed that pattern recognition receptors (PRR) 
present on the surface of host cells were the mediators of this discriminatory 
function. They suggest that these receptors are germ-line encoded and able to 
recognise a range of conserved motifs which are prevalent on pathogens, but not 
host molecules. The targets for these receptors are referred to as pathogen- 
associated molecular patterns (PAMPs) and include components of yeast, such as 
mannans, components of bacteria including lipopolysaccharide (LPS), 
lipoteichoic acid (LTA), peptidoglycan and double-stranded RNA of viruses 
(Janeway 1992). Two types of PAMPs have been described, those that are cell- 
associated and soluble; the latter are considered to be components of the humoral 
immune system such as mannose binding lectin (MBL) (Medzhitov and Janeway 
1997). Macrophages express a number of PRRs including C1314, complement 
receptor 3 (CR3), scavenger receptors (SR), mannose receptor (MR) and toll-like 
receptors (TLRs), which will be discussed in more detail later. Part of Janeway's 
hypothesis is that not only must PRRs be able to distinguish between non-self 
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and self, but they are also be able to recognise modified-self. Although 
Janeway's model of PRRs may require expansion as a number of the PRRs 
mentioned have endogenous and exogenous ligand and have be associated with 
homeostatic functions (Devitt, Moffat et al. 1998): as yet it is not known how 
these receptors discriminate between different ligands and carry out a suitable 
response. Matzinger developed this hypothesis further by suggesting the "danger 
theory" hypothesis (Matzinger 1998). She theorised that as well as monitoring 
the presence or absence of pathogens, the system may also monitor the damage 
by detecting molecules released by invading antigens or cells with defective 
innate cellular programming, and thus detect the "danger signals" released. 
Her theory is supported by the identification of host-derived ligands for some 
PRR. Mammalian and bacterial heat-shock proteins are highly conserved and 
HSP60 can cause potent pro-inflammatory cytokine release in various 
mammalian cells as predicted by using this model (Chen, Syldath et al. 1999). 
Toll-like receptor 4 (TLR4) recognise some host-derived heat shock proteins 
such as the 60Da heat shock protein (HSP60) (Ukeki, Tabeta et al. 2002), and 
host response to them supports this model of innate immune function (Matzinger 
1994; Kop and Medzhitov 1999). 
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1.2 Macrophage differentiation and ontogeny 
Macrophages belong to the mononuclear-phagocyte system (MPS) (van Furth 
1972) and originate in the bone marrow (BM) from stem cells (van Furth 1985). 
The sequence of differentiation is as follows; promonoblasts give rise to 
monoblasts, promonocytes, monocytes and mature macrophages (van Furth 
1985). All the cell types are found in the bone marrow, and monocytes enter the 
circulation where they remain for 36-104h and from there, in response to 
environmental stimuli, they migrate into the tissue where maturation and 
differentiation occurs, giving rise to long-lived mature macrophages (v°an Furth 
1985; Johnston Jr. 1988). As the body is constantly challenged with an 
enormous variety of exogenous material, it is essential that phagocytes, being 
amongst the body's first line of defence, are able to distinguish between cells or 
soluble molecules that are harmless or potentially dangerous ("non-infectious 
self and infectious non-self') and signal that danger is present (Janeway 1992). 
These terminally differentiated macrophages are quite distinctive in their ability 
to perform a wide variety of functions. They play a central role in tissue 
remodelling for both development, repair and maintenance, are active in 
scavenging effete cells, as well as playing a role in regulating differentiation of 
other cell types e. g. phagocytosis, microbicidal and tumouricidal activity, 
antigen presentation. They can secrete a range of substances including enzymes, 
complement components, tissue clotting factors, growth factors and 
immunoregulating substances. Monocytes in circulation represent around 5% of 
the white blood cell count, and are heterogeneous with regard to cell density, 
size, morphology, cytochemistry, expression of cell surface receptors and 
cytokine secretion (Forster and Landy 1981; Figdor, to Velde et al. 1986). Most 
of this heterogeneity is produced as a result of differences in the maturational 
stage or activation state of the cells (Dransfield, Corcoran et al. 1988). It is 
unclear whether cells of the MPS all develop along a single pathway and it is 
suggested that macrophage heterogeneity may be based on the existence of 
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distinct precursor subsets in the BM. Despite their probable common BM 
progenitor, macrophages display considerable heterogeneity (Forster and Landy 
1981; Walker, Warner et al. 1985). And unlike granulocytes, they differ 
considerably in phenotype and morphology depending on their location. Once in 
the tissue, monocytes differentiate into characteristically different tissue 
macrophages depending on tissue-specific stimuli present in the local 
microenvironment. 
While the most common haemopoietic stem cell origin of macrophages is 
regulated by haemopoietic growth factors, including CSF and inteleukin, 
macrophages in tissues have also been studied extensively for their self-renewal 
capacity in sitzt (Huang, Nocka et al. 1990). After leaving the bone marrow, the 
elements of most lineages of haematopoietic cells retain this attribute, including 
lymphocytes and mononuclear phagocytes. Proliferation of these cells is 
dependant on specific haematopoietic growth factors, such as GM-CSF. 
1.2.1 Interactions between cytokines and macrophages 
The two principle classes of professional phagocytic cells are monocyte- 
macrophages and polymorphonuclear leukocytes. Monocytes/macrophages are 
very versatile cells and play a central role in non-specific immunity through their 
ability to remove antigens by phagocytosis and intracellular killing. They are 
also involved in specific cell-mediated immunity by acting as antigen presenting 
cells (APC), as well as their ability to release a number of soluble mediators; 
cytokines. Cytokines are low molecular weight secreted proteins, usually 
between 15-25 kDa, and are mediators of inflammation, cell growth, immunity, 
differentiation and repair. Cytokines are able to act in a paracrine fashion in the 
local microenvironment, but also in an endocrine-like manner on distant organs. 
Most cytokines have a number of biological activities on different target cells, 
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and in addition to macrophages, a number of other cell types secrete them in 
response to different stimuli. So cytokines have a pleiotropic effect, in that they 
have multiple effects on the growth and differentiation of a number of cell types, 
and the expression of one cytokine is influenced by others, forming a cytokine 
network. 
The table below lists some of the cytokines secreted by activated macrophages, 
and their properties: 
Biological properties of some cytokines produced by activated macrophages 
Cytokine Biological properties 
IL-I a/ß Immunostimulatory molecule, mediator of shock and 
inflammation 
IL-6 Induction of acute phase response, regulation of 
haematopoeisis and immune response 
IL-8 Chemoattractant for granulocytes and lymphocytes 
IL-10 Suppresses cytokine production (ThI lymphocyte subset, 
monocytes) and monocyte/macrophage antigen-presenting 
function 
TNF-a Immunostimulatory molecule, mediator of shock and 
inflammation 
M-CSF Induction of monocyte migration, growth and differentiation 
factor, potentiates survival and effector function of mature 
monocytes/macrophages 
GM-CSF Induction of monocyte migration, growth and differentiation 
factor, potentiates survival and effector function of mature 
monocytes/macrophages 
MCP Monocyte chemoattractant protein 
TGF-ß Acts on cell proliferation, fibrosis, healing angiogenesis, 
immune response, haematopoiesis, etc. 
Adapted from (Stites, Terr et al. 1997) 
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1.3 Macrophage phagocytosis 
Metchnikoff coined the term phagocytosis over a century ago and it is now 
defined as the ingestion of large particles ranging 0.5-5µm in diameter in an 
actin-based conserved mechanism. Phagocytosis is the primary defence of both 
innate and adaptive host defence against infectious agents as it allows the uptake 
and degradation of microbial pathogens, by participating in the immune and 
inflammatory responses. 
The process of phagocytosis is comprised of several sequential and complex 
events that are initiated by the crucial step of recognition of the ligand destined 
for phagocytosis via specific receptors on the surface of phagocytic cells. The 
status of professional phagocytes is given to cells such as monocytes, 
macrophages, dentritic cells and neutrophils, whilst other cell types that display 
some of the attributes of professional phagocytes are referred to as semi- 
professional phagocytes (Rabinovitch 1995). The main differences between 
these types are their expression of a diverse array of dedicated phagocytic 
receptors designed to bind and internalise infectious agents, and the relative 
efficiency of particle phagocytosis. 
Phagocytosis is a complex process that is initiated by ligand attachment to a 
specific phagocytic receptor; although binding to a receptor does not 
automatically prompt uptake (Aderem and Underhill 1999). Receptor clustering 
at the attachment site generates a phagocytic signal that in turn leads to local 
polymerisation of actin filaments directly beneath the phagocytic target, which 
pushes the membrane forward to form pseudopodia and form a phagocytic cup 
through which the particle is internalised. Actin polymerisation beneath the 
phagocytic target drives particle uptake and is a trademark of phagocytosis, but 
is shed rapidly after particle ingestion as the phagosome subsequently fuses with 
intracellular endocytic markers such as lysosomes leading to the breakdown of 
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the particle. Among the best-characterised phagocytic receptors are the opsonic 
receptors, Fey receptors (FcyR) and complement receptors (CRI, CR3 and CR4) 
that recognise IgG or complement bound particles in an opsonin-dependent 
manner (Aderem and Underhill 1999). Other opsonins include 
Iipopolysaccharide binding protein (LBP), fibronectin, thrombospondin and 
collectins. Non-opsonic receptors such as CD 14, scavenger receptor (SR) can 
bind particles directly and will be discussed in further detail. 
1.3.1 Opsonophagocytosis 
The word opsonin is derived from the Greek for "prepare for eating". Opsonins 
are soluble mediators that promote the phagocytosis of bacteria and other 
antigens, by coating their surface, which has the effect of making the antigens 
bind more readily to the phagocytic cells, as they possess surface receptors for 
the opsonic proteins, thus allowing the target to undergo receptor-mediated 
engulfment (Stites, Terr et al. 1997). 
The most effective antibody opsonins are from the lgG subclass, and their ability 
to opsonise is mediated through Fc receptors found on the surface of professional 
phagocytes. There are three distinct classes of receptors specific to the Fc 
portion of IgG, and they are collectively termed Fey receptors (FcyRs). IgG 1 and 
IgG3 bind with a high affinity to the Fc receptors (FcyRII and FcyRIII 
respectively), and so are the most effective opsonins. Complement receptors 
(CRs) recognise complement-opsonised particles and are present on macrophages 
and PMN's. C3 components can act as opsonins, specifically C3b and iC3b that 
bind to CR1 and CR3 respectively (Mosser 1994). Fey receptors and CR3 differ 
in a number of ways, for example Fcy receptors are constitutively active for 
phagocytosis (Ravetch 1994), whereas CR3 requires additional activation to 
phagocytose particles (Wright, Craigmyle et al. 1983). Cytokines, such as IFN-y, 
are able to up-regulate receptor expression in monocytes by as much as a 20-fold 
increase. 
A number of precise regulatory signalling molecules linking ligated phagocytic 
receptors to actin polymerisation are involved in FcyR-mediated phagocytosis 
(type I phagocytosis), including Rho GTPases and members of Src family of 
tyrosine kinases Lyn, Hck, Fgr and Syk kinases (Greenberg, Chang et al. 1993; 
Greenberg, Chang et al. 1996). Many of these signalling cascades have yet to be 
completely understood, but it is clear that during particle uptake in mammalian 
professional phagocytes, Rho GTPases control the cytoskeletal rearrangements 
(Ridley and Hall 1994). These small GTPases control the formation of actin-rich 
filopodia and membrane ruffling, (Cox, Chang et al. 1997) as well as controlling 
different stages in FcR-mediated phagocytosis process, namely pseudopod 
emission for Cdc42 and phagocyte closure for Racl. (Caron and Hall 1995; 
Massol, Montcourrier et al. 1998) IgG-opsonised particles require the presence 
of Cdc42 and Racl for F-actin polymerisation through the WASP (Wiskott- 
Aldrich Syndrome Protein) family of proteins that induce actin nucleation 
mediated by the Arp2/3 complex which translocates to phagocytic cup and co- 
localises with actin, (Machesky and Insall 1998) leading to F-actin rich 
lamellipodia extensions that engulf the particle. The central role of WASP in Fc- 
mediated phagocytosis is highlighted in WAS patients, who display an absence 
or reduced concentration of WASP protein in their leukocytes. This condition 
results in a marked reduction in the internalisation of IgG-opsonised particles 
(Lorenzi, Brickell et al. 2000). Vesicle fusion with the plasma membrane is 
controlled by regulatory proteins, such as phosphatidylinositol 3-kinase (P13-K), 
an enzyme activated during phagocytosis (Cox, Tseng et al. 1999), localised to 
the phagocytic cup (Marshall, Booth et al. 2001), and involved in the supply of 
membrane required for the formation of phagosomes. Soon after phagocytosis is 
completed F-actin is quickly lost from the phagosomes. 
12 
Recruitment of the active forms of these proteins to the plasma membrane occurs 
via the rapamycin system, and has confirmed the differential roles of Cdc42 and 
Rad l (Castellano, Montcourrier et al. 1999; Castellano, Montcourrier et al. 
2000). In contrast, the actin polymerisation downstream of the integrin family 
member CR3 depends on the activity of RhoA, and neither Rad 1 nor Cdc42 are 
necessary in this pathway. Complement factors bind particles through thiol ester 
bonds on free surface hydroxyl or a groups. CR3-mediated uptake (type II 
phagocytosis) leads to a transient accumulation underneath bound particles of F- 
actin and various cytoskeletal elements in small foci (Caron and Hall 1995; Allen 
and Aderem 1996); and particles sink straight into the cytoplasm of the cell 
without being engulfed through protruding pseudopodia as is the case for 
antibody-opsonised particles (Kaplan 1977). Although the presence of Arp2/3 
complex has recently been demonstrated in the actin-rich foci (Mary, Caron et al. 
2000), the upstream signalling of type II phagocytosis, linking CR3 activation to 
particle uptake is not known. Protein kinase C (PKC) involvement has been 
observed in both types of phagocytosis described, but unlike antibody-mediated 
phagocytosis protein tyrosine kinases are not thought to be involved in 
phagocytosis through complement receptors (Allen and Aderem 1996). 
Additionally type I phagocytosis usually triggers a pro-inflammatory response 
and respiratory burst that is not evident in type II phagocytosis. As actin 
dynamics are central to the process of phagocytosis, it is not surprising that 
several bacterial pathogens have evolved virulence mechanisms able to interfere 
with or promote uptake. What is interesting is that the regulatory switch of Rho 
GTPases is a common target, and emphasises the important role these signalling 
elements play in phagocytosis. 
From the point of view of the microbe, phagocytosis can be seen as an 
opportunity for intracellular pathogens to enter immune cells without inciting an 
anti-microbial response by avoiding engulfment altogether or by blocking a 
phagocytic response once inside the cell. Bacterial pathogens have developed 
various strategies to avoid recognition of phagocytic receptors, Neisseria 
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meningitidis, Klebsiellsa pneumoniae and Streptococcus pneumoniae for example 
are all in possession of a polysaccharide capsule which can physically interfere 
with complement deposition and therefore impair opsonin-mediated 
phagocytosis. Neisseria can also alter the antigenicity of certain surface 
molecules. Other microbial pathogens, such as Yer"sinia species, Salmonella and 
Pseudomonas aeruginosa, are able to use specialised highly regulated secretion 
systems (type III secretion systems or TTSS) to interrupt the formation of 
cytoskeletal arrangements and/or phagocytic signalling pathways of opsonin- 
independent receptors (Simonet, Richard et al. 1990). 
A normal functioning complement system, as well as the co-operation of specific 
antibodies, are essential in protection from invasive N. meningitidis, since 
intravascular clearance of gram-negative bacteria is mediated through the 
deposition of complement components: C3b for phagocytic clearance, the MAC 
or C5-C9 for lysis. The fact that immune lysis is the immunological barrier that 
restricts meningococci from colonising mucosal sites is most apparent in 
individuals who have genetic deficiencies in the terminal complement 
components required for immune lysis. These individuals are prone to recurrent 
neisserial infections, despite having acceptable levels of anti-meningococcal 
antibodies and having intact C3-dependent opsonophagocytic killing. Whereas 
other mucosal bacteria that can also cause disseminated disease in the absence of 
immune lysis do not disseminate in the sera of complement deficient people. 
There must therefore be something unique in the way that complement interacts 
with the surface of Neisser"ia (Brandtzaeg 1995). 
The role of other serum opsonins are not explored in this manuscript, but it is 
important to note that collectins, which include mannose-binding lectin (MBL), 
lung surfactant proteins A and D, are thought to contribute to innate immune 
defence. MBL is distinguished by its ability to activate the complement system, 
and enhance host bactericidal responses by binding to the surface of a range of 
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organisms, including Staphylococcus, Salmonella and N. meningitidis (in the 
absence of sialylated lipooligosaccharides or LOS) (Jack, Klein et al. 2001). 
The complexity, diversity and variety of phagocytic receptors and their 
signalling pathways are becoming more apparent as time goes on; as are the 
incredibly intricate methods that some bacterial pathogens have developed to 
avoid phagocytosis, as a means of intracellular survival. Non-opsonic 
phagocytic pathways have yet to be characterised in such detail; therefore in 
vitro studies such as this are important, as the role of opsonophagocytosis in the 
defence against meningococcal infection in vivo is largely unknown. 
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1.4 Mucosal immunity against N. meningitidis 
The nasopharynx is the initial site of meningococcal colonisation and is 
presumed to be the primary site of invasion. Certain strains of Neisser"ia 
meningitidis are potential pathogens, and this appears to be conferred in part by 
their ability to adhere and invade mucosal surface structures (Townsend, 
Goodwin et al. 2002), and both survive and multiply after entering the 
bloodstream of certain individuals (Brandtzaeg 1995). The evolution of bacterial 
meningitis follows the general sequence of exposure to the pathogen, acquisition 
and then invasion; and invasion itself can be said to comprise three steps, 
mucosal penetration, invasion into the bloodstream and finally invasion of the 
meninges (Stephens and Farley 1991; Brandtzaeg 1995). 
Specific surface structures are thought to be responsible for the pathogenic 
potential of a meningococcal strain, coupled with individual response to 
colonisation (Dehio, Gray-Owen et al. 2000), as it is the host's immunological 
response to these organelles that restricts the bacteria to mucosal sites of 
colonisation. It has also been hypothesised that if a strain makes more of these 
immunogenic organelles, there is a greater chance that it will colonise the 
mucosa without invading/killing the host. However, the low incidence of disease 
suggests that for most individuals natural immunity is successful in preventing 
meningococcal invasion. Studying disease in immunodeficient individuals has 
been extremely useful in highlighting the complexity of immune response to 
meningococci (Ross and Densen 1984). 
There are a number of structures on the surface of the bacteria that are involved 
in host cell attachment; these include pill, capsule, and outer membrane proteins. 
Such attachment processes are important as they allow the bacteria to overcome 
repulsive charge, or the hydrophilic/phobic affects of different surfaces (Criado, 
Ferreiros et al. 1985). Some of these structures can also undergo phase and/or 
antigenic variation, by DNA rearrangement, as a mechanism to evade specific 
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host defences (McLeod Griffis 1995). Acquisition of N. meningitidis in the 
nasopharynx and the severity of disease are affected by both host (Heist, Solis- 
Cohen et at. 1922) and environmental factors, such as age, antibody or 
complement deficiency, any existing bactericidal or opsonic activity, co- 
infection and any changes that damage the nasopharynx (Goldschneider, 
Gotschlich et al. 1969; Reller, MacGregor et al. 1973; Nicholson and Lepow 
1979). Tobacco smoke also affects the surface charge of cells, and consequently 
the adhesion of potential pathogens associated with an increased risk of invasive 
disease (El Ahmer, Essery et al. 1999). 
The carriage of N. ineningitidis in adults is known to induce cross-protection 
between strains, and carriage of N. lactainica, a non-pathogenic species of 
Neisser-ia usually carried during early childhood, is associated with an increase 
in antibody titres to pathogenic meningococci strains. Over 90% of 12-18 year 
olds in a UK-based study displayed bactericidal activity against N. lactamica, 
that were consistent with high levels of carriage of the same organism or 
related/cross-reactive organisms throughout childhood (Zorgani, James et at. 
1996). Carriage of non-pathogenic organisms that are capable of inducing 
immune responses are thought to be important for acquiring a natural immunity 
to pathogenic meningococci; and it may be these differences in carriage of cross- 
reacting non-pathogenic strains within a population may, in some part contribute 
to the worldwide variation of prominent serogroups and strains, and incidence of 
meningococcal disease (MCD). Relatively little is known about mucosal 
immunity to MCD, but in order for Neisseria meningitidis to cause disease it 
must both attack (colonise) and invade epithelial cells. So, in fact effective 
mucosal immunity really need only prevent invasion, not colonisation - but as yet 
we have no way of measuring mucosal immunity to epithelial cells, other than by 
noting the absence of disseminated disease. 
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1.5 Antigen recognition by macrophages 
1.5.1 CD14 
1.5.1.1 Structure and expression 
CD I4 was first described in 1982 during the First Leukocyte Typing Workshop 
(Bernard, Boumsell et al. 1984) and was later identified as a 55kD glycoprotein 
expressed on neutrophils, monocytes and macrophages (Todd, Bhan et at. 1984). 
Although it was not until 1990 that Wright and colleagues established the 
receptors main functional role, which was that of a high affinity LPS receptor 
that could induce macrophage activation and cytokine production in response to 
LPS (Wright, Ramos et al. 1990). 
Human CD 14 receptors are present on cells belonging to myeloid, erythroid, 
megakaryocytic and lymphoid lineages, and the gene consists of two exons that 
encode a 356 amino acid protein with multiple leucine-rich repeats. The mature 
protein occurs in two forms, as a membrane-bound glycosylphosphatidyl-inositol 
(GPI)-anchored protein (mCD 14) (Haziot, Chen et al. 1988), and a soluble form 
(sCD 14), which is present in normal human serum at a concentration of 2-6µg/ml 
(Bazil, Horejsi et at. 1986; Wright 1999). The presence of this anchor means 
that it is classified as belonging to the PI-anchored family of receptors (Haziot, 
Chen et at. 1988; Simmons, Tan et at. 1989). Macrophages express greater 
numbers of mCD14 than neutrophils, with approximately 105 receptors per cell 
compared to 3x 103 receptors per cell respectively (Antal-Szalmas, Van Strijp et 
al. 1997). Two soluble forms of sCD14 are obtained in quite different ways; 
proteolytic cleavage of the cell membrane through a serine protease generates a 
49kD form and a 55kD form of sCD14 can be liberated from its GPI-anchor 
(Buffer, Stiegler et al. 1995) by phospholipase D cleavage. Treatment of 
macrophages with phosphatidylinositol phospholipase C (PI-PLC), an enzyme 
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specific for the cleavage of all PI-anchored molecules, results in the removal of 
CD 14 from the cell surface (Haziot, Chen et al. 1988). 
Expression of mCD 14 and release of sCD 14 are subject to bacteria and cytokine- 
induced regulation, as both mCD14 and sCD14 expression are up regulated in the 
presence of bacterial ligands (Landmann, Ludwig et al. 1991; Watanabe, 
Takeshita et at. 1996). sCD14 can bind a wide range of amphipathic lipids, 
including bacterial proteins OSP-A, P1, PS, PC and Rhodamine-PE (Hailman, 
Lichenstein et al. 1994; Savedra, Delude et al. 1996; Yu, Hailman et at. 1997; 
Wang , Kitchens et al. 1998; Wooten, Morrison et al. 1998; 
Wang and Munford 
1999; Wright 1999), and contributes to the transport of phospholipids in the 
blood by mediating the transport of bacterial LPS and phospholipid monomers 
both in and out of cell membranes (Sugiyama and Wright 2001). 
1.5.1.2 Ligmrds and binding properties 
CD 14 is an important LPS receptor, and the majority of low-dose LPS effects in 
myeloid cells are attributed to C1314-dependant interactions (Wright, Ramos et 
at. 1990). Moreover, it is essential for TNF-a and IL-1 production (Couturier, 
Jahns et at. 1992; Martin, Mathison et al. 1992). CD14 can bind both soluble 
LPS and whole gram-negative organisms, which are subsequently internalised in 
a complement-independent manner, but the role of mCD14 in bacterial 
phagocytosis is not yet clear. 
The binding of most ligands to CD 14 evokes a pro-inflammatory response with a 
few notable exceptions including anionic phospholipids which are present on the 
surface of apoptotic cells (Savill 1998); thus ensuring that the surrounding tissue 
is protected from inflammatory injury (Savill 1998). Such a pro-inflammatory 
cytokine response in macrophages against apoptotic cells is inhibited by 
autocrine TGFß, PGE2 and PAF release (Fadok, Bratton et al. 1998). Both 
mCD14 and sCD14 bind LPS (Gallay, Jongeneel et al. 1993; Tobias, Soldau et 
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al. 1995), and a number of studies to establish the precise region of the LPS 
binding site have been undertaken, but results have been variable and largely 
depend on the methods used. C-terminus amino acid residues after 152 are not 
thought to have a role in LPS binding and the promoting of cellular responses, so 
further work has concentrated on hydrophilic regions at the N-terminus. 
Several regions between residues 7-65 have been implicated, and deletion 
mutagenesis studies of sCD14 have identified residues 39-44 and 57-64 as 
important LPS binding domains (Juan, Hailman et al. 1995; McGinley, Narhi et 
al. 1995; Stelter, Bernheiden et al. 1997). 
As well as LPS, as a PRR CD 14 can also interact with a number of microbial 
products including muramyldipeptide, polymannuronic acid, lipoaribinomannan 
and high doses of peptidoglycan, but it has yet to be established whether such 
ligands all bind to the same site on the receptor (Pugin, Heumann et al. 1994). 
CD14 is mobile in the plane of the membrane, and is quite distinct from other 
macrophage receptors. Cells that do not express C1314 (e. g. lymphocytes, NK 
cells, fibroblasts) still respond to high concentrations of LPS in a C1314- 
independent manner. 
1.5.1.3 Function of CD14 
Pattern recognition receptors on cells of the innate immune system include 
signalling receptors and phagocytic receptors, but CD14 lacks a transmembrane 
or cytoplasmic domain, so its role as a receptor capable of transducing signals 
into the cell is rather controversial. LPS interactions with macrophages via 
CD 14 trigger several phosphorylation cascades, including NFKB activation and 
MAP kinase pathways. 
Due to its structure, CD 14 is not able to function as signal transducing molecule 
and must therefore transmit appropriate signals into the cell by an alternate 
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method. A number of mechanisms have been proposed for CD14-mediated 
macrophage activation by LPS, and include: 
Studies using labelled anti-CD14 monoclonal antibodies have 
demonstrated that CD14 internalisation into the cell occurs through 
uncoated invaginations which is a known characteristic of receptor- 
mediated endocytosis which may serve to transduce a signal (Schutt, 
Ringel et al. 1988; Jonas, Schutt et al. 1990). 
TLRs and CD14 may co-operate to transduce signal into the cell 
(Shimazu, Akashi et al. 1999; Beutler 2000), Studies by Pridmore and 
Wylie et al also suggest that CD14 responsiveness to N. meningitidis LPS 
occurs in conjunction with TLR4 and its cofactor MD2 (Pridmore, Wylie 
et al. 2001). 
" Physical and functional association of GPI-anchored receptors, including 
CD14, with (32 integrins that can in turn act as a signalling conduit for 
CD 14 (Petty and Todd 1996). 
Ceramide has structural similarity to LPS, so a suggestion is that if LPS 
binds to CD14, the LPS can be integrated into the phospholipid layer of 
the cell membrane and interact with ceramide-activated protein kinase 
(CAPK) in place of ceramide, thus leading to activation of the cell 
(Joseph, Wright et at. 1994). Later evidence calls into question whether 
this effect is specific to LPS, as both TNF-a and IL-1 can also activate 
CAPK. Perhaps then ceramide mimics LPS, rather than the converse as 
was first thought (Sweet and Hume 1996). 
f Unknown co-receptors or accessory proteins involved in the binding of 
microbes and the subsequent activation of the cell. 
The targeted deletion of the CD 14 gene in mice confirmed the importance of 
CD 14 in LPS responsiveness, as monocytes and macrophages were found to be 
profoundly hyporesponsive to LPS. Small amounts of TNF-a and trivial 
amounts of IL-lß and IL-6 were produced in response to high doses of LPS (1- 
10µg/ml); this is 4-5 logs above threshold concentration for LPS responses. In 
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this manuscript the role of CD 14 as a potential binding or signalling receptor for 
serogroup B N. meningitidis is explored. 
1.5.1.4 Paroxysmal nocturnal ltaemoglobinuria (PNH) 
PNH is a relatively rare acquired clonal disorder of the haemopoeietic stem cell 
(HSC). The disease is characterised by the formation of defective granulocytes, 
lymphocytes, platelets and erythrocytes. Sufferers display a large number of 
membrane protein deficiencies, including CD 14, CD59, CD58, decay 
accelerating factor (DAF), and acetylcholinesterase (AChE) and alkaline 
phosphates in erythrocytes and neutrophils respectively (Schubert, Uchiechowski 
et al. 1990; Bessler and Fehr 1991; Rotoli, Bessler et al. 1993). Current 
pathogenetic models predict that autoreactive T cells target normal (non- 
mutated) HSCs sparing mutated HSCs. In this context, PNH HSC cells expand 
and supply the periphery with mature blood cells which at various proportions 
lack surface expression of glycosylphosphatidylinositol (GPI)-linked proteins. 
All the deficient membrane proteins possess a GPI-anchor, and PNH effects the 
formation of GPI-anchors (Rosse 1990; Rotoli, Bessler et al. 1993). The range 
of cells this disorder affects suggests that the somatic mutations have taken place 
in a totipotent cell, confirming that PNH is a stem cell disorder. The proportion 
of PNH cells in PNH patients who have a normal or reduced cell count can be up 
to 90% or even more. The genetic lesion is mutation(s) affecting the X-linked 
gene PIG-A. The PIG-A gene has been isolated and mapped to the X- 
chromosome on Xp21.3(Takeda, Miyata et al. 1993; Bessler, Hillmen et al. 
1994). PIG-A has been shown to correct the membrane abnormality of PNH 
cells, and further anaiysis of the gene has revealed mutations (often small 
insertion deletions or point mutations) in the PNH cell population, but not in the 
normal cell population of PNH sufferers(Bessler, Mason et al. 1994; Ware, Rosse 
et al. 1994; Nafa, Mason et al. 1995; Yamada, Miyata et al. 1995). 
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CD59, also referred to as membrane inhibitor of reactive lysis (MIRL), is 
important in preventing cellular death via the complement membrane attack 
complex (MAC), and cells lacking CD59 become highly susceptible to 
complement-mediated lysis. Consequently many patients with PNH tend to be 
anaemic, and have neutropenia or thrombocytopenia (or both) at some in the 
course of their disease. Inherited absence of PIG-A protein product produces a 
similar phenotype to PNH (Yamashina, Ueda et al. 1990). 
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1.5.2 Complement Receptor 3 
Part of the complexity of phagocytosis is due to the wide variety of microbes that 
can interact with the cell via a diverse array of cellular receptors. A number of 
phagocytic receptors have dual functions, and are able to mediate opsonic and 
non-opsonic interactions, as well as bind and subsequently internalise invading 
microbes; complement receptor 3 (CR3) is an example of such a receptor. CR3 
is widely held as being a crucial component of the innate immune system, and an 
essential LPS receptor. As a versatile adhesion and recognition receptor, CR3 
mediates phagocytosis and has signalling capabilities via kinase cascades and 
cytoskeletal arrangements, as well as activating other important adhesion and 
defence receptors (Todds III 1996; Wagner, Hansch et at. 2001). 
The integrin superfamily are a collection of transmembrane glycoproteins that 
can mediate both cell-substrate and cell-cell interactions, and CR3 shares many 
common features with other members; such as a propensity for clustering, 
associating with cytoskeletal and signalling complexes, activating signalling 
cascades and regulation of cell spreading and migration through Rho GTPases 
(Giancotti and Ruoslahti 1999). Integrins are present in a wide variety of species 
from sponges to mammals, and are therefore widely held as an important link 
between cells and the extracellular matrix (ECM). 
1.5.2.1. Structure 
CR3 is a heterodimeric type I transmembrane glycoprotein, comprising an a sub- 
unit (CD IIa, b or c) and a non-covalently associated ß sub-unit (CD 18). CD 18 
is a 95kD polypeptide of which there is only one form that is shared by all the 
three 32-integrins. CD18 is encoded on chromosome 21 and is linked to one of 
the three CDII subunits that are all encoded on chromosome 16. Electron 
microscopy studies suggest that structurally an integrin comprises a globular 
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"head" that is formed by the amino regions of the a and ß chains, which is 
thought to be the ligand binding site. This is in turn attached to "legs" that are 
formed by the carboxyl regions of each chain. Disulphide bonds stabilise the 
complicated tertiary structure of the receptor, and form bridges between a 
number of cysteine residues that are highly conserved (Todds III 1996). 
The four homologous heterodimers that comprise the P2-integrin family of 
receptors are: leukocyte-function associated molecule-1 (LFA-1, CDi la/CD18, 
CRI), complement receptor type 3 (CR3, CD! l b/CD 18, Mac-1, Mo-1), CR4 
(CD ll c/CD 18) and the more obscure aD132 (CD ll d/18). CRI, CR3 and CR4 are 
all expressed on macrophages and participate in the phagocytosis of complement 
opsonised particles, though CR3 is present in the greater numbers (Larson and 
Springer 1990; Springer 1995). 
LFA-1 contains the 170kDa a-subunit CD 1la (or OCO, is expressed on all 
leukocytes and mediates intercellular adhesion between leukocytes and other host 
cells via intercellular adhesion molecule (ICAM) -1,2 and 3. The CR3 a- 
subunit CD 11b (ah, ) is 1 136 residues long and encodes a 165kD polypeptide that 
is expressed on a range of leukocytes such as monocytes, macrophages, NK cells, 
granulocytes, but only a minor subset of B-cells (CD5+) and even less T-cells. 
Together CR3 and LFA-1 are essential in the process of diapedesis, where they 
act as cellular adhesion receptors that facilitate the migration of phagocytic cells 
from the blood vessels to sites of infection. 
1.5.2.2 Ligapuls 
A known PRR, CR3 receptors interact with an impressive array of ligands both 
protein and non-protein which bind to the two main binding regions present on 
the a-subunit. Bacterial LPS, as well as other diverse microbial conjugates, 
bind to CR3 both in the presence or absence of serum opsonins; and the ability of 
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CR3 to recognise a variety of endogenous and exogenous substances has raised a 
lot of interest in the receptor. 
The I (inserted) domain (also known as A domain) is located at the N-terminus, 
and most, if not all, of the endogenous and microbial ligands bind via this 
specialised domain, including complement components C3b, iC3b, C3d and 
C3dg, coagulation proteins such as fibrinogen (Wright, Weitz et al. 1988) and 
factor X (Altieri and Edington 1988), Zymosan (Yalamanchili, Lu et at. 2000) 
and counter receptors ICAM-1 and 2 (Diamond, Staunton et al. 1990). ICAM-1 
and iC3b bind to overlapping sites within the I-domain of CDI lb. The I domain 
contains binding sites that are distinct and overlapping but not identical, and also 
has a distinctive metal ion-dependent adhesion site (MIDAS) (Diamond, Garcia- 
Aguilar et al. 1993). 
The second main binding domain is located C-terminus to the I domain and is 
referred to as the polysaccharide lectin binding site. The lectin site is a divalent 
cation-independent domain that has a broad specificity for certain glucose- and 
mannose-containing polysaccharides (Thornton, Vetvicka et al. 1996). This 
lectin binding site is less well resolved, but is known to have a wide sugar 
specificity, able to bind both bacterial and yeast cell wall polysaccharide, which 
in turn triggers phagocytosis and extracellular cytotoxicity. CR3 expressing 
cells, blocking monoclonal antibodies and transfected cell lines have all been 
used in studies to identify the ligand specificity of this site (Shang and Issekutz 
1998; Xia and Ross 1998). Microbial ligands include lipopolysaccharide (LPS), 
Mycobacteria polysaccharides, K. pneumoniae acylpolygalactoside (APG), 
Leishmania lipophosphoglycan (LPG), as well as soluble and particulate 
saccharides such as ß-glucan and zymosan. 
Suggestions that LPS and ß-glucan binding may occur at distinct sites on the 
lectin binding site have been made and imply that either the lectin site is an 
individual binding site that can recognise different types of sugars, or a second 
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lectin site may exist. A broad range of micro-organisms have been shown to 
interact with leukocytes in a CR3-mediated manner, including Mycobacterium 
tuberculosis (Zimmerli, Edwards et al. 1996; Peyron, Bordier et al. 2000; 
Thorson, Doxsee et al. 2001), HIV (Bouhlal, Galon et al. 2001), Cryptococcus 
neofor"mans (Levitz, Tabuni et al. 1997), group B Streptococci (Goodrum, 
McCormick et al. 1994), Lister"ia monocytogenes (Drevets, Leenen et al. 1996), 
Pseudonionas aeruglnosa (Heale, Pollard et al. 2001), Escherichia coli 
(Agramonte-Heva, Gonzalez-Arenas et al. 2002) and Neisser"ia gonorrhoeae 
(Edwards, Brown et al. 2002). 
Signalling is quite complex for CR3 as it has two activation signalling processes 
that are quite different. High-affinity ligand binding results in an inside-out 
signalling state for CR3, and phagocytic activation of CR3 leads to outside-in 
signalling. LPS activation of macrophages induces a marked upregulation in 
CR3 expression and initiates inside-out signalling, which is essential for high- 
affinity binding of integrin ligands. This is an intrinsic property of integrin 
receptors where binding of ligands results in conformational changes in the 
external domain of the receptor; and results in allowing the ligand to gain better 
access to the binding pocket formed by the intertwined ß and a chains. For 
example LPS binding to CR3 has the affect of revealing otherwise hidden, high- 
affinity binding sites for ICAM-l. Activated CR3 form a strong attachment with 
host endothelial cells that express ICAM-1, without eliciting a cytotoxic 
response. Another form of activated CR3 can recognise opsonin-coated bacteria 
and cell wall polysaccharide through the lectin-binding site, resulting in a strong 
cytotoxic response, which includes phagocytosis and cytokine production and 
secretion. It is clear that functionally both forms of the activated CR3 are quite 
different. 
A number of studies have observed that CR3 can associate with several GPI- 
linked proteins, both physically and functionally (Petty and Todds III 1996). 
These proteins tend be heavily glycosylated and are thought to bind directly to 
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CR3 via the lectin site. GPI-linked receptors, such as CD 14, CD 16 (FcyRIIIB) 
and uPAR aggregate on cholesterol-rich regions, referred to as lipid rafts, present 
on cell surfaces, and this association may mediate the cross-talk of both 
receptors in response to LPS and result in effective signal transduction to the 
cell. Association of CR3 to GPI-anchored receptors is thought to result in their 
translocation to lipid rafts, at which point pathogenic microbes, such as 
Mycobacteria species are able to bind to and internalise through CR3 receptors 
without inciting a cytotoxic immune response (Peyron, Bordier et al. 2000). 
Although CR3 is central to our innate immune response, it is interesting to note 
that a number of diverse microorganisms use CR3 as a safe portal of entry into 
the cell. N. gonorrhoeae for example uses CR3 as a primary receptor to infect 
and invade cervical epithelial cells, but whether gonococci interact with CR3 
directly or if complement deposition is a specific requirement or whether these 
interactions take place via the I domain are all questions that have yet to be 
answered. Edwards et al (Edwards, Brown et al. 2001; Edwards, Brown et al. 
2002) suggest that gonococci can bind to human cervical epithelium in an 
opsonin-dependent and -independent manner. The relationship between N. 
meningitidis and CR3-mediated entry has not been previously studied in detail, 
and will be examined as part of this study. 
1.5.2.3 CR3 printing and activation 
The functional status of inflammatory cells can be enhanced depending on 
specific conditions in vivo and in vitro. Priming is a phenomenon that is used by 
a number of cell types, including neutrophils, basophils, eosinophils as well as 
macrophages. Both human and murine CR3 can prime macrophages, neutrophils 
and NK cells for increased cytotoxicity or phagocytosis. 
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As well as an increase in function, priming is also associated with 
morphological, physical and phenotypic changes of the cell and provides the 
basis for the concept of cellular heterogeneity. Johnson ei al (Johnston Jr. 1988) 
first introduced the concept of macrophage priming by observing an increase in 
oxidative burst after exposure to proteases in vitro. The local microenvironment 
of inflammatory cells accounts for their heterogeneity but the relationship 
between priming and other cell changes has yet to be elucidated. 
Analysis of the response of human leukocytes to ß-glucans has revealed that CR3 
is primarily responsible for the high affinity binding of particulate (Ross, Cain et 
at. 1987) or soluble (Thornton, Vetvicka et at. 1996) ß-glucans (Cain, Newman 
et al. 1987; Vetvicka, Thornton et al. 1996; Vetvicka, Thornton et al. 1997) that 
have highly variable structures and sizes and are present on a wide variety of 
fungi. For over 30 years ß-glucans have been known to promote tumouricidal 
activity in mice; and recent in vitro studies revealed that ß-glucans can activate 
these human and murine cells to kill sensitive tumour cells and potentiate T-cell 
responses to cellular antigens (Cook, Taylor et al. 1978; Amino, Noguchi et al. 
1983; Seljelid, Bogwald et at. 1984; Sugawara, Lee et at. 1984; Morikawa, 
Noguchi et at. 1986; Sherwood, Williams et al. 1987). 
High molecular weight soluble or particulate ß-glucans have been shown to 
cross-link membrane CR3 and multiple cell surface CR3 molecules, resulting in 
the secretion of IL-l, TNF-a from macrophages (Doita, Rasmussen et al. 1991; 
Ohno, Saito et al. 1993; Ljungman, Leanderson et al. 1998), degranulation and 
respiratory burst of neutrophils. But small soluble ß-glucans were shown to 
saturate the individual cell surface CR3 molecule (Thornton, Vetvicka et al. 
1996) and generate a primed state of the receptor capable of mediating 
cytotoxicity of iC3b-opsonised tumour cells that otherwise would not trigger this 
CR3-dependent response (Vetvicka, Thornton et al. 1996; Vetvicka, Thornton et 
al. 1997). But interestingly ß-glucan priming of CR3 does not lead to the 
presentation of a high-affinity epitope required for the efficient binding of 
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ligands, such as ICAM-1 (Vetvicka, Thornton et al. 1996); suggesting that CR3 
has more than one primed or activation state. (3-glucan tumouricidal activity by 
neutrophils, macrophages and NK cells require tumour cells to be opsonised with 
iC3b, therefore ß-glucan therapy may be more effective when tumour cells 
generate a humoral response and are opsonised with antibody and C3. In vitro 
macrophage CR3 can remain primed for toxicity of iC3b-opsonised tumour cells 
hours after exposure, which may be useful in the study of ß-glucan therapeutics 
in cancer research. The use of (3-glucan as a tumouricidal agent has produced 
variable results in studies carried on cancer patients in Japan, but a clearer 
understanding of the mechanisms involved will allow their use to be more 
precise. 
Small soluble ß-glucans released from S. cerevisiae have been shown to be 
particularly effective in blocking macrophage phagocytosis of yeast (Goldman 
1988; Goldman 1988) and Giamis et al observed that macrophage phagocytosis 
of non-opsonised heat-killed yeast was mediated by both ß-glucans and mannose 
receptors (Giamis, Lombard et al. 1993). Seljelid et al produced a soluble ß- 
glucan that activated murine macrophages for both anti-tumour and anti-bacterial 
activities (Seljelid, Bogwald et al. 1984; Seljelid 1986; Seljelid, Rasmussen et al. 
1987; Doita, Rasmussen et al. 1991), and showed that the activity of these 
soluble ß-glucans could not be blocked by mannose or mannan, demonstrating 
that the murine receptor for soluble ß-glucan was distinct from the mannose 
receptor (Konopski, Smedsrod et al. 1994). The relationship between the CR3 
activation states for high affinity adhesion versus cell-mediated cytotoxicity is 
unknown. 
The important role of CR3 in human innate and microbial defences is highlighted 
in disorders associated with this receptor. Leukocyte adhesion deficiency (LAD) 
syndrome is a condition where the patient suffers recurrent life-threatening 
infections due to impaired transendothelial emigration, the result of impaired 
leukocyte adhesion and phagocytosis. This condition occurs because of 
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mutations in the ß-subunit CD 18, which affects the expression of all ß2 integrins. 
CR3 also has a role in apoptosis, as C113-deficient mice display a significant 
delay in the apoptosis of extravasated neutrophils. 
Some integrin ligands such as fibrinogen, vitronectin and fibronectin, contain an 
Arg-Gly-Asp (RGD) motif that is thought to be important for receptor binding. 
Small RGD-containing peptides can readily gain access to the ligand-binding 
region, and the presentation of this motif on a ß-turn has been linked to the 
specificity of integrin receptors. Cyclic peptides containing the RGD motif are 
known inhibitors of integrin receptors, and RGD-based antagonists inhibit 
tumour-induced angiogenesis and tumour growth. Further investigation revealed 
a family of potent and selective RGD-based peptides - called the S787 class of 
integrin antagonists-specific. for aVP3 integrin, which have marked anti-tumour 
and anti-angiogenic properties in tumour models (Buerkle, Pahernik et al. 2002). 
The involvement of CR3 and members of the integrin family that recognise the 
RGD motif in N. meningitidis will be examined in this study. 
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1.5.3 Mannose receptor 
The macrophage mannose receptor (MR) is a 175kD type I transmembrane 
glycoprotein that mediates the endocytosis and phagocytosis of micro-organisms 
via carbohydrates expressed on their surface, such as fucose, mannose and D-N- 
acetyl-glucosamine (Stahl, Rodman et at. 1978). Macrophage MR activity was 
initially identified in the liver and on alveolar macrophages (Stahl, Rodman et at. 
1978) and expression has since been shown on dendritic cells and most 
differentiated macrophages, including resident and elicited peritoneal 
macrophages (Stahl and Gordon 1982), monocyte-derived macrophages 
(Shepherd, Konish et al. 1985), bone marrow-derived macrophages (Shepherd, 
Campbell et al. 1982) and rat kupffer cells (Maynard and Baenziger 1987). 
Soluble receptor which maintains carbohydrate-binding function has also been 
detected in mouse serum (Martinez-Pomares, Mahoney et at. 1998). 
Structurally the receptor is composed of a cytoplasmic and a transmembrane 
domain, eight carbohydrate recognition domains (CRDs), a fibronectin type II- 
like repeat and a cysteine-rich domain. Ligands bind to the cysteine-rich domain 
and the CRDs, particularly CRDs4-8 (Taylor, Bezouska et al. 1992; Martinez- 
Pomares, Kosco-Vilbois et al. 1996). MR are involved in the phagocytosis of a 
range of bacteria, yeast and protozoa, including Al. tuberculosis (Schlesinger 
1994), K. pneumoniae (Kabha, Nissimov et al. 1995), P. aerruginosa (Speert, 
Wong et al. 1997), S. cerevisiae (Giamis, Lombard et al. 1993), C. albicans 
(Ezekowitz, Sastry et al. 1990) and Pneumocystis carninii (Ezekowitz, Williams 
et al. 1991). Production of cytokines, TNF-a, IL-6, IL-I and IL-12, following 
ligand binding has also been reported (Fraser and Ezekowitz 1998). It has been 
suggested that this receptor may be involved in antigen transport, by shuttling 
antigens from its cysteine-rich domain to lymphocytes present in the lymph 
nodes and spleen 
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As a PRR mannose receptors have a prominent role in host defence and 
molecular scavenging from plasma or extracellular medium. It can also 
recognise a variety of endogenous glycoproteins such as lysosomal glycosidases 
and proteases and tissue plasminogen activator that may associate the receptor in 
homeostasis (Pontow, Kery et al. 1992; Linehan, Martinez_Pomares et al. 2000). 
1.5.4 Toll-like receptors 
Toll-like receptors (TLRs) are members of the IL-1 receptor gene family that 
play a role in the host defence of organisms from Drosophila to plants. This 
high homology with Drosophila Toll receptors has led to them being named Toll- 
like receptors (Medzhitov, Preston Huriburt et al. 1997; Kopp and Medzhitov 
1999) of which there are ten members of this growing family of receptors (TLRs 
1-10). Regarded as PRRs, numerous studies have shown these receptors to be 
involved in innate immune defence systems, and are particularly associated with 
CD 14. As discussed above, CD 14 is a GPI-linked outer membrane proteins that 
lacks transmembrane and cytoplasmic domains, and can bind LPS but have no 
signal transducing ability thus requiring co-receptor(s) to fulfil this function; of 
which TLRs are an example. Molecules involved in TLR signalling cascades 
include MyD88, which serves as an adapter molecule, and binds to IL-1 receptor- 
associated (serine/threonine) kinase (IRAK), which in turn undergoes 
autophosphorylation and dissociates from the complex. IRAK then interacts with 
TNF-receptor associated factor 6 (TRAF6) and results in the activation of NFKB- 
inducing kinases (NIK) and IKB kinases (IKK); and it is IKK that phosphorlates 
IKcB that results in NFicB translocation to the nucleus where it is involved in 
activation of specific genes, inducing release of pro-inflammatory cytokines and 
immune activation (Kopp and Medzhitov 1999). 
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In flies, Toll is activated by a proteolytically cleaved form of a secreted ligand, 
known as Spätzle (Morisato and Anderson 194), but mammalian TLRs are orphan 
molecules and it is not yet known whether they bind molecules directly or 
require activation from molecules similar to Spätzle; Smiley et al (Smiley, King 
et al. 2001) recently suggested that that fibronectin might function as a Spätzle 
homolgue in higher eukaryotes . 
TLRs appear to provide protection against invading pathogens, such as gram- 
positive and gram-negative bacteria and yeast, of which TLR2 and TLR4 have 
been studied most, but the roles of these two TLRs in LPS responsiveness in vivo 
and in vitro has caused some controversy. Studies using TLR2 and TLR4 
knockout mice to investigate LPS responsiveness have suggested that TLR2-'- 
mice responded normally to Salmonella and Escheric/tia LPS but TLR4"'" were 
unresponsive (Tapping, Akashi et al. 2000). MD2, a protein bound to TLR4 that 
facilitates LPS responsiveness, and TLR4 are thought to be in close proximity to 
CD14 (Jiang, Akashi et al. 2000). E. coli LPS, which depends on TLR4 for 
signalling, and P. gingivalis LPS, a TLR2 agonist, both bind to CD 14 but on 
distinctive sites (Cunningham, J. et al. 1999). Recent work by Pridmore and 
Wylie et al (Pridmore, Wylie et al. 2001) using N. meningitidis observed that 
activation of signalling pathways occured via TLR4/MD2 and CD14, but results 
using an LPS-deficient mutant showed that the organisms elicited biological 
responses via TLR2 and not TLR4/MD2, implying that other outer membrane 
components of the bacteria could induce signalling activity. Also TLR4- 
mediated NFKB activation by LPS is enhanced by sCD 14 (Chow, Young et at. 
1999). The role of CD 14 in Neisseria recognition will be discussed in more 
detail. 
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1.6 Class A Scavenger receptor 
1.6.1 Introduction 
Scavenger receptors (SRs) were first discovered in 1979 when studies examining 
the mechanism by which cholesterol from lipoproteins (LDL) were able to 
accumulate in macrophages (Goldstein, Ho et al. 1979). Studies have shown that 
scavenger receptors are involved in cholesterol deposition on the arterial wall, as 
is the case in the formation of atherolsclerotic plaques, as the excessive 
internalisation of modified LDL, via SR, converts macrophages to lipid-rich 
foam cells which form fatty streaks and atherolsclerotic lesions (Brown and 
Goldstein 1983). Scavenger receptors are multidomained transmembrane 
glycoproteins that are defined by their ability to recognize and bind a broad 
range of polyanionic macromolecules, including modified (not native) LDLs. No 
single domain is common to all members of this family of receptors, but they 
share the ability to bind an extensive and varied range of ligands. Macrophages, 
dendritic cells, endothelial and smooth muscle cells have all been shown to 
express SRs. The receptor present on microglia also binds ß-amyloid peptides 
and may cause the onset of Alzheimer's disease (Christie, Freeman et al. 1996; 
el-Khoury, Hickman et al. 1996). Human families have been identified in which 
some members display extensive collections of cholesterol under the skin, 
producing a yellow discolouration (xanthelasmas and planar xanthomata), and 
have a4 to 7-fold increase in Class A Scavenger receptor (SR-A) expression. 
Macrophage SR-A (MSR-A) play important roles in the non-inflammatory 
clearance and degradation of endotoxic lipids (Hampton, Golenbock et al. 1991), 
resulting in the non- inflammatory removal of LPS from the body (Haworth, Platt 
et al. 1997). Studies using SR-A-1- mice have demonstrated that these animals 
become hypersensitive to endotoxin, and exhibit an increased susceptibility to 
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invasion by bacteria such as Listeria monocytogenes (Suzuki, Kurihara et al. 
1997; Peiser, Gough et al. 2000; Thomas, Li et al. 2000). 
As a multiligand receptor, MSR-A have been implicated in a number of 
macrophage-associated processes such as phagocytosis of microbes, apoptosis 
(Platt, Suzuki et al. 1996; Terpstra and van_Berkel 2000), clearance and 
detoxification of microbial products; as well as diseases such as arteriosclerosis, 
Alzheimer's disease and other CNS disorders (Kodama, Freeman et al. 1990; 
Matsumoto, Naito et al. 1990; Naito, Kodama et al. 1991; el_Khoury, Hickman et 
al. 1996; Paresce, Ghosh et al. 1996). 
1.6.2 Structure and expression of SRA 
Class A macrophage scavenger receptors (MSR-A) are homotrimeric 
multidomained molecules that comprise types I and II, a non-functional splice 
variant III, and a more distant receptor known as MARCO (Gough, Greaves et al. 
1998). A single gene encodes types I and II receptors (SR-Al, SR-All) but 
generates the two forms through alternative mRNA splicing (Freeman, Ashkenas 
et al. 1990; Kodama, Freeman et al. 1990). 
Types I and II SR-A comprise six domains, of which I-V are shared by the two 
receptor types, whereas domain VI is restricted to the Type I receptor. Murine 
type I is 1457bp in length and encodes a protein of 454 amino acid residues, 
whereas the 4kb transcript of type II receptor cDNA encodes a 350 amino acid 
molecule. The two sequences diverge at residue 348, at which point the type II 
cDNA encodes 3 additional amino acids to complete the 6 amino acid C-terminal 
domain, and a long 3' UTR follows these 9 nucleotides. 
The 6 domains that make up SR-A are as follows: 
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Domain I (residues 1-51 of murine sequence) comprises the SR-A cytoplasmic 
tail that contains the N-terminal part of the polypeptide, which orientates the 
protein as a type II transmembrane molecule. Typical motifs that are present in 
other endocytic receptors are notably absent from the cytoplasmic tail. Of the 
three conserved potential phosphorylation sites, two contain the consensus motif 
for protein kinase C and one for calmodulin-dependant protein kinase II. There 
is species divergence in the N-terminal region of the cytoplasmic tail, this 
implies that it does not play a critical role in receptor-mediated endocytosis. 
Domain 11 is the transmembrane domain (26-28 hydrophobic residues) and 
contains a conserved proline residue at position 67, which may affect the packing 
of the trimers in the membrane. 
Domain III is the spacer domain and has 2 of the seven potential N-linked 
glycosylation sites. Domain IV forms a a-helical coiled coil structure on the 
basis of 23 heptad repeats, and has been strongly implicated in trimer assembly 
during SR-A biosynthesis (Ashkenas, Penman et al. 1993). Analyses of 
recombinant mutants of human SR-A have established that the seven-residue 
sequence Ile173 - Ser'79 is essential for receptor oligomerisation, and the 
remaining five sites for N-linked glycosylation are located in this domain (Frank, 
Lustig et al. 2000). Intracellular dissociation of endocytosed ligands and 
recycling of the receptor are thought to be due to a pH-dependent conformational 
change within this domain. 
Domain V, the collagenous domain, mediates the binding of ligands, including 
modified lipoprotein such as acetylated and oxidised LDL (ac-/ox-LDL) (Doi, 
Higashino et al. 1993). Both SR-Al and SR-All express uninterrupted Gly-X-Y 
(where X or Y is any residue) tripeptide repeats - 23 (human) or 24 (bovine, 
murine, rabbit) - which form the collagenous triplex helix. The majority of these 
residues are believed to be neutral or positively charged at physiological pH with 
clusters of positively charged residues highly conserved across species 
(Ashkenas, Penman et al. 1993). 
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Within this collagenous domain is a cluster of five lysine residues, which are 
highly conserved among animal species. Binding studies on a series of point 
mutation and truncation receptors indicates this region is essential for mediating 
the specific binding and internalisation of chemically modified lipoproteins 
(acetylated and oxidized LDL) (Kodama, Freeman et al. 1990; Matsumoto, Naito 
et al. 1990; Rohrer, Freeman et al. 1990; Naito, Kodama et al. 1991). 
These unpaired lysine residues at the outer edge of the helix would be available 
for intermolecular interactions with negatively charged ligands, such as Poly I 
and G, which can both block the ligand-binding site by forming quadraplexes on 
the surface of the receptor, with the stereospecific position of the phosphate 
groups together generate a negative charge that is complimentary to this binding 
site (Yamamoto, Nishimura et al. 1997). In addition to LDLs, other ligands 
include the lipid A domain of LPS, LTA, some sulphated polysaccharides 
(fucoidan, dextran sulphate) and some polynucleotides (Poly I and Poly G, but 
not Poly C or A) (Brown, Basu et al. 1980). 
Studies using truncation and point mutation constructs have revealed that the 
carboxyl terminal 22 amino acids contain the site of acLDL recognition. 
Mutation of Lys337 of the bovine protein abolished all acLDL binding (Doi, 
Higashino et al. 1993). Although studies using the collagenous domain of the 
rabbit receptor indicated that residues distinct from the 22 amino acids also 
affect binding of modified lipoprotein (Andersson and Freeman 1998): the fact 
that these studies were performed at different temperatures (37°C and/or 4°C) 
may explain these differences. Ligand recognition appears to require complex 
conformational interactions independent of the terminal collagenous sequence, 
which may explain the failure of short peptide models to mimic the properties of 
the entire domain (Mielewczyk, Breslauer et al. 1996). 
CR ,A ýv w 11 , rPý Perýtýr 
;ý-, IPfine-o by llý in V.! CR ,A iI c Kw-- Vs trwinrýtPýi ('_ 
terminal domain of seventeen (human) or six (bovine and murine) residues. In 
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contrast, the type I receptor contains a hinge (Via; 7 amino acids) and a cysteine 
rich domain (SRCR - VIb 101 amino acid residues) at the C-terminus. No clear 
role has been assigned to this domain and its function remains obscure, but as a 
structural motif it has been highly conserved across a vide range of species and 
is found in an increasing number of proteins, including other immune system 
proteins such as CD5 and CD6 (Freeman, Ashkenas et al. 1990). No NMR 
spectroscopy or crystallographic data are available for either Type I or 11 SR-A, 
but electron microscopy and biophysical methods have reported the presence of 
covalent structures that resemble those predicted from the primary amino acid 
sequence. 
Domains IV and V are joined by a flexible hinge with a variable angle between 
the two. When most extended the receptor resembles the structure predicted 
from the primary sequence, but at physiological pH the structure is more compact 
with the collagen domain bent back onto the coiled coil. The functional 
significance of these alternative forms is unclear. A highly flexible hinge 
appears to join the fibrous domains which allow the receptors a fair degree of 
movement as the angle ranges between 0- 180°. 
1.6.3 Molecular Structure 
The organisation of the genes for human and murine SR-A has been reported. 
Both are located on chromosome 8 and the coding regions are spread across 11 
exons; the first 8 encode sequences common to both types I and II receptors. 
Type I is generated through splicing of exons 8 to 10 and 11, the latter encodes 
the SRCR domain. Type 11 results from splicing of exon 8 to 9, which includes 
the C-terminal structure. A third splice variant was reported by Gough and 
colleagues (Gough, Greaves et al. 1998) and arises from the splicing of exon 8 
directly onto exon II which results in a novel shorter cysteine-rich region of 44 
amino acids. When this form of SR-A was transfected into CHO cells, it was not 
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expressed at the cell surface and was unable to internalise acLDL but inhibited 
the binding of lipoproteins to SRA-I and SRA-II by acting as a dominant 
negative receptor. 
1.6.4 Ligand-binding properties of SRA 
The feature of SRA that almost certainly underlines its contributions to a 
multitude of biological processes is its broad, high-affinity ligand binding 
property. This feature is shared with members of other classes of SRs and sets 
SRA apart from the majority of membrane receptors that can bind only a single 
ligand. Hence SRs have been termed "molecular flypaper". The range of ligands 
include non-physiological ones (e. g. acLDL), those derived from the 
environment (Silica particles, crocidolite asbestos) and those of microbial origin 
(LPS). Chemical modification that includes acetylation and oxidation convert 
LDL into a SRA ligand and abolish binding to the LDL receptor. A minimum 
modification of 15-20% of lysine residues of LDL is sufficient to facilitate 
binding to SRA. Another interesting and important feature of the binding 
properties of SRA is the phenomenon of "non-reciprocal cross-competition". 
That is the binding of ligand A to the receptor can be totally competed out with 
an excess of ligand B, and the reverse is not true. An example is the relationship 
of acLDL and oxLDL with SR-A: as competition of acLDL for SRA by oxLDL is 
absolute, but when the situation is reversed, inhibition is only partial. This 
implies the existence of distinct, though probably overlapping, binding sites on 
SRA for the two modified lipoproteins. The list of known ligands is long (Platt 
and Gordon 1998; Gough and Gordon 2000), but as work in this area continues it 
becomes apparent that more are being found. 
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1.6.5 Expression of SR-A 
The presence of SRA has been determined in many species, including murine 
(Hughes, Fraser et al. 1995) bovine (Naito, Kodama et al. 1991) and humans 
(Matsumoto, Naito et al. 1990) cells. Less information exists on the expression 
pattern of SRA-l/II, though co-expression was observed in atherosclerotic 
streaks, Kupffer cells and alveolar macrophages, but the specificity of 
antipeptide antibodies has been questioned (Honda, Akiyama et al. 1998). The 
murine monoclonal antibody 2F8 reacts to both receptors type I and II and 
staining is usually macrophage specific but is restricted to subpopulations in 
various organs; cellular expression may also be species-dependant (Matsumoto, 
Naito et al. 1990; Hughes, Fraser et al. 1995). 
There have been a number of studies that have demonstrated the association of 
SR-A with disease, particularly atherogenesis where the presence of SRA on 
macrophage foam cells are characteristic of lipid accumulation in human lesions 
(Naito, Suzuki et al. 1992) and murine and rabbit models (De_Winther, Gijbels et 
al. 2000). This study implicates SRA in the phagocytosis of N. rneningitidis by 
human macrophages. 
1.6.6 Conservation of SR-A 
Cloning of the cDNA encoding SR-A from four mammalian species revealed 
remarkable conservation of the species, with around 70% homology between 
amino acid sequences. Differences have been found in the properties of the 
receptor for each species, for example the Re form of LPS can inhibit high- 
affinity binding of acLDL to marine type I receptor, but had no such effect on 
the bovine receptor (Ashkenas, Penman et al. 1993); this may be due to the 
difference in sequence of particular Gly-X-Y triplets in the collagenous domain. 
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Due to our limited understanding of the evolution of SRA, conclusions of their 
evolutionary origin and relationships are unclear. 
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1.7 Membrane rafts 
Membrane rafts or lipid rafts are distinct sub-microscopic microdomains 
characteristically rich in cholesterol and sphingolipids (sphingomyelin and 
glycosphingolipids) (Thompson and Tillack 1985) and are present on the plasma 
and endosomal membrane of eukaryotic cells (Brown and Rose 1992; 
Fridriksson, Shipkova et al. 1999). These lipid-enriched regions are too small to 
view using optical microscopes, as they appear to range from 10-300nm in size, 
and have certain characteristics that differentiate them from the surrounding 
environment, including their low buoyant density and resistance to solubilisation 
by non-ionic detergents, such as Triton X-100, at 4°C. 
Detergent-insolubility is thought to be due to the tight packing of cholesterol 
with saturated fatty acid chains of sphingolipids, resulting in the formation of a 
liquid-ordered (lo) phase at low temperatures (Ahmed, Brown et at. 1997). In 
contrast, the phospholipids in the surrounding cell membrane are detergent- 
soluble, as they lie in a more fluid, liquid-disordered state due to the presence of 
unsaturated, branched (kinked) fatty acid chains. It is these liquid-ordered 
regions present on the fluid lipid bilayers that are referred to as "lipid rafts" 
(Simons and Ikonen 1997). Based on biochemical characteristics, these 
distinctive raft microdomains are also referred to by a number of names 
including detergent-resistant membranes (DRMs), detergent-insoluble glycolipid- 
rich membranes and glycolipid-enriched membranes, but throughout this study 
the terms "lipid raft" or "membrane rafts" shall be used to refer to these 
structures. 
It may be erroneous to assume cell membranes are merely composed of "raft" or 
"non-raft" environments. Recently rafts have been further sub-divided into 
different types based on their resistance to solubility in non-ionic detergents, 
(Roper, Corbeil et al. 2000), and this may be reliant, to some degree, on the 
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detergent used. Furthermore, chemical disruption of actin cytoskeleton in 
epithelial cells was required to isolate a subset of lipid rafts containing CD44, 
which would have otherwise been missed by sucrose density gradient, suggesting 
that two distinct types of lipid rafts are present, dependent on their association to 
actin cytoskeleton of the cell (Oliferenko, Paiha et al. 1999). CD44 is a 
transmembrane receptor associated with ordered microenvironments in a number 
of different cell types is linked to actin cytoskeleton. 
In addition to lipids, it has been discovered that a number of molecules also 
cluster on lipid rafts. Yamada (Yamada 1955) assigned the name "caveolae 
intracellularis" to distinctive 50-70nm flask-shaped or omega-shaped 
invaginations present on the plasma membranes of a number of cell types, which 
have since been implicated in endocytosis and signal transduction. Caveolae are 
largely covered by a family of integral membrane proteins ranging in size from 
21-25-kDa called caveolins, of which there are three main isoforms of caveolin, 
caveolin-1, -2 and -3 (Scherer, Tang et al. 1995). Caveolins play an essential 
role in the structural formation of caveolae, (Rothberg, Heuser et al. 1992; Fra, 
Williamson et al. 1995) and their discovery greatly aided research in this field, as 
caveolin expression was the first marker protein used to correlate the presence of 
caveolae on cells (Rothberg, Heuser et al. 1992; Fra, Williamson et al. 1995; 
Smart, Ying et al. 1996). An important point is that lipid rafts are riot limited to 
caveolae, as rafts have been implicated in signal transduction processes on cells 
such as T cells and basophils, which notably lack distinct caveolae. 
Many proteins found on membrane rafts of mammalian cells are linked to 
saturated acyl chains (found particularly in sphingolipids), as it is probable that 
they prefer a more ordered environment. Two ways in which proteins are linked 
to saturated acyl chains on mammalian cells are through acylation with myristate 
or palmitate (Brown and London 1997) or by attachment to a 
glycosylphosphatidylinositol (GPI) anchor (McConville and Ferguson 1993). 
Proteins tethered to the membrane by their GPI-anchor are characteristically 
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found in rafts (Brown and Rose 1992), and the hydrophobic interactions between 
long saturated fatty acids hold these structures together on the cell (Schroeder, 
London et al. 1994). 
Cholesterol-depleting agents such as ß-cyclodextrin (ßCD), nystatin, filipin, 
lovastatin and cholesterol oxidase are all used to disrupt lipid rafts resulting in 
loss of distinct caveolae and causing GPI-linked proteins to disperse into the 
plasma membrane (Smart, Graf et al. 1999; Pralle, Keller et al. 2000). Use of 
cholesterol depleting agents to disrupt rafts is known to block a number of 
compartmentalised signalling pathways (Simons and Toomre 2000). Lipid rafts 
appear to have a variety of functions from membrane transport, transcytosis 
across epithelial monolayers to signal transduction and generating cell polarity. 
In terms of cell polarity, the transition from resting cells to polarised cells able 
to migrate to sites of infection, is a complex series of reactions that requires a 
high level of co-ordination of signalling molecules to ensure that cellular 
attachment and cell membrane extension take place at the front of the cell 
(lamella) and detachment and membrane retraction at the back (uropod). Recent 
studies have found that the distribution of lipids on the plasma membrane are 
essential for this process, and treatment of motile cells with cholesterol-depleting 
agents results in the inhibition of cellular polarisation and migration. This 
suggests that the presence of lipids normally associated with raft formation, 
which in turn are essential in signalling networks, may be important sites for the 
signal transduction events associated with cell polarisation and motility. Recent 
work by Gomez-Mouton and colleagues found that different types of rafts were 
situated at opposite ends of polarised migrating T-cells, with ganglioside GM3- 
enriched rafts concentrated at the lamella and GMI-enriched rafts at the back of 
the cell (Gomez-Mouton, Abad et al. 2001). 
Signal transducing family of proteins, Src-family kinases, are involved in the 
tyrosine phosphorylation of conserved sequences in the cytoplasmic domain of 
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cell surface receptors in a range of haematopoietic cells (Isakov 1997). Ligation 
or clustering of GPI-linked proteins can, in itself, induce transmembrane signal 
transduction which can be through Src-family kinase activation (Brown 1993; 
Zisch, D'Alessandri et al. 1995). As neither GPI-proteins nor Src-family kinases 
penetrate the cell membrane, precisely how these signals are transduced into the 
cell is unknown, but signal transducing Toll-like receptors have been associated 
with GPI-linked receptor. TNF receptor-] are also able to translocate to these 
microdomains on binding TNF-a, where the receptor associates with signalling 
complexes such as Serine/Threonine kinases, to form signalling complexes, as 
disruption of lipid rafts results in the TNF-a transferring its signal from inducing 
NFKB activation to upregulation of apoptotic signals (Legler, Micheau et at. 
2003). 
1.7.1 Rafts and disease 
The study of lipid rafts, though limited by current techniques, is potentially a 
useful way of examining how microbes enter host cells and survive or how lipid 
rafts alert the host to the presence of pathogenic organisms. Signalling networks 
affect the growth, differentiation, motility and adhesion of cells, and so up- 
regulation of signalling can result in a number of diseases. Rafts play an 
important role in signalling pathways, and have been implicated in a number of 
diseases including prion diseases, Alzheimer's disease and cancer. In the case of 
Alzheimer's disease the production of ß-amyloid plaques from precursor proteins 
has be shown to take place on lipid rafts, in a cholesterol-dependent manner 
(Ikezu, Trapp et al. 1998). 
Evasions of cytotoxic immune responses are a common characteristic of 
intracellular pathogenic organisms, as their route of entry into immune cells will 
ultimately determine their survival. Lipid rafts do not make 'up a large 
proportion of the cell membrane, but the dense collection of signalling molecules 
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prevalent in these structures has meant that a range of microbial pathogens 
specifically target lipid rafts as a favourable or preferential point of entry into 
host cells. Rafts can be viewed as "safe" points of entry for some pathogens but 
they also have the potential to trigger cytotoxic responses in host cells. Studies 
using cholesterol-disrupting agents have been found to block the internalisation 
of organisms through rafts. Bacteria, prions, viruses and parasites have all been 
associated with using lipid rafts to gain entry into immune cells, and may aid the 
intracellular survival of these organisms 
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1.8 Neisseria meningifidis 
1.8.1 Meningitis 
Meningitis is inflammation of the meninges, which comprise the three 
membranes that enclose the brain and spinal cord. It may involve the dura and 
lead to pachymeningitis or the pia/arachnoid to cause leptomeningitis. The latter 
is more common, and is generally referred to as meningitis (Strausbaugh). The 
brain and spinal cord are relatively well protected from bacteria, but once the 
microbes have penetrated the host's defences the infection can spread rapidly via 
CSF pathways. So many microbes that ordinarily pose a threat elsewhere in the 
body can cause serious and fatal infections of the CNS (Strausbaugh; McLeod 
Griffis 1995). 
Acute pyogenic meningitis is caused by infection of the sub-arachnoid space, the 
most common organisms being N. meningilydis (Nm), S. pneumoniae and 
Haemophilus - with E. coli being common in infants. Meningitis may also occur 
as a result of local spread from infection in the bones of the skull, or after 
compound fracture of the skull. A number of pathological processes can also 
results in the onset of meningitis including: cyst/haemorrhage rupture into the 
subarachnoid space and/or tumourous involvement of the meninges. The 
extension of inflammation from the bones in the skull almost always results in 
acute inflammation of the dura. Suppuration occurs between the bone and dura 
resulting in the formation of an extradural abscess. The pus can spread widely 
over the cerebral hemisphere and the infection may spread through the dura to 
form a sub-dural abscess (Strausbaugh; Stephens and Farley 1991). Diagnosis 
can often be established by examining the CSF, and principal findings in the CSF 
are inflammatory cells, proteinacious exudates (and depending on the cause, 
reduction in glucose concentration) or viable microbes. Changes in CSF include 
it becoming turbid or becoming distinctly purulent, with a marked increase in the 
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number of neutrophils (Stephens and Farley 1991; Brandtzaeg 1995). Bacteria, 
fungi, viruses, protozoa and helminths can all cause this disease, and other more 
common bacteria that can cause meningitis include Listeria Ino, nocytogenes, 
Streptococcus agalactiae, aerobic gram-negative bacilli such as E. coli), S. 
aureus and M. tuberculosis. 
1.8.2 N. meningitidis 
The Neisseria species are non-motile, non-spore forming gram-negative 
diplococci that have a characteristic kidney/coffee bean shape. Size can vary 
from 0.6 - 1.5µm, this can depend on the species, the age of the culture and the 
source of the isolate. They also have specific growth requirements, as the 
optimum temperature is between 35 and 37°C. All species are aerobes and 
produce catalase (except N. elongata), and cytochrome oxidase (Pujol 1997). 
Only N. gonorrhoeae and N. meningitidis are primary pathogens that only infect 
humans. Although both N. gonorrhoeae and N. nieningitidis can both be isolated 
from asymptomatic individuals, N. gonorr"hoeae (Ng) is always considered to be 
a disease producer, whereas N. meningitidis (Nmn) is commonly isolated from the 
throat or nasopharynx of healthy individuals as well as from patients with 
meningococcal disease (MCD) (Pujol 1997; Stites, Terr et al. 1997). 
Meningococci colonise the nasopharynx and gain entry into the bloodstream, 
where they cause meningococcaemia or fulminant septicaemia, and/or progress to 
the CSF to cause meningitis (McLeod Griffis 1995). 
Humans are the major reservoir for meningococci, and transmission between 
individuals occurs as a result of direct contact with respiratory secretions or by 
aerosol droplets that are contaminated with the organism. Meningococci are 
susceptible to drying and do not survive long in airborne droplets; person-to- 
person transmission requires frequent or close contact. MCD is still a relatively 
rare disease between I and 12 cases of invasive MCD occur per 100,000 of 
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morbidity, with a peak incidence of children between 6 months to 2 years of age 
(Riedo, Plikaytis et at. 1995). Up to approximately 10% of healthy individuals 
carry the organism in the nasopharynx at any one time, usually for between 6- 
9months; but this rises significantly in confined populations such as army 
barracks. (Riordan, Cartwright et al. 1998) 
N. meningitidis are subdivided into a number of serological groups depending on 
the chemical composition of capsular or cell wall antigens; such groups include 
A, B, C, D, X, Y, Z, W135. Worldwide five of these serogroups are responsible 
for causing the majority of MCD cases: A, B, C, W135 and Y. Serogroups B and 
C are most prevalent in industrialised countries, with over 50% of cases due to 
serogroup B, which as yet has no effective vaccine (Connolly and Noah 1999; 
Donaldson, Moores et al. 1999). Most epidemic and endemic cases of MCD are 
caused by strains of a limited number of genetically defined meningococcal 
clonal groups that are associated with high rates of disease once acquired. These 
include ET-35 (mostly serogroup B), ET-37 (mostly serogroup C, Y and W135), 
serogroup A clonal groups and the A4 cluster. Once in the population, these 
virulent clonal groups can both diversify and decay over time through immune 
selection, genetic recombination and mutation (Fell 1999), but the reduction of 
carriage rates and acquisition of carriage of circulating meningococcal clonal 
groups may be an important strategy in the development of meningococcal 
vaccines. Such genetic alterations are advantageous to the organisms, as the 
variation enables them to evade immune responses and go on to cause disease 
(Levin and Bull 1994; Zhu 2001). 
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1.8.3 Virulence determinants 
Pathogenesis of meningococcal infection is as yet unclear, but evidence suggests 
that N. meningitidis has developed mechanisms to avoid recognition by the 
immune system, including the presence of structures on the surface of the cell. 
Virulence determinants whose presence is essential for successful meningococcal 
invasion include outer membrane proteins, pili, and capsular polysaccharide and 
LPS, which are discussed in more detail below. 
1.8.3.1 Polysaccharide capsule 
Most meningococci are surrounded by an acidic and hydrophilic polysaccharide 
capsule that provides the surface charge and humid environment necessary for 
the survival of the MC in aerosol droplets, and the structural differences among 
these capsules account for serogroup specificity. The sialylation of bacterial cell 
membrane glycoconjugates prevent the assembly of the membrane attack 
complex (MAC) on the bacteria, thus aborting complement-mediated lysis. 
Capsule also prevents C3b attachment to the surface of the bacteria during 
incubation in non-immune serum (Capel, Groeneboer et at. 1978), which may be 
an important virulence determinant of N. meningitidis, and one of the 
contributing factors for the predominance of serogroup B disease in 
industrialised countries. 
The (a2-8)-linked polysialic acid capsule of serogroup B N. meningilidis is a 
major virulence factor since only capsulate organisms are recovered from the 
blood and CSF, whereas both capsulate and acapsulate organisms were recovered 
from the nasopharynx (Read, Zimmerli et al. 1996). Serogroups B, C, Y and W 
all possess capsules that are polymers of sialic acid. As the meningococcal 
capsule is involved in adhesion to target cells, modifications to the capsule can 
affect the transmissibility of the organisms. Capsule switching is thought to be. a 
result of allelic replacement of the SiaD gene through recombination and 
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transformation. SiaD is responsible for sialic acid capsule specificity. A recent 
example of this would be the outbreak of W135 MCD in returning Hajj pilgrims 
in 2000 (Popovic 2000; Taha 2000). The organisms isolated were all identical 
and belonged to the most common ST (sequence type) of ET-37, ST-11; the 
origin of the clone was unknown. Pilgrims were vaccinated against serogroup A 
and C, but the extremely high numbers of people congregating at the Hajj 
allowed the epidemic clonal expansion within the ET37 clonal complex. This 
outbreak may have been a result of a capsule switch from C to W135 or as a 
result of an old clone of ET-37. The extremely rapid spread of this new variant 
to both household and non-household members suggest a new member of a 
virulent clone (Taha 2000). Vaccination campaigns against serogroup A and C 
may give rise to specific immune responses against serogroup C, so W135 
organisms may in fact represent genetic variants (capsule escape switch) of a 
virulent serogroup C ET37 clone. The horizontal exchange, DNA repeats and 
recombination of Neisseria allows genome shuffling within a population that 
leads to rapid phenotypic diversity or fitness, which may account for the 
apparent success of this human-based organism. 
Studies using serogroup B Nm. have shown that the polysaccharide capsule non- 
specifically inhibits macrophage bactericidal activity against meningococci, and 
Read et al observed that capsule presence prevented bacterial binding to 
macrophages, and also appears to delay phagolysosome formation (Read, 
Zimmerli et al. 1996). Though the serum of adults carries low levels of anti-B- 
polysaccharide IgM, the antibodies are not particularly bactericidal and are of 
low avidity, so their presence probably does not contribute a great deal to the 
immunity against group B meningococci (Griffiss, Brandt et al. 1984). 
Serogroup B capsule is poorly immunogenic in humans, as human complement 
appears to direct its bactericidal abilities at non-capsulate antigens; but as the 
capsule is the antigen common to all group B meningococci work continues on 
developing a polysaccharide-based vaccine, as it is essentially the only antigenic 
structure shared by all serogroup B meningococci (Fusco, Michon et al. 1997). 
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1.8.3.2 Lipopolysaccharide 
Lipopolysaccharide (LPS), or endotoxin, is present in the outer membrane of 
gram-negative bacteria and is a major inflammation-inducing component of the 
bacterial cells. An important characteristic is that unlike exotoxins, the toxic 
symptoms of LPS are not caused by its direct action on the phagocyte, but 
instead the macrophages respond to LPS by secreting cytokines such as TNF-a, 
IL-I, 8,6,10, IFN-a/-ß, TGF-ß and CSFs, which in turn induce the 
inflammatory responses that may ultimately lead to the destruction of bacteria 
(Beaty, Franklin et al. 1994). Early studies showed that the LPS is a major toxic 
agent, and once it has entered the circulation, the range of inflammatory 
responses that it activates can ultimately lead to organ failure and death. High 
levels of endotoxin were found in lethal cases with irreversible septic shock and 
further studies confirmed that increased levels of circulatory endotoxin were 
associated with an increase in fatality rate (Brandtzaeg, Kierulf et al. 1989). 
LPS can affect macrophage physiology in a number of ways, including provoking 
an increase in glucose, oxygen consumption, cell size and membrane ruffling. It 
also increases the synthesis of a number of cellular and secreted proteins/lipids, 
whilst others are reduced. The ability of macrophages to destroy bacteria and 
tumour cells is also enhanced, although their motility is diminished. Structurally 
meningococcal LPS is an amphipathic glycolipid, and is composed of a lipid A 
core structure that is embedded in the outer membrane of the bacterium, and 
covalently linked to the lipid A is a polysaccharide structure that extends out 
from the surface of the cell. The hydrophobic lipid A region is highly conserved 
within families of bacteria, and is referred to as the endotoxic centre. The 
segment of polysaccharide furthest away from the lipid A, known as the 0- 
antigen, are variable, immunodominant and confer serological specificity to the 
bacteria. Between the 0-antigen and the lipid A is the core region, and this is 
more conserved than the O-antigen. Neisseria LPS, often referred to as 
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lipooligosaccharide (LOS), is relatively small in size compared to E. coli or 
Salmonella LPS and lacks O-antigen altogether. 
An important aspect of bacterial protection against immune responses is the 
sialylation of LOS, which can protect Neisseria from complement-mediated 
serum lysis and phagocytosis by neutrophils (Smith, Parsons et al. 1995; Ram, 
Mackinnon et al. 1999). Sialylation is catalysed by an a-2,3-sialyltransferase 
(Lst) using both endogenous and exogenous sources of 5'-cytidinemonophospho- 
N-acetylneuraminic acid (CMP-NANA) to monosialylate the terminal galactose 
of LOS (Mandrell, Lesse et al. 1990; Gilbert, Cunningham et al. 1997). The 
extent of serum resistance conferred by meningococcal LPS sialylation varies 
between different serogroups and at different stages of meningococcal disease 
pathogenesis (Kahler, Martin et al. 1998; Vogel, Claus et al. 1999). 
Previous work has shown that free LPS binds poorly to macrophages, but found 
that LPS-plasma protein complexes bind efficiently via specific receptors. Such 
serum proteins include lipopolysaccharide binding protein (LBP), O-Ag specific 
antibodies, complement, HDL albumin and septin. LBP functions both as a 
bacterial opsonin and a cofactor that increases the efficiency of LPS stimulation 
of macrophages (Schumann, Leong et al. 1990). This 60kD glycoprotein is 
synthesized in hepatocytes as a 50kD single chain polypeptide, and binds 
specifically to the lipid A component of LPS. Even though LBP is an acute- 
phase reactant, there is enough present in normal plasma to function as an early 
defence mechanism during infection. 
The binding of LPS/LBP complexes to CD 14 receptors, which lack 
transmembrane or cytoplasmic regions, and are mobile in the plane of the 
membrane, results in cellular activation through CD14 or LPS neutralisation 
through high-density lipoproteins (HDL). Kinetics of these reactions have 
suggested that LPS/LBP complexes bind to CD14 before LPS is transferred to 
HDL; suggesting that cellular activation by immune cells occurs before the LPS 
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is neutralised as a mechanism of avoiding over stimulation of the immune system 
(Frey, Miller et al. 1992). 
LPS is also a known ligand for a number of macrophage receptors, including 
CR3, Toll-like receptors and scavenger receptors. Type A scavenger receptors 
(SR-A) bind to a wide range of polyanionic ligands such the tetra- 
acyldisaccharide lipid A precursor lipid IVA, modified lipoproteins and 
lipoteichoic acid of gram-positive bacteria. Irr vivo studies using mice lacking 
SR-A were found to be more susceptible to endotoxic shock and produced more 
TNF-a and IL-6 in response to LPS. TNF-a activity was also suppressed using 
antibodies, and this was found to reduce LPS-induced mortality in the mice. SR- 
A is therefore considered to have a protective role in host defences by 
scavenging LPS and reducing the release of pro-inflammatory cytokines 
(Haworth, Platt et al. 1997). 
Nuclear factor-KB (NFKB) is a heterodimeric transcription factor formed by 
dimerization of proteins from the Rel famiy of proteins, and is thought to play a 
central role in immune and inflammatory responses by regulating genes that 
encode pro-inflammatory cytokines, adhesion molecules, growth factors, 
chemokines and inducible nitric oxide synthase (iNOS) (Hobbs and Moncada 
1999; Karin and Ben-Neriah 2000). NFxB comprises 50kD and 65kD structures 
bound to the cystolic protein IKB. Once the cell is activated IKB is 
phosphorylated, NFKB dissociates and moves to the nucleus, where it binds 
upstream of specific genes. 
LPS alters the distribution of microfilaments and microtubules of macrophages, 
resulting in reduced phagocytic activity, suggesting that LPS may be suppressing 
phagocytosis via its effects on the cell cytoskeletal network. LPS suppression of 
phagocytosis is not mediated by the induction of cytokines, and was observed 
when LPS was administered in vivo (Wonduly, Ghaffar et al. 1996). 
55 
The development of the first viable LPS-deficient mutant of N. meningitidis may 
help in illustrating the role of LPS in meningococcal-cell interactions in more 
detail, as even though this mutant lacks LPS, the capsule and PorA expression 
appear to remain intact. 
1.8.4 Possible mechanisms for meningeal invasion 
Meningeal invasion usually takes place as a result of nasopharyngeal 
colonisation followed by bloodstream invasion, but exactly how these pathogenic 
microbes gain access from the bloodstream to the meninges and subarachnoid 
space is not known. The site of entry could involve the choroid plexus epithelium 
or the vascular endothelium. 
It is unlikely that leukocytes are used to gain entry into the subarachnoid space, 
as a large number of bacteria may be present in the CSF before leukocyte 
migration commences. In order to cross the brain barriers N. meningilidis must 
cross a monolayer of endothelial or epithelial cell tight junctions, by either 
moving between the tight junctions (paracellular route) or by intracellular 
transport (transcellular route). Further understanding of these mechanisms might 
allow us to understand the cause for the neurotropism of meningeal pathogens, 
including N. nteningilidis, and elucidate the role of microbial factors e. g. pill, 
capsule, OMP and LPS; as these factors may themselves mediate brain barrier 
opening or endothelial cell entry. 
Unfortunately animal models that can adequately represent individual 
components of the blood brain barriers are not available, as a result of this 
indirect evidence is used to suggest that both N. meningilidis and S. pnetunoniae 
pass through the monolayer by transcytosis. Evidence for this hypothesis 
comprises in vivo studies that have shown N. meningitidis localized inside 
endothelial cells of the brain of an infected patient, and in vitro meningococci 
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have been observed crossing the monolayer of tight junction-forming cells by 
transcytosis, without altering the organization of tight junctions. The implication 
being that once the organisms are internalized, they cross the cytoplasm and are 
exocytosed at the other side. In vitro studies using S. pneumoniae found that 
only organisms that express an adhesin, choline-binding protein, are internalized 
and transcytose through endothelial cells before exiting at the basolateral 
surface. 
There are few bacterial pathogens able to invade the brain, due to the 
physiological barriers between the CNS and bloodstream. Two main structures 
also act as brain barriers, the blood brain barrier (BBB) and the blood- 
cerebrospinal fluid barrier (BCSFB), make up one of the tightest barriers in the 
body. The exact site of entry into the CSF is unknown for most organisms, but 
studies using N. meningitidis have shown that they come into direct contact with 
the BBB, and judging by the frequency and efficiency that meningococci cross 
the blood brain barriers, meningococci appear to have developed highly elaborate 
methods to overcome these physical obstacles. A favoured hypothesis is that 
meningococcal structures primarily required to interact with mucosal cells, may 
not have meant to be of use in meningeal invasion, and may be an unlucky 
accident (Meyer 1999; Pollard and Frasch 2001). 
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1.9 Aims of thesis 
The aim of this thesis was to investigate the contribution of a number of cell 
surface receptors, both opsonic and non-opsonic, expressed by monocytes and/or 
macrophages, and study roles these receptors may play in the adherence and 
uptake of serogroup B N. meningitidis, as well as events following ingestion. 
Model systems were established to examine the contribution of a number of 
pattern recognition receptors in theses interactions, including CR3, CD 14, SR-A, 
PAF receptor, MR. 
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Chapter 2 
Methods and Materials 
2.1 Materials 
2.1.1 General chemicals 
Chemicals were of analytical grade and obtained from either BDH Merck 
(Dorset, UK) or Sigma (Dorset, UK). 
2.1.2 Human Cell Lines 
Cell lines were obtained from stocks kept at the University of Sheffield, and had 
been originally from ATCC (American Type Culture Collection) or ECACC 
(European Collection of Animal Cell Cultures). THP-1, human pre-monocytic 
leukaemia cells (Tsuchiya, 1980), HeLa (ECACC 85060701) cervical epithelial 
cell line and J774A. 1 a macrophage-like mouse cell line were all used. 
2.1.3 Cell Culture Reagents 
RPMI 1640 and Dulbecco's modified Eagle media (DMEM) were obtained from 
GibcoBRL (Paisley, UK), foetal bovine (calf) serum (FCS) from Autogen 
Bioclear (Wiltshire, UK), L-glutamine and phorbol 12-myristate 13-acetate 
(PMA) was from Sigma. Heat-inactivated FCS was made by incubating FCS for 
30 minutes at 56°C before cooling and centrifuging at 3000g to remove fibrin. 
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2.1.4 Other reagents 
Dil-labelled acetylated LDL (DiI-acLDL) and DAPI (4' , 6-diamidino-2- 
phenylindole dihydrochloride) were obtained from Molecular Probes 
(Cambridge, UK). Platelet activating factor receptor antagonist (PAFRa) was 
from Calbiochem (UK). ß-cyclodextrin, nystatin and phosphatidylinositol- 
specific phospholipase C (PIPLC), bovine-a-D-mannosylated-PITC-albumin 
(mBSA), RCDS and RGES containing peptides, poly-iniosinic acid (poly I), - 
guanylinic (Poly G), -cytidylic (Poly C) and -adenylic acid (Poly A), saponin 
(Quillaja bark), trypan blue (0.4%), Lidocaine-HCI and Triton X-100 (t- 
octylphenoxypolyethoxyethanol) were all obtained from Sigma (Dorset, UK). 
Cytokine ELISA kit was from Pharmingen. 
2.1.5 Solutions 
Phosphate buffered saline (PBS) was obtained from Oxoid and tablets were made 
up according to manufacturers instructions and autoclaved prior to use. PBS: 
137mM NaCl, 8.1 mM Na2HPO422.7mM HCI and 1.5mM KH2PO4 at pH 7.3. 
Distilled water (dH2O) was purified using the Millipore-Ro6 plus system and 
autoclaved prior to use. Paraformaldehyde (pfa) was obtained from BDH Merck 
(Dorset, UK): 4% (w/v) pfa was made up in distilled water, buffered to pH 7.2 
using IN sodium hydroxide, and passed through a 0.22µm filter prior to use. To 
avoid using trypsin where possible, a detachment buffer used to remove adherent 
macrophages was made up 10mM EDTA and 10mM Lidocaine-HCI in PBS 
buffered to p1--17.3 and passed through a 0.22µm filter. 
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2.1.6 Antibodies 
The table below lists some of the antibodies used: 
Antigen Species Clone Conjugation Source 
Mouse IgG sheep FITC Sigma (Dorset, UK) 
Mouse IgG sheep Cy3 Sigma 
Rabbit IgG goat FITC Sigma 
Human IgG (Fc goat FITC Sigma 
specific) 
Anti-human CDI lb mouse 2LMPI9c DAKO 
IgG l (Cambdridgeshire, 
UK) 
IgGI (negative mouse DAK-G01 DAKO 
control) 
Anti-human CD14 mouse MY4 Beckman Coulter 
IgG2b 
Anti-human CD14 mouse MY4 FITC Beckman Coulter 
IgG2b 
IgG2b (negative mouse DAK-G09 DAKO 
control) 
Anti-serogroup B rabbit Difco (Detroit, USA) 
N. meningilidis 
Anti-human LAMP-1 mouse H4A3 
IgG I 
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2.2 Mammalian cells 
2.2.1 General growth conditions for mammalian cell culture 
MDMs and cell lines were all maintained at 37°C in 5% CO2 and a 95% humidity 
incubator. All growth culture media was supplemented with 10% heat- 
inactivated FCS (HIFCS); 2mM L-glutamine was also added to RPMI 1640. 
Primary macrophages were detached by 10min incubation in detachment buffer 
(see above) followed by vigorous pipetting (Rabinovitch and de Stefano 1976). 
HeLa cell lines were detached by incubating with 5mM EDTA and 0.125% (w/v) 
trypsin in PBS for 5 min at room temperature. 
2.2.2 Isolation and culture of human monocytes from peripheral blood 
monocytes 
Peripheral blood mononuclear cells (PBMC) were obtained from apparently 
healthy volunteers and isolated using Ficoll-Paque (Pharmacia, Amersham) by 
density sedimentation at 1500g for 20min at 21°C (Falcon 6/300). Cells were 
washed three times in PBS in order to remove platelets and red blood cells and 
resuspended in enriched RPMI 1640 culture media, and plated on glass 
coverslips in 24-well tissue culture plates (Costar) at a density of Ix 106 
cells/ml. Non-adherent cells, such as lymphocytes, were separated by allowing 
cells to adhere to tissue culture plates for one hour at 37°C and subsequently 
washing wells three times with warm culture media. Cells were cultivated for a 
further 24h at 37°C in enriched RPMI 1640 before washing and incubating in 
fresh media. 
Monocytes differentiated into mature macrophages, gaining a distinctive 
flattened, adherent phenotype and becoming terminally differentiated after 6-7 
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days in culture: 8-12day old cells were used throughout this study. Previous 
studies have indicated this type of protocol isolates over 95% of the pre- 
macrophage population (Montaner, 1996). Isolation and culture of all blood 
monocytes used in this study were carried out by staff in the tissue culture 
laboratory, due to the high volume of cells required by researchers in the 
department. 
2.2.3 Cell lines 
THP-1 are a human pre-monocytic leukaemia cell line (Tsuchiya 1980) and are 
semi-adherent cell line. Cells were plated onto glass coverslips on 24-well tissue 
culture plates at a density of Ix 106 cells/ml in enriched RPMI 1640 media and 
used the following day. Incubation of 1x 105 cells/ml in the presence of 25nM 
PMA (0.05% DMSO) over 7 days, with media changed every 2 days, resulted in 
differentiation to adherent macrophage-like cells (Hassall 1992). 
HeLa cells are a cervical epithelial cell line and J774A. 1 cells, which are a 
macrophage-like mouse cell line derived from a tumour in female BALB/c 
mouse, were used. Both cell lines were grown and maintained in enriched 
DMEM. All cell lines were grown in 25ml tissue culture flasks (NUNC), and 
were routinely passaged between 1: 5 and 1: 10 every three days. 
2.2.4 Transfection of HeLa cells 
HeLa cells were passaged every 3days in DMEM supplemented with antibiotics. 
Cells were seeded down at 3.5 x 104 cells/ml in 24-well tissue culture plates for 
24h before achieving -80% confluency, and were underwent transient 
transfection using a Superfect kit (Qiagen) according to manufacturers 
instructions. Generation of HeLa cell CD14 transfectants has been previously 
63 
described (Pridmore, Wylie et al. 2001). Wild-type HeLa cells and HeLa cells 
transfected with the vector were used as controls. The cells were kept in DMEM 
and 10% heat-inactivated FBS and were propagated by seeding down 3.5 x 105 
cells/ml in 24-well culture plates and passaged using EDTA treatment. 
Immediately before exposure to bacteria the confluent HeLa cells were washed 3 
times and fresh culture media was added. Plasmids pCDM8-CD14 was a gift 
from Prof B. Seed (Molecular Biology, Harvard Medical School, Boston) and 
vector pcDNA3 was purchased from Invitrogen. (Simmons, Tan et al. 1989). 
2.2.5 Selection of high levels of CD14 expression in HeLa cells 
Transfected cells were incubated with FITC-conjugated anti-human anti-CD 14 
monoclonal antibody and analysed using a fluorescent microscope to ensure that 
a high proportion of cells expressed mCD14. 
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2.3 Bacteria 
2.3.1 Bacterial strains 
Neisser"ia used throughout study are listed in the table below: 
Species Strain or 
acquisition no. 
Genotype Serogroup Immunotype 
N. meningitidis MC58 , B L3 
H44/76 2 B L3 
H44/76 
(pLAK33) 2 
LpxA mutant B - 
K454 B L3 
N. lactamica 10617 - 
N. animalis 10212 N462 - 
MC58 was isolated from a clinical case in UK (Virji, Kaughty et at. 1991) and 2 H44/76 was 
isolated in Norway 1976. (Holten 1979) 2 N. meningitidis H44/76 and pLAK33 were obtained 
from L. Steeghs at Laboratory of Vaccine Research (Bilthoven, Netherlands). 
2.3.2 Bacterial growth media 
H44/76 and LPS-deficient mutant were grown in Muller-Hinton broth, and 
remaining Neisseria species were cultivated in Tryptone Soya broth, both made 
up to manufacturers instructions. 
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2.3.3 Growth and maintenance of bacteria 
All Neisser-ia strains were maintained in liquid nitrogen, and once removed from 
storage were sub-cultured twice on chocolate or blood agar plates before 
transferring -8 colonies to liquid growth media and grown to mid-log phase at 
37°C, 5% C02 (v/v). Cultures required between 4 and 4.5h in this environment 
to reach optimum growth. Gentle shaking during incubation did not appear to 
have a detrimental affect on bacteria and resulted in significantly reduced 
incubation time, but both N. lactanrica and LPS-deficient mutant pLAK33 did 
not respond well to this method. Bacterial growth was measured using optical 
density at 620nm (Jenway 6105 spectrophotometer) and viability was determined 
by Miles and Misra method of colony counting throughout experiments (Miles 
and Misra, 1938). 
2.4 Methods 
2.4.1 Serum extraction from LCCD patient 
Following approval by the South Sheffield Research Ethics Committee, my 
supervisor (Prof. RC Read) would periodically draw 50m1 aliquots of blood from 
a female patient with absolute C7-deficiency who presented to the Royal 
Hallamshire Hospital in 1997 with serogroup B meningococcal disease. Blood 
was centrifuged at 3000 xg for 10min, and serum was harvested and stored at 
-70°C in 0.5m1 aliquots. In order to establish that serum contained C3 and lgG, 
MDM were incubated with N. meningitidis opsonised with serum (see above) and 
treated with anti-human C3 and/or FITC-conjugated goat anti-human IgG. To 
ensure no bacterial contamination was present, serum was cultured on blood agar 
plates 
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2.4.2 IgG adsorption 
To remove IgG from serum, serum was passed through ImmunoPure plus 
Immobilised Protein A IgG purification kit (Pierce, IL, USA) according to 
manufacturer's instructions. Fluorescence for both IgG and C3 was observed in 
serum opsonised organisms; absence of IgG in IgG-depleted serum was also 
checked this way prior to use. 
2.4.3 Cultivation and opsonisation of N. meningitidis 
Bacterial strains were grown to mid-log phase in liquid culture media, and 
bacterial suspensions were washed by being centrifuged at 2000g for 5 min and 
resuspended in PBS; this was repeated three times. At this stage, non-opsonised 
bacteria were resuspended in RPMI 1640 and used to inoculate 24-well cell 
cultures; or alternatively bacteria were opsonised. Viability was measured by 
serial dilutional counting (Miles and Misra 1938). After a third wash bacteria 
were resuspended in RPMI 1640 and complement-deficient serum (immune 
serum or IgG deplete serum). Bacteria were placed on a roller at 37°C for 
15min, washed twice using PBS, resuspended in RPMI 1640 enriched with 10% 
heat-inactivated FCS, and vortexed with glass beads to disrupt any clumped 
bacteria. Again, final concentration of viable bacteria was established by 
standard serial dilution technique. 
2.4.4 Receptor inhibition of mammalian cells 
All monocyte/macrophage populations were seeded into 24-well culture plates 
prior to bacterial inoculation. Cultured cells were washed three times using 
warmed culture media and incubated in the presence of inhibitor(s) for 15-30 min 
before infecting with prepared mid-log phase bacteria (as described above). 
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Viability was ensured using a trypan blue exclusion assay. Inhibitor(s) were 
used at the following concentrations and remained in culture media throughout 
experiments unless otherwise stated. 
Table below shows inhibitory reagents used: 
Reagent Target Concentration Incubation Source 
time (min) 
Poly-I Scavenger receptor 50 µg/ml 30 Sigma 
(& Poly C control) 
MY4 
(& isotype control CD14 10 µg/ml 30 
IgG2b) 
Phosphatidylinositol GPI-receptors I unit/ml 30 Sigma 
phospholipase C 
enzyme 
2LMPI9c CDl lb/CDI8 2.5 pg/ml 30 DAKO 
(& isot}pe control JgG 1) 
mannosylated-BSA Mannose receptor 0- I00µg/ml 30 Sigma 
PAF-Ra PAF receptor 1- lOOnM 30 Calbiochem 
RGDS-containing 50 ug/ml 30 
peptides Integrins Sigma 
(& control RGES) 
Cytochalasin D Actin disruptor 3µM Sigma 
ß-cyclodextrin Lipid rafts 5- 20 µM 15 Sigma 
Nystatin Lipid rafts 25 pg/mI 15 Sigma 
Dil-acetylated LDL Class A scavenger 5 pg/ml 60 Molecular 
receptors Probes 
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2.4.5 Analysis of bacterial association by mammalian cells 
Association studies involved cooling cells (final density 5x l07cfu/mI unless 
otherwise stated) and culture media was replaced with 250µl of the prepared 
bacterial suspension (MOI of 30-50: 1) and incubated for one hour at 4°C to allow 
bacteria to adhere to the surface of cells without being internalised. Supernate 
was aspirated, wells were washed three times to remove non-adherent cells and 
fixed with 4% paraformaldehyde for 15min. When necessary, the inoculum was 
adjusted so that the numbers of organisms that associated on the surface of the 
MDM were approximately equal, thus allowing direct comparisons to be made 
between intracellular behaviour of opsonised and non-opsonised meningococci. 
2.4.6 Bacterial uptake by mammalian cells 
Bacterial uptake was measured following by washing infected wells three times 
to remove non-adherent organisms following adherence at 4°C, and replacement 
with 25011 warm enriched media and incubated at 37°C before fixing at set time 
points. Internalisation was also measured by establishing suitable MOI for equal 
binding, and omitting the cold incubation step and incubating infected cells 
directly at 37°C. Wells were then fixed at different time points. DiI-acetylated 
LDL, a ligand of SR-A, was used to observe bacterial uptake. After incubation 
with bacteria, cells remain unfixed and are washed 3 times with warm culture 
media. Flasks/wells were incubated in the presence of 5µg/ml DilacLDL in 
enriched culture media and incubated for at least lh at 37°C, 5% CO2. For 
microscopic analysis cells were then treated with 4% pfa or further treatment 
took place in preparation of FACS analysis. Viability was measured using 
trypan blue exclusion. 
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2.4.7 Microscopic analysis 
Paraformaldehyde fixed cells were washed three times with PBS. In order to 
distinguish between extracellular and intracellular bacteria, cells were incubated 
for 12 min with rabbit anti-group B meningococcal antibody diluted 1: 50 in PBS. 
Wells were washed three times with PBS, and incubated for 12min in the 
presence of FITC-conjugated goat anti-rabbit IgG and goat serurn, both diluted 
1: 20 in PBS. Cells were then counter-stained with 0.5µg/ml DAPI. Intracellular 
trafficking to terminal phagolysosomes/endosomes was observed by noting 
LAMP-1 co-localisation in cells. MDM were treated with the anti-LAMP-1 
monoclonal antibody (H4A3) in the presence of saponin, before counterstaining 
with DAPI. Wells were washed once with PBS and three times with distilled 
water, air-dried and mounted onto glass slides in Vectashield (Vector Lab Inc, 
Burlingame, CA) mounting media with DAPI. Results were obtained by 
fluorescent microscopy as previously described. (Read, Zimmerli et al. 1996) 
Extracellular bacteria bound to the surface of cells were FITC-positive and 
DAPI-positive, whereas internalised bacteria were only DAPI-positive. 
Percentage internalisation was calculated by subtracting FITC-positive from 
FITC-negative (DAPI positive) bacteria. 
2.4.8 Measurement of extracellular TNF-a 
In order for sufficient quantities of TNF-a to be measured, the MDM were 
incubated with non-opsonised H44/76 for 2h at 37°C. The concentration of TNF- 
a from the supernatants were measured by ELISA, using a murine anti-human 
TNF-a Mab (PharMingen) for capture, a recombinant human TNF-a Mab 
(PharMingen) as the standard, and a biotinylated murine anti-human TNF-a Mab 
(PharMingen) as the detection antibody. The assay was performed according to 
the manufacturer's protocol. The lower limit of detection of the assay was 15 
pg/ml of TNF-a. 
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2.4.9 Flow cytometry analysis 
To prepare cells for flow cytometric analysis detachment buffer (10mM EDTA 
and 10mM Lidocaine-HCI in PBS) was used to lift cells tissue culture flasks. 
Standard RPMI 1640 was substituted with phenol red free RPMI 1640 
(GibcoBRL) for all experiments involving flow cytometric analysis to minimize 
acquired autofluorescence. Culture media in wells was aspirated, and wells were 
washed 3 times with PBS before adding enough detachment buffer to cover cells 
(5m1) and incubate for 15min at 37°C, 5% CO2. Cells were lifted by vigorously 
pipetting buffer over cells and transferring to centrifuge tubes; from this point 
cells were kept at 4°C to prevent the cells adhering to the inside surface of the 
plastic centrifuge tubes. Cells were harvested by centrifugation at 1500 xg for 
5min and aspirated in 4% pfa, azide and PBS for 15min. Viability using trypan 
blue exclusion assay was carried out before fixation, and suspension was 
analysed for clumping using inverted light microscope. Fluorescence was 
analysed using FACScan (Beckton Dickinson) using the FL-1 or FL-2 
photomultiplier as required, and results were analysed using CellQuest software. 
Results are representative of at least 3 independent experiments. 
Statistics throughout this study are non-parametric and results were generally 
determined using Mann-Whitney and/or Kruskall-Wallis analysis. 
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Chapter 3 
Development of a model of macrophage phagocytosis of 
N. meningitidis 
3.1 Introduction 
Despite their probable common bone marrow progenitor, macrophages display 
considerable heterogeneity (Forster and Landy 1981; Walker, Warner et al. 
1985), and depending on their location, they can differ considerably in phenotype 
and morphology. Once in the tissue, monocytes differentiate into 
characteristically different tissue macrophages depending on tissue-specific 
stimuli present in the local microenvironment. 
Numerous studies have shown that contact between phagocytes and bacterial 
pathogens result in the release of toxic compounds including reactive oxygen 
intermediates (ROI), and pro-inflammatory cytokines such as TNF-a, IL-I, IL-6 
(Beaty, Franklin et al. 1994; Van Deuren, van der Ven-Jongekrijg et al. 1995; 
Astiz, Saha et al. 1996); however gram-positive and gram-negative cells are 
thought to induce monocytic cytokine production through different signal 
transducing pathways (Rabehi, Irinopoulou et al. 2001). These cytotoxic 
compounds are not only lethal for the microbe, but also for host cells, thus 
leading to the destructive affects that characterise inflammation (Perdomo, 
Cavaillon et al. 1994). It is, therefore, the relationship between phagocyte and 
bacteria that lies at the very heart of the innate immune system. 
The nasopharynx is the known site of meningococcal colonisation (Olcen, 
Kjellander et al. 1979), and is presumed to be the primary site of invasion; 
although relatively little is known about mucosal immunity to meningococcal 
disease, or precisely where within the nasopharynx meningococci colonise and 
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attack. In order for cells of N. ineningltidls to cause disease they must both 
colonise and invade mucosal epithelial cells, where they come into direct contact 
with macrophages which make up a large proportion of host immune cells in the 
region. Experiments using human nasal explants have shown that macrophages 
phagocytose N. meningitidis on infection (Read, Fox et al. 1995; Read and 
Goodwin 2001), suggesting that macrophages are a central line of defence 
against meningococci. No previous work has been published on the close 
relationship between N. ineningilidls and human macrophages in terms of 
specific receptors engaged by the bacteria, and subsequent intracellular 
trafficking. 
Particular strains of Neisseria are potential pathogens, and this is exhibited in 
their ability to adhere to and invade mucosal surface structures, and both survive 
and multiply after entering the bloodstream of certain individuals. Therefore, in 
this chapter the direct interactions between macrophages and different Neisser"ia 
species were studied; specifically in terms of recognition, phagocytosis, internal 
trafficking and subsequent cytokine production in the absence of serum opsonins. 
The role of serum opsonins in this relationship was also examined as the 
principal role that terminal pathways of the complement system play in 
meningococcal lysis are most apparent in individuals that have a late 
complement-component deficiency (LCCD). Meningococci are highly 
susceptible to complement-mediated lysis, therefore LCCD individuals have an 
almost 1000-fold higher risk of developing MCD than complement-sufficient 
individuals, as they lack one of the `late' or `terminal' components (from C5 to 
C9) and serum bactericidal function is severely impaired (Figueroa and Densen 
1991; Platanov, Beloborodov et al. 1993; Esser 1994). In order to examine the 
role serum opsonins play in meningococcal processing by macrophages via 
specific opsonic receptors, N. ineningilidis cells were opsonised with serum 
obtained from an LCCD patient who has a C7-deficiency, as the absence of the 
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late complement components in the serum prevented complement-mediated lysis 
of the meningococci. 
Suitable cell-line models for the use of N. meningitidis studies are rather limited, 
as most phagocytic cell lines are derived from immature precursor cells of 
monocytes and permanent human mature cell lines do not exist. None the less I 
looked at the use of cell lines to model meningococcal interactions within this 
study. Previous studies have shown that the in vitro differentiation of a 
monocytic cell line such as THP-1 provides an appropriate model to study 
macrophage-pathogen interactions, as differentiation induces the cells to take on 
a more macrophage-like phenotype, resulting in the improved phagocytic 
capability of the cells compared to undifferentiated cells (Tsuchiya, Kobayashi et 
al. 1982), this was explored further in Chapter 4. 
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3.2 Results 
To examine the relationship between Neisseria and macrophages an effective 
general method of measuring bacterial adherence and uptake by macrophages 
was required. Throughout all the experiments in this chapter a monolayer of Ix 
106 peripheral blood monocyte cells, obtained from apparently healthy 
volunteers, were grown in 24-well culture plates for 8-12 days at 37°C, 
(described in Chapter 2). At this point, the cells had matured and acquired the 
distinctive characteristics of macrophages. Each Neisseria strain was cultured 
and grown individually to mid-exponential phase at which point the bacteria 
were harvested and introduced to the monocyte-derived macrophages (MDM) at 
a concentration of 5x 107 cfu/ml (MOI 50: 1) unless otherwise stated. 
Experiments to examine binding of bacteria to the surface of macrophages were 
carried out at 4°C for one hour, and were based on previous established methods 
of studying bacterial adhesion, which had ascertained that phagocytes could 
survive the cooling/warming process involved allowing bacteria to bind at this 
temperature. Incubation at 4°C allows the macrophages to remain viable but 
deprives the cell membrane of its fluidity, and so the actin-based phagocytic 
machinery of the cell does not function. This permits the bacteria to interact 
with available surface receptors present on the macrophages without initiating 
phagocytosis, thus allowing the measurement of adherence independently of 
phagocytosis. 
Tissue culture wells were fixed using 4% paraformaldehyde and layered with 
fluorescent antibodies (see Methods and Materials). Differential fluorescent 
microscopy identified extracellular organisms as being FITC positive (green), 
DAPI positive (blue), and internalised organisms as FITC negative, DAPI 
positive (see Figure 1). This method of staining was extremely effective in 
establishing how successfully the bacteria bound to these cells as well as 
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measure the proportion of adherent organisms that were subsequently 
internalised by the cells. 
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Figure 3.0 
Indirect Immunofluorescent staining 
Bacteria stained both FITC-positive (green) and DAPI-positive (blue) are extracellular 
Bacteria stained DAPI-positive (blue) alone indicate internalisation, and internalised organisms 
surrounded by labelled LAMP-1 rings (red - see arrow) indicate trafficking to late 
endosome/phagosome. 
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3.2.1 N. lactamica associates more effectively than pathogenic Neisseria to 
human macrophages 
Experiments were conducted to observe how effectively two strains of serogroup 
B N. ineningitidis widely used in studies of pathogenesis (MC58 and K454) 
adhered to the surface of monocyte-derived macrophages (MDM) when 
compared with two contrasting Neisseria strains. The first was Neisser"ia 
lactamica, a human commensal that rarely causes disease. This organisms is 
chiefly a commensal of children and is considered capable of generating an 
acquired cross-reactive immunity against meningococci. Neisseria animalis was 
the second species used and is a commensal of guinea pigs and has never been 
isolated from a human source. These organisms also differ in their outer 
membrane structure, and direct comparison between species would be an 
insightful way of noting if N. rneningitidis behaves differently to these bacteria 
in relation to macrophages. 
All organisms were grown to mid-log phase, used to infect human macrophages 
under non-opsonic conditions and incubated for one hour at 4°C; units were 
measured as mean numbers of bacteria per macrophage. Under each condition 
100 macrophages from each slide were examined and the numbers of bacteria 
adherent to the surface of the cell and/or internalised were noted. It was possible 
to measure bacterial adherence to macrophage surfaces and compare species of 
Neisser"ia. 
As shown in Fig. 3.1 although the binding of Neisseria species to the surface was 
broadly comparable, it is notable that N. laclainica exhibited quite exuberant 
adherence. 
78 
N. animalis 
N. lactamica 
N. meningitidis MC58 
N. meningilidis K454 
bacteria per cell 
Figure 3.1 
N. lactamica binds in greater numbers than N. meningitidis to MDM 
Adherence of Neisser"ia strains to MDM after 60min incubation at 4°C and MOI 50: 1. 
Data represented as mean (±SEM); experiment performed using five donors each 
experiment done in triplicate. Statistical significance denoted using *P<0.05; 
calculated using Mann-Whitney U test and comparing strains with N. meningitidis. 
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3.2.2 Uptake of Neisseria species 
A methodological approach was designed to measure subsequent internalisation 
of species of Neisseria. Experiments were performed by allowing the bacteria to 
adhere to the surface of the macrophages, as described earlier, macrophages were 
then washed three times in warm culture medium in order to remove any non- 
adherent organisms present, fresh culture media replaced and cells were allowed 
to incubate at 37°C over 2h. Every 30min wells were fixed using 4% 
paraformaldehyde. Experiments were performed (data not shown) to find the 
suitable concentration at which N. lactamica adhered to macrophages in similar 
numbers to the other bacteria; attempts were made to increase the numbers of 
adherent N. meningitidis and N. animalis to levels comparable to N. lactamica, 
but I observed that under non-opsonic conditions N. meningitidis MC58 did not 
bind at more that 2-3 bacteria per cell up to an MOI 200: 1. (data not shown). 
The number of adherent bacteria per macrophage were subsequently equalised by 
reducing the MOI of N. lactarnica from 50 to 20, thus allowing internalisation of 
all four Neisseria species to be directly compared. MDM were incubated at 4°C 
for one hour, before a further 2h incubation at 37°C, fixing wells every 30min, 
and internalisation at each time point was measured by differential fluorescent 
microscopy. Fig. 3.2 demonstrates that by 30min both N. lactamica and N. 
animalis were apparently internalised by MDM more effectively than the two N. 
meningitidis species. Interestingly here we observe that MDM internalised the 
only non-human pathogen, N. animalis, at significantly greater levels than the 
two human species. This suggests that in this study N. aninnalis, the non-human 
pathogens, may possess certain attributes that are more likely to alert the human 
macrophages to their presence. In contrast, the two pathogenic meningococci 
strains are found in humans, and are known to express virulence determinants 
that are thought to help successfully mask their presence from the hosts immune 
systems. 
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Figure 3.2 
Non-pathogenic Neisseria strains ingested most effectively 
Graph shows percentage of adherent Neisseria internalised by MDM. Concentration of 
N. lactamica was reduced to ensure adherence of Neisseria strains at 4°C was equal,, 
bacteria were then incubated for a further 120min at 37°C. Data represented as mean 
(±SEM); experiment performed using six donors each experiment done in triplicate. 
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3.2.3 Intracellular trafficking of N. meningitidis 
Lysosome-associated membrane protein 1 (LAMP-1) is a member of a highly 
glycosylated protein group present in the lysosomal membranes of most cells. 
During phagocytosis, LAMP proteins are concentrated around the internalised 
particle and fluorescent antibodies raised against LAMP-1 proteins can be used 
to track bacteria within late endosomal/lysosomal compartments of macrophages. 
Serogroup B N. meningilidis are known to co-localise with LAMP in 
macrophages and are able to affect the bactericidal mechanism of the cell by 
reducing the rate of LAMP incorporation (Read, Zimmerli et al. 1996). 
The fusion of lysosomes to phagosomes is the primary bactericidal mechanism of 
macrophages. In order to determine whether phagosome-lysosome fusion was 
occurring in MDM, the mouse mAb H4A3 that is directed against the late 
endosome-lysosomal marker glycoprotein LAMP-1, is used as a marker for 
fusion. The ability of N. meningitidis to prevent lysosomal association may 
play a role in the survival of N. meningitidis inside MDM cells. Intracellular 
bacteria can prevent association with lysosomes by preventing phagosome- 
lysosome fusion or by escaping the phagososme into the cytoplasm. 
Lysosome-associated membrane protein 1 (LAMP-1) co-localisation of Neisser"ia 
is noted in Fig. 3.3, N. lactamica is taken into terminal phagolysosomes, and by 
120 min the proportion of internalised N. meningitidis MC58, co-localising with 
LAMP-1 is significantly higher than the other Neisseria species. These two 
points show that N. lactamica appears to be both bound in greater numbers and 
internalised into terminal phagosomes more quickly than the other species. 
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Figure 3.3 
Intracellular trafficking of Neisseria 
Graph shows percentage of ingested Neisseria (see Fig 3.2) taken into LAMP-I-labelled 
phagolysosome/endosome vacuoles by MDM. Concentration of N. lactamfca reduced 
to ensure adherence of Neisseria strains at 4°C are equal, bacteria were then incubated 
for a further 120min incubation at 37 °C. Data represented as mean (±SEM); 
experiment performed using six donors each experiment done in triplicate. 
83 
cold 30 60 90 120 
3.2.4 IgG contributes to efficient binding of opsonised N. meningitidis 
I was able to study both the adherence and the internalisation of Neisserria strains 
as two quite distinct individual processes by the use of the protocols discussed 
above; thus facilitating the study of possible receptor involvement in each of 
these interactions. Fig. 3.4A and 3.4B show findings obtained with the use of 
C7-deficient serum opsonised bacteria. N. meningitidis MC58 were cultured as 
described previously and opsonised for 15min at 37°C. Serum from the same 
source was also passed through a Protein A column in order to remove IgG 
antibodies, leaving IgG-depleted serum, which was also used to opsonise bacteria 
before inoculation onto MDM. Non-opsonised control organisms were opsonised 
in an equal concentration of PBS. Fluorescently labelled antibody staining 
revealed that this treatment resulted in opsonised bacteria that were not coated 
with human IgG, but complement opsonins were present (see Methods and 
Materials). 
Interactions of serogroup B N. meningitidis MC58 with MDM were observed 
after opsonisation in order to assess whether bacteria were more readily bound 
and internalised when compared with control organisms. Fig. 3.4A demonstrated 
that when bacteria were opsonised and used to inoculate MDM in relatively equal 
numbers (MOI 50: 1), immune serum opsonised bacteria appeared to bind in 
greater numbers per macrophage than IgG-deplete opsonised and non-opsonised 
MC58. This observation was obtained using six human donors, and implies that 
Fcy receptors are involved in meningococcal adherence to macrophages as the 
absence of IgG clearly impairs bacterial association. 
In order to observe any differences in internalisation of the opsonised organisms, 
the MOI was reduced from 50 to 10 thus equalising the mean numbers of 
adherent bacteria per cell after lh at 4°C (Fig. 3.4A); thus allowing direct 
comparisons between the treatments used. Subsequent internalisation of 
organisms over 90min at 37°C were measured using fluorescent microscopy (Fig. 
84 
3.4B). By 60 min uptake of both groups of opsonised bacteria is four times 
higher than the non-opsonised control organisms, suggesting that as the absence 
of IgG has no effect on internalisation, non-FcyR appear to play a role in 
meningococcal uptake. Interestingly IgG-deplete opsonised bacteria were 
internalised by macrophage receptors as efficiently as immune serum opsonised 
bacteria over 90min. The role of the phagocytic complement receptors such as 
CR3 will be explored in Chapter 5. 
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Figure 3.4 
Immunoglobulin-mediated binding of meningococci 
Adherence and internalisation of N. ineningitidis MC58 by MDM under opsonic 
conditions (A) Ratio of bacteria per macrophage (1x106), cells fixed after lh 
incubation at 4°C; includes equalised results for immune serum opsonised MC58; 
bacterial concentration 5xl07cfu/ml (open bars), 5-1Oxl06cfu/ml (filled bar). (B) 
Percentage internalisation of adherent bacteria, using equalised data; (")non- 
opsonised PBS control, or opsonised using (m)immune serum (' )adsorbed serum 
(IgG deplete). Macrophages washed and subsequently incubated at 37°C, and at 
each time point monolayers were washed extensively and fixed. Presence or absence 
of JgG was confirmed using FITC-labelled anti-IgG antibodies (see Methods). Data 
are depicted as mean values (± standard error of mean) from six donors, with each 
experiment done in triplicate. Significance denoted by *P<0.05, **P<0.01, 
***P<0.001 using Mann Whitney test comparing opsonised bacteria with control 
organisms. 
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3.2.5 Primary human macrophages internalise N. meningitidis more 
effectively than cell lines 
Throughout the study a number of different cell types are used, including MDM, 
THP-1 monocytic cell line, J774 murine macrophage-like cells. The expression 
of surface receptors on these cells determines how efficiently they bind and 
ingest bacteria such as N. ineningltldls. Fig. 3.5 demonstrates that 
meningococcal adherence to cell lines is most effective in macrophage-like cells 
such as J774. Fig. 3.6 demonstrates that MDM appear to express more functional 
phagocytic receptors that can internalise N. meningitidis H44/76 successfully. 
THP-1 cells are undifferentiated leukaemic cell lines whose growth is arrested at 
the precursor stage before they develop into mature macrophages, and the 
relative lack of phagocytic potency is a characteristic of immature cells. 
Differentiated THP-1 interactions with meningococci are explored further in in 
Chapter 4 and 6. 
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Figure 3.5 
Cell lines models 
Binding of N. meningitidis H44/76 to different cell types after 60min 
incubation at 4°C. Cells used were monocyte-derived macrophages 
(MDM), undifferentiated THP-1 cells (THP-1) and a murine 
macrophage cell line J774. A. Results based on four separate 
experiments, each repeated at least three times. Significance denoted 
by *P<0.05 using Mann Whitney test comparing cell lines to primary 
human macrophages. 
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Figure 3.6 
Uptake of bacteria by cell lines 
QMDM 
QTHP-1 
J774. A 
Phagocytosis of N. meningitidis H44/76 to different cell types after 
60min incubation at 37°C. Cell were monocyte-derived macrophages 
(MDM), undifferentiated THP-1 cells (THP-l) and a murine 
macrophage cell line J774. A. Results based on four separate 
experiments, each repeated at least three times. Significance denoted 
by *P<0.05, **P<0.01 using Mann Whitney test comparing cell lines 
with MDM. 
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3.3 Summary and discussion 
Macrophages are considered the first line of defence against invading Neisser"ia 
species in the upper respiratory tract, and it is therefore important to consider the 
question of how these distinctive organisms are able to overcome a number of 
innate defence systems present in their environment. This study examines the 
involvement of specific macrophage receptors in the recognition of 
N. meningitidis, and to this end, cell lines have proven to be a useful tool. 
This chapter has described initial pilot work to design a robust assay of the 
interaction of human macrophages with pathogenic Neisseria. The process of 
phagocytosis is complex and often involves cross talk and synergy between 
receptors and signal transduction molecules. Macrophages express an array of 
surface receptors; multiple receptors can be involved in the processing of single 
bacteria cells. These events are initiated by the crucial step of ligand recognition 
via specific receptors. 
In the absence of serum, Neisseria strains N. lactanrica and N. aninialis, were 
respectively bound and internalised by macrophages in significantly greater 
numbers than pathogenic strains of N. meningitidis using this assay. These 
findings suggest that N. lactamica, as the only non-pathogenic strain, is more 
readily recognised by the MDM as its outer membrane differs from that of N. 
meningilidis and N. animalis which might allow for greater affinity between 
cells. Although a relatively rare occurrence, the fact meningococci are able to 
avoid the gauntlet of innate immune responses, suggests that either host cells fail 
to recognise and destroy the invasive bacteria, or that virulence determinants on 
the outer surface of the microbes are successful in preventing direct recognition. 
The N. meningitidis strains used are capsulate and express both Opa and Pi1C, 
whereas N. lactaniica lacks Opa expression and N. animalis expresses neither 
Opa nor Pi1C. Of all three Neisseria species examined, N. animalis was 
internalised most effectively by MDM, which is consistent with the fact that this 
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organism has never been isolated in humans, and is more usually found in 
mammals including guinea pigs. N. lactamica was found to bind most 
successfully to macrophages. LAMP incorporation was dependent on species, 
strain and time of incubation. A significant decrease in LAMP incorporation was 
observed by 90min (see Fig 3.3), even though internalisation had reached its 
peak, and this may occur because even though organisms are being ingested 
effectively it may be via different receptors or alternatively the bacteria may not 
all be viable and by 90min a proportion have died and are not therefore being 
picked up by the staining antibodies; or perhaps the bacteria are multiplying in 
the media during incubation and there is a limit to the number the macrophages 
can traffic into terminal phagolysosomes. 
Present results indicate that different cell lines interact to varying degrees with 
N. ineningitidls H44/76, and these interactions are likely to be dependent on 
receptor expression. The experiments demonstrated that cultured cell lines, such 
as THP-1 and J774, can express receptors able to interact directly with N. 
meningitidis and could be used as suitable models for the study of bacteria- 
macrophage interactions. 
Once meningococci are in the bloodstream complement-mediated responses are 
the first line of defence, and are usually dependent on bacterial lysis by C5b to 
C9 complement components. If organisms can evade such an attack then they are 
able to proliferate relatively unhindered and reach concentrations that activate a 
more pronounced complement-mediated response that can lead to tissue damage 
by neutrophil activation. Therefore examination of opsonic receptor involvement 
in meningococcal recognition of macrophages was carried out, and experiments 
using this model implied that meningococcal interactions in the presence of 
immune serum were governed by different opsonic receptors. Adherence to 
macrophages appeared to be an FcyR-mediated process, whereas the data 
suggested that non-FcyR receptors contributed significantly to bacterial uptake 
(see Fig 3.4B). A similar pattern of opsonin-mediated bacterial recognition was 
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observed by Gordon and colleagues (Gordon, Irving et al. 2000) when similar 
experiments were performed using S. pneumoniae and alveolar macrophages. 
The role of CR3 will be examined further in Chapter 5. Mutant strains of N. 
meningitidis were used in the following chapter to examine the role of 
meningococcal lipopolysaccharide, a pathogen-associated molecular pattern, on 
immune activation. 
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Chapter 4 
Influence of lipopolysaccharide on internalisation of N. meningitidis 
by human macrophages 
4.1 Introduction 
N. meningitidis is a host-adapted pathogen that possesses known conserved key 
surface structures, and has developed a high level of antigenic variability that is 
used as an effective strategy to evade immune surveillance by the host. Both 
capsular polysaccharide and lipopolysaccharide display this variability, and are 
essential virulence factors in meningococcal pathogenesis, as both structures 
have been shown to contribute to the bactericidal activity of human sera (Kahler 
and Stephens 1998; Tzeng and Stephens 2000). As an integral and essential 
component of the outer membrane of gram-negative bacteria, LPS can activate 
macrophages and trigger a number of pro-inflammatory cytotoxic responses. 
Lipopolysaccharide (LPS) is the major lipid component of the outer surface 
monolayer of the outer membrane, is highly conserved and present on the outer 
membrane of all gram-negative bacteria. Considerable work has been amassed 
on the role of LPS as a trigger for a range of pro-inflammatory responses in 
macrophages (Beaty, Franklin et al. 1994). 
In the studies described in this chapter wild-type N. rneningitidis H44/76 and an 
LPS-deficient isogenic mutant pLAK33 were used. LPS is responsible for the 
composition or asymmetry of the outer membrane of most gram-negative 
organisms, and is therefore an essential component of these bacteria. Steeghs 
and colleagues (Steeghs, den Hartog et al. 1998) developed the LPS-deficient 
mutant used in this study by the insertional inactivation of the lpxA gene that 
encodes UDP-G1cNAc acyltransferase that is required for the first step in lipid A 
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biosynthesis, leaving a viable organism completely deficient of LPS and yet in 
possession of a complete outer membrane. 
Further study confirmed that LPS is not essential for the assembly of the outer 
membrane proteins such as porins, and to date the main difference between N. 
meningitidis pLAK33 and the wild-type strain N. meningitidis H44/76 are the 
phospholipid composition on both the inner and outer membrane. Evidence 
suggests that the missing LPS is replaced with short fatty acyl chain 
phospholipids, that have an increased saturation of the acyl chains, comparable 
to the fatty acyl chains of LPS that are also highly saturated. The presence of a 
a-2,8-polysialic acid capsule also appears to be essential for viability of the 
mutant strain (Steeghs, de Cock et at. 2001). Recent observation using a LPS- 
deficient serogroup C N. meningilidis strain observed differences in expression 
of pilus-associated characteristics, which have not been reported for the LPS- 
deficient pLAK33 strain used in this study, and this affected the organisms 
ability to enter human epithelial cells (Albiger, Johansson et al. 2003). 
Capsulate and piliated pathogenic meningococci are normally recovered from the 
CSF. 
The LPS-deficient mutant strain, N. mneningitidis pLAK33, is the first viable 
gram-negative bacteria that is completely deficient of LPS, and is theºefore an 
extremely useful organism in the study of meningococci-host cell contact, and 
involvement of endotoxin in meningococci-macrophage interactions in terms of 
receptor interactions, phagocytosis, subsequent cytokine production, and 
intracellular trafficking. 
The method of cellular differentiation employed is known to affect receptor 
expression, and a number of agents have been shown to induce differentiation in 
human leukaemia-derived cell lines, including vitamin analogues, cytokines and 
anti-leukaemic drugs such as phorbol esters, retinoic acid, bufalin, vitamin D3, 
TNF-a, IFNy and GM-CSF, all of which been reported to promote monocyte- 
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macrophage differentiation (Grilli, Chiu et al. 1993; Schwende, Fitzke et al. 
1996). Treatment of THP-1 cells induces them to mature into macrophage-like 
cells, as cellular receptor expression is upregulated resulting in a larger number 
of receptors that can internalise meningococci. THP-1 cell differentiation 
increases cellular adherence, stop proliferating, increase in latex bead 
phagocytosis was observed and increased expression of macrophage receptors 
(Schwende, Fitzke et al. 1996). The differentiation process is a complex one and 
is controlled by the expression or activation of several transcription factors, and 
the actual events during this process of terminal differentiation of the cells that 
lead to improved bactericidal performance have yet to be fully elucidated 
(Valledor, Borras et al. 1998). Differentiating agents are known to induce the 
appearance of NFKB in the cytoplasm and its translocation into the nucleus 
(Grilli, Chiu et al. 1993), and differentiation of THP-l cells using phorbol 
myristate acetate (PMA) strongly activates protein kinase C (PKC). Using a 
PMA-induced cell differentiation model of this human monocytic cell line, we 
were able to study the effects of the differentiation process on the functional 
activity of the macrophages in relation to N. meningitidis. 
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4.2 Results 
4.2.1 lpxA mutant exhibits increased adherence to THP-1 cells 
Undifferentiated monocytic cell line, THP-l, cells were infected with equivalent 
numbers of mid-log phase N. meizingitid s H44/76 and the isogenic strain N. 
meningitidis pLAK33, (MOI 50: 1) and incubated for lh at 4°C. A number of 
phagocytic receptors normally present in mature macrophages are noticeably 
absent on THP-1 cells, including scavenger receptors and mannose receptors, and 
though complement receptors and CD 14 are present they are significantly 
reduced in number (Schwende, Fitzke et al. 1996). No difference was observed 
in either adherence or uptake of N. meningitidis H44/76 and isogenic mutant by 
THP-1 after 1.5h at 37°C. This sharply contrasts with the following data using 
MDM. 
4.2.2 lpxA mutant exhibits increased adherence to human rnonocyte-derived 
macrophages (MDM) 
The experiment described above was repeated substituting undifferentiated THP- 
I cells for primary human macrophages, which were infected with N. 
meningitidis H44/76 and the isogenic strain N. meningitidis pLAK33, (MOI 50: 1) 
and incubated for lh at 4°C. Figure 4.2A shows that LPS-deficient N. 
meningilidis mutant associates with MDM in significantly greater numbers than 
the wild-type strain. Significant differences were observed in both adherence 
and uptake of parent and mutant strain., and the differences in outer membrane 
composition of the two strains (see discussion) may explain how LPS-deficient 
N. meningitidis pLAK33 can to adhere to the surface of MDM more effectively. 
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Ingestion of lpxA mutant by THP-1 cells is not impaired 
Comparison of bacterial binding and internalisation of LPS-deficient mutant 
and wild type strain by undifferentiated THP-1 cells (106cfu/ml). 
(A) Adherence of LPS-deficient mutant increased after 30min incubation 
(*P<0.05) (B) Percentage of bound organisms internalised. Results show no 
significant difference between phagocytosis of the two strains (P>0.05). 
Significance calculated using Mann-Whitney U test at each time point. 
Experiments were performed eight times, each experiment repeated at least 
three times. 
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4.2.3 Internalisation of IpxA mutant bound to the surface of MDMs is 
impaired 
N. 1nen1ngitidis H44/76 and LPS-deficient mutant were used to infect MDM in 
the absence of serum. Macrophages were incubated at 4°C, before unattached 
bacteria were washed off and cells were incubated at 37°C for a further 1.5h. 
The complete absence of LPS in the lpxA mutant had a profound effect on the 
internalisation of mutant organisms once bound to MDM: as the LPS-deficient 
mutant bacteria were internalised 58% less effectively than N. ineningitidis 
H44/76 parent strain by 30min (Fig. 4.2A). 
LPS is an important ligand for a number of phagocytic receptors, and the marked 
decrease in the internalisation of associated LPS-deficient organisms compared 
to wild-type implies that LPS receptors play a pivotal role in meningococcal 
phagocytosis. 
4.2.4 Impaired LAMP-1 acquisition by phagosomes containing lpxA mutant 
Along with a marked decrease in internalisation of LPS-deficient mutants, 
subsequent maturation of phagosomes was also impaired in Figure 4.3. 
Extensive measurement of intracellular trafficking using a range of antibodies, 
such as Rab 5 and Rab 7 proved difficult using this organism, as it would require 
levels of bacterial internalisation of different strains to be equalised; this study 
has found macrophage internalisation of adherent meningococci or populations 
of macrophages engaged in meningococcal internalisation/binding in the absence 
of immune serum rarely exceeded 25%, therefore monitoring differential 
trafficking would be limited. Intracellular trafficking of meningococci was 
therefore restricted to measurement of LAMP-1 co-localisation as a marker of 
late endosome/phagosome fusion. 
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Contribution of LPS to interactions with primary human 
macrophages 
LPS-deficient mutant pLAK33 and wild-type H44/76 were incubated with MDM 
(A) Adherence ratio per macrophage (B) Internalisation after 30min (as shown 
in Fig. 1) was reduced by 72.5% for the mutant when compared to the wild-type 
strain. Illustrating that LPS receptors appear to be important for meningococcal 
internalization. Boxes represent first and third quartiles, lines within each box 
are median values and black dots represent mean values. Results based on eight 
human donors, each experiment done in triplicate. Statistical significance 
denoted by *P<0.05, **P<0.01, ***P<0.001 using Mann-Whitney U test 
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Figure 4.3 
IpxA mutant taken into phagolysosomes less efficiently than 
wild type 
Graph shows percentage of ingested bacteria taken into LAMP-1-labelled 
phagolysosome/endosome vacuoles by MDM. Both H44/76 and pLAK33 
were incubated at 4°C, before a further 90min incubation at 37 °C. Data 
represented as mean (±SEM); experiment performed using five donors 
each experiment done in triplicate. Statistical significance between two 
strains is denoted using *P<0.05, calculated using Mann-\Vhitney U test. 
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4.2.5 Differentiation of THP-1 with phorbol myristate acetate (PMA) 
results in recovery of internalisation 
THP-1 cells were incubated in the presence of PMA for 7 days at a final 
concentration of 25nM, with media changed every two days. Undifferentiated 
and differentiated THP-1 cells (dTHP-1) were incubated in the presence of N. 
nieningitidis H44/76 for lh at 37°C, 5% CO2. Preliminary experiments 
comparing primary human MDM to differentiated (dTHP-1) and undifferentiated 
THP-1 reveals enhanced phagocytic activity of THP-1 cells following PMA- 
induced differentiation was detected (Fig. 4.5) and was accompanied by a 
marked increase in numbers of bacteria adhering to the surface of the cells (Fig. 
4.4). Demonstrating that in vitro-differentiated monocytes, such as THP-1, can 
express receptors able to interact directly with N. meningitidis and could be used 
as suitable models for the study of bacteria-macrophage interactions, as PMA- 
differentiation appears to confer the same ability to recognise N. meningitidis as 
primary human cells (see Fig. 4.4). 
Fig. 4.5 shows that levels of adherence, uptake and the proportion of cells 
directly interacting with bacteria at 37°C, all significantly increased following 
PMA treatment. Suggesting that receptors employed in meningococcal 
recognition are specific to mature macrophages, expression of which can be 
induced by PMA. 
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THP-1 + PMA 
Monocyte differentiation enhances adherence 
Comparison of PMA-differentiated and MDMs incubated with non-opsonised 
N. ineningitidis H44/76 and incubated at 4°C for 60min. Results were based on 
at least four experiments, each experiment performed in triplicate. No 
significant difference observed using Mann-Whitney U test to compare each 
condition (P>0.05). 
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Figure 4.5 
Monocyte differentiation enhances N. meningitidis recognition 
Comparison of PMA-differentiated and undifferentiated THP-1 cells 
inoculated with non-opsonised N. meningitidis H44/76 and incubated at 37°C 
for 60min. (A) mean number of bacteria per cell (B) percentage of 
organisms ingested (C) percentage of cells interacting with bacteria. Results 
were based on at least four experiments, each experiment performed in 
triplicate. Statistical significance denoted by *P<0.05, **P<0.01, ***P<0.001 
using Mann-Whitney U test to compare dTHP-1 and THP-1 at each time 
point.. 
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4.2.6 Absence of LPS reduces TNF-a production 
Meningococcal disease (MCD) is characterised by high levels of circulating 
endotoxin which have a detrimental effect on the host, and trigger a range of 
inflammatory reactions that can ultimately lead to septic shock and death 
(Brandtzaeg 1996). These increased levels of circulatory LPS indicate severity 
of disease, and are closely associated with an increase in fatality rate 
(Brandtzaeg, Kierulf et al. 1989). The binding of LPS to specific surface 
receptors can induce macrophage activation, and result in a number of cellular 
changes, including secretion of pro-inflammatory cytokines such as TNF-a. 
To examine the contribution of endotoxin on N. meningitidis-induced TNF-a 
secretion upon exposure to wild-type N. meningitidis H44/76 and LPS-deficient 
mutant pLAK33, MDM were incubated in the presence of the two strains for 2h 
at 37°C, 5% CO2. The culture media was harvested and concentrations of TNF-a 
secreted measured using ELISA. Supernates were obtained from six human 
donors. Fig. 4.6 shows significant differences in levels of secreted TNF-a 
between parent and mutant N. rneningitidis strains of H44/76. Results were 
expressed as proportion of the mean response to 3.3x 106cfu/ml doses of H44/76 
and pLAK33. 
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Figure 4.6 
Absence of LPS impairs TNF-a production 
Difference in TNF-a secretion after exposure to a range of 
concentrations of LPS-deficient mutant pLAK33 and wild-type H44/76 
to MDM. Results based on six human donors and results expressed as a 
percentage of the mean TNF-a concentration induced in each 
preparation of MDM by 3.3x108 cfu/ml of H44/76 and pLAK33. 
Statistical significance denoted by *P<0.05. 
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4.3 Summary and discussion 
The examination of non-opsonic interactions of N. meningitidis is noteworthy, 
since once meningococci are in the nasopharynx they are likely to be exposed to 
resident macrophages and dendritic cells which are widely distributed 
extravascularly, where opsonins may be low or absent, and also in the liver, 
adrenal glands and chocoid plexus they would be in direct contact with blood and 
CSF (Gordon, Lawson et al. 1992): 
The use of the first viable N. meningitidis organism that completely lacks LPS 
allowed us to study how effectively whole organisms interact with, and are 
recognised by, host immune cells. These observations strongly suggest that LPS 
plays an important role in meningococcal recognition by macrophages during 
non-opsonic interactions. Internalisation, intracellular trafficking and cytokine 
production by human macrophages were all inhibited by the notable absence of 
LPS in the pLAK33 lpxA mutant compared with wild-type H44/76. Although 
TNF-a secretion following exposure to the LPS-deficient mutant was markedly 
reduced, it was not completely absent, implying that outer membrane components 
of gram-negative bacteria, other than LPS, may also trigger cytokine production 
and induce cellular activation. 
Adherence by the LPS-deficient mutant was improved in the lpxA mutant strain. 
It is known that the outer membrane structure of the LPS-deficient mutant is 
quite different from that of the wild type, particularly with respect to 
phospholipid composition, as the length and the saturation of the fatty acyl 
chains of phophatidylethanolamine (PE), and the relative proportions of other 
phospholipids are different. These differences could affect how successfully 
these organisms interact with the macrophages; for example in the mutant strain 
a greater proportion of more positively charged phospholipids, such as 
phophatidylcholine (PC), are present which might affect bacterial adherence to 
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macrophages. The LPS-deficient mutant may engage with alternative receptors 
with a high affinity via its other outer membrane proteins, such as pili and 
opacity proteins, or perhaps the differences in the proportion of charged 
molecules present may enhance adherence to macrophages (see Fig. 4.2A). 
The conspicuous difference between the ability of primary human macrophages 
and undifferentiated THP-1 to internalise these two strains of N. meningilidis 
H44/76 (see Figs. 4.1 and 4.2) may be due to these differences in outer 
membrane compositions of the neisserial strains used, but is more likely a result 
of the significant differences in receptor expression of MDM and 
undifferentiated THP-1 cells. Meningococcal recognition by THP-1 was 
enhanced considerably by PMA-differentiation (see Fig. 4.4 and 4.5), and 
previous studies have observed that PMA differentiation of THP-1 cells increases 
numbers of receptors expressed as well as diversity thus allowing us to conclude 
that one or more receptors expressed on mature macrophages are able to interact 
directly with meningococci. 
The notable difference in LPS-mutant behaviour compared to H44/76 prompted 
further exploration into the role of LPS receptors as a possible route of entry into 
the macrophage was the central theme of this study; as the receptor(s) of choice 
for N. meningitidis by human macrophages under opsonic and non-opsonic 
conditions have yet to be reported. The following chapter examines the roles of 
two LPS receptors, CD 14 and CR3, and the contribution of cholesterol-rich 
membrane rafts in meningococcal interactions with human macrophages. 
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Chapter 5 
Roles of CD14, CR3 and membrane rafts in non-immune and 
opsonic internalisation of N. meningitidis 
5.1 Introduction 
The work described in this chapter examines how potential macrophage receptors 
utilised by N. ineningitidis to gain entry into human macrophages under non- 
immune and opsonic conditions were explored. Evidence from Chapter 4 
suggests that LPS is an important component of these interactions, attention was 
therefore directed at two important LPS receptors, CD 14 and CR3. 
CD 14 is a GPI-anchored LPS receptor (Simmons, Tan et al. 1989) that can bind 
whole gram-negative bacteria as well as soluble LPS, and apart from a few 
notable exceptions, most CD14 ligands induce a pro-inflammatory response 
which serves to eliminate pathogens and their toxic compounds in a controlled 
manner. Uncontrolled stimulation could result in the life-threatening symptoms 
of septic shock. Interaction of LPS with monocytes/macrophages via specific 
membrane receptors (Bone, Grodzin et al. 1997) is the first step in the in the 
pathogenesis of endotoxic shock. Based on a number of in vitro studies, CD 14 
involvement in the phagocytosis of gram-negative bacteria via LPS has been 
observed (Grunwald, Fan et al. 1996), but its lack of transmembrane and 
cytoplasmic domains suggests that the organisms are internalised independently 
of CD14 (Kop and Medzhitov 1999), implicating one or more other phagocytic 
receptors such as TLR4, CR3 and as this study suggest SR-A. It is not known 
exactly how signals are transduced by CD 14 over the plasma membrane, as GPI 
lacks the ability to transduce signals directly into the cells. Stimuli such as 
PMA, LPS or IFNy induce the shedding of mCD I4 (to 48kDa sCD 14) from the 
surface of monocytes/macrophages; which may be mediated by the activation of 
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a membrane-associated serine protease. The role of CD 14 in cell-cell 
interactions with monocytes has been reported, as the use of anti-CD 14 mAb 
induces the monocyte-mediated activation of T-cells and ICAM-I-mediated 
attachment to monocytes (Lauener, Geha et at. 1990; Lue, Lauener et al. 1991), 
but no reports into the role of CD 14 in the processing of N. meningitidis by 
macrophages have been published to date. 
Phosphatidylinositol-specific phospholipase C (PIPLC) is an enzyme that 
specifically cleaves protein from the phosphatidylinositol component of the GPI 
anchor, and structural studies focusing on the glycan component that connects 
the protein to phosphatidylinositol molecule has shown that it has been 
conserved during evolution. Use of PIPLC is an effective method of removing 
GPI-linked proteins from the surface of macrophages or neutrophils. The GPI 
anchor may play a versatile role in the regulation of cell surface expression, and 
may offer a site for the degradation of proteins by specific endogenous 
phospholipases, resulting in the release of protein from the cell surface. 
Products of such degradation may then in turn have a role in cellular 
communication. 
In this study MDM cells were treated with phosphatidylinositol phospholipase C 
(PIPLC), which cleaves the GPI-anchor of surface proteins, resulting in the 
complete removal of CD 14 from the surface of the cell, leaving sCD 14 molecules 
in the surrounding media which were subsequently removed during washing. In 
order to examine the relationship between mCD 14 and N. inen1ngllidis 
specifically, an anti-human CD 14 blocking mAb (MY4) was also used in 
adherence and internalisation studies in different environments. 
As human macrophages express a wide array of receptors capable of binding and 
internalising gram-negative bacteria, a model system was used to allow the study 
of human CD 14 in isolation from other phagocytic receptors, by transfecting 
HeLa cells with CD14. HeLa cells are a human epithelial cell line that possess 
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limited phagocytic ability, but are able to successfully express transfected 
receptors and incite pro-inflammatory responses as a consequent-2. Transfected 
cells were therefore used to examine meningococcal association, and differential 
fluorescent microscopy was used to obtain these results. In this chapter, the 
results indicate show that serogroup B N. meningilidis adhere to non-immune 
macrophages almost exclusively through CD 14 in the absence of serum. 
A range of integrins also express RGD (Arg-Gly-Asp) sequences which function 
as cell adhesion sites for a number of endogenous molecules including 
fibronectin, vitronectin, fibrinogen, thrombospondin and laminin (Ruoslahti 
1996). A number of microorganisms have been found to bind to these sequences 
as a means of gaining entry into the cell, for example Bor"datella pertussis 
through its surface protein (Leininger, Roberts et al. 1991). Yersinia 
pseudotuberculosis produces an invasin to invade cells, and although this invasin 
does not contain RGD sequences, RGD peptides can inhibit invasin binding and 
bacterial entry (Van Nhieu and Isberg 1991). RGD peptides have also been 
successfully used to block entry of N. meningitidis into human endothelial cells 
(Virji, Makepeace et al. 1995), therefore these peptides were also used to 
examine whether meningococci interact with RGD-containing sites present on 
the surface of macrophages using this model. 
Observations from Chapter 3 led us to conclude that non-Fcy receptors are 
involved in the internalisation but not the binding of N. nteningitidis in the 
presence of immune serum, we therefore also examined Neisseria interactions 
with CR3 in this chapter. This was a natural avenue to explore, as CR3 is 
considered a cornerstone of the innate immune system, and as a prominent 
phagocytic receptor that binds and internalises particles in both the presence and 
absence of opsonins, I wanted to observe the role, if any, this receptor played in 
neisserial interactions with human macrophages. A number of studies over the 
years have established that a range of saccharides, including bacterial LPS and 
NADG (Thornton, Vetvicka et al. 1996), bind to the polysaccharide lectin site of 
CR3, situated C-terminus to the 1-domain, but this has not been observed with 
Neisseria species. 
Previous studies have shown that a number of different micro-organisms, such as 
Mycobacteria species and Listeria monocytogenes, use macrophage CR3 as a 
port of entry into leukocytes. Lister"ia are killed effectively, but in contrast 
Mycobacteria enter the cells without alerting normal immune responses (Stokes, 
Haidl et al. 1993; Drevets, Leenen et al. 1996; Zimmerli, Edwards et al. 1996; 
Le_Cabec, Cols et al. 2000). GPI-proteins aggregate on cholesterol-rich micro- 
domains known as lipid rafts, and evidence has been found to suggest that in the 
binding and internalisation of certain pathogenic bacteria, such as Mycobacteria 
kansasii, CR3 are also mobilised to these lipid rafts. Here they interact both 
physically and functionally with CD 14, which themselves form large non- 
covalently bound aggregates on specific plasma membrane microdomains known 
as caveolae, which are known to be sites on which GPI-linked receptors localise 
(Pierini and Maxfield 2001). Lipid raft disrupting agents, Nystatin and ß- 
cyclodextrin, were used in this study in an attempt to identify if this is also the 
case in meningococcal processing. 
In summary, this chapter examines the roles of CD 14 and CR3; meningococcal- 
CR3 interactions are observed in a number of different ways; (a) Non-opsonic 
interactions with the lectin binding site of CDllb/18 were inhibited using N- 
acetyl D-glucosamine (NADG) (b) The I-domain (and/or lectin site) was blocked 
with anti-human CD I1b mAb (2LMP 19c) under both opsonic and non-opsonic 
_UrVUi 
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binding sites on primary human macrophages and interactions with meningococci 
observed. The contribution of lipid-rich membrane rafts in macrophage 
interactions with N. meningitidis in the presence/absence of immune serum was 
also examined by using raft disrupting chemicals, ß-Cyclodextrin and Nystatin. 
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5.2 Results 
Part I: CD14 
5.2.1.1 Human macrophages can capture N. meningitidis through GPI- 
anchored receptors 
Activating agents, such as LPS, have the effect of inducing the translocation of 
intracellular pools of GPI-linked proteins to the cell surface, and therefore 
increase expression of CD14 receptors. Therefore, when internalisation studies 
at warm temperatures looking specifically at the role of C1314 were carried out, 
this effect was compensated for by ensuring the continuous presence of PIPLC 
enzyme or anti-CD 14 antibody in the surrounding media. I had initially observed 
that following PIPLC treatment of human macrophages, the absence of the 
PIPLC enzyme during bacterial infection did not inhibit GPI protein function 
with respect to binding, as no difference in meningococcal binding was observed 
between enzyme-treated and control cells (data not shown). A difference was 
only observed if the enzyme was maintained in the media throughout. 
For this adherence study MDM were incubated with I unit/ml PIPLC for 30min 
at 37°C, 5% CO2 before cells were washed three times in warm culture media and 
infected with non-opsonised N. nienirrgitidis H44/76 at MOI of 50: 1 in the 
presence of enzyme for Ih at 4°C. Cells were fixed after incubation and 
analysed. Following incubation with PIPLC at 4°C a 25.1% reduction in the 
numbers of N. ineningitidis H44/76 adherent per macrophage was noted. (Fig. 
5.1A) GPI-receptor cleavage also had a marked effect on the percentage 
population of macrophages capable of binding N. ineningilidls H44/76 after 
PIPLC treatment. Compared with untreated control cells, a 58.14% reduction 
was noted. (Fig. 5.1 B) 
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Comparison of H44/76 adherence to pre-treated MDM under non-opsonic conditions. 
MDM were treated with anti-CD14 mAb MY4, control antibody IgG2b or I unit/ml 
phosphatidylinositol phospholipase C (PI-PLC) before exposure to bacteria for Ih at 
4°C. Graphs represent (A) ratio of bacteria associated per macrophage, out of 200 
(B) Percentage population of MDM with bacteria associated on surface. Data shown 
from four different donors, each experiment done in triplicate. Boxes represent first 
and third quartiles; lines within each box are median values; black dots represent 
mean values. individual P values obtained using Mann-Whitney U test comparing 
antibody-treated cells with untreated control. Kruskal Wallis P<0.01 for graph (B). 
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The conspicuous difference of meningococcal recognition at 4°C following 
PIPLC treatment may have been a temperature dependent response, therefore the 
experiment was repeated at 37°C, and bacteria were incubated for 30min and 
60min before fixing and staining. The effects of PIPLC treatment followed a 
different pattern at 37°C, as the only change observed was the percentage of 
adherent bacteria internalised following 30min incubation fell dramatically by 
57.7% (Fig. 5.2). Effects of PIPLC on bacterial adherence also appear to be 
temperature dependent, as no difference was observed at 37°C. 
5.2.1.2 Blocking CD14 inhibits meningococcal adherence and 
internalisation by human macrophages 
As a general GPI cleavage enzyme, the action of PIPLC was not specific to one 
surface protein expressed on macrophages, so in order to identify which possible 
receptors were involved in meningococcal recognition monoclonal antibodies 
were used. As a prominent LPS receptor present on human macrophages and 
known to contribute to bacterial recognition by immune cells, I wanted to 
ascertain whether CD 14 contributed to the marked reduction in bacterial 
adherence and internalisation of serogroup B N. meningitidis to PIPLC-treated 
macrophages. In order to examine this phenomenon in greater detail, MDM 
were incubated in the presence of MY4, a mouse anti-human CD 14 monoclonal 
antibody that blocks the LPS-binding site of CD 14. 
MDM were incubated in the presence of 59g/ml MY4 mAb for 30min at 37°C, 
5% C02, before wells were washed three times in warm culture media and 
exposed to N. meningitidis H44/76 in the absence of serum opsonins. Again, for 
all studies carried out at 37°C, macrophages were continuously incubated in the 
presence of MY4 in order to compensate for the translocation of intracellular 
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pools of CD 14 to the cell surface. MY4 appeared to reduce macrophage 
recognition of meningococci at both 4°C and 37°C. 
5.2.1.3 Effect of temperature on bacterial interactions 
MDM were pre-incubated in the presence of 5µg/ml MY4 or same concentration 
of the isotype control antibody IgG2b before infecting with N. meningitidis 
H44/76. Bacterial adherence studies carried out at 4°C show that MY4 treatment 
clearly diminishes bacterial recognition when compared to both untreated control 
cells and isotype control antibody IgG2b (see Fig. 5.1). MY4 had a most 
significant effect on the population of macrophages with adherent bacteria on 
their surface, as a 72.36% reduction was observed in Figure 5.1 B. This response 
to anti-CD14 mAb was even more marked than the more general PIPLC enzyme, 
suggesting that of the GPI-anchored receptors present on the surface on human 
macrophages, CD 14 may play an important role in meningococcal recognition. 
To study the effects of these treatments on bacterial internalisation, pre-treated 
MDM cells were incubated with bacteria at 37°C for 30min and 60min. Fig. 
5.2A demonstrates numbers of adherent bacteria declined by 30.27%, although 
by 60min this had recovered to levels equivalent with control cells. MY4 
appeared to have no significant effect on the internalisation of N. meningitidis 
H44/76 at 30min, but by 60min bacterial uptake had fallen by 43.05% (Fig. 
5.2B). Following 30min incubation, fewer organisms are adherent to fewer 
macrophages (Fig. 5.2C) and the percentage of these bacteria internalised by 
MDM remains the same as the untreated control cells. 
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Figure 5.2 
Absence of GPI-linked proteins and CD14 reduces bacterial uptake 
Comparison of H44/76 adherence to pre-treated MDM under non-immune 
conditions. MDM were treated with anti-CD14 mAb MY4 (5µg/ml), or I 
unit/ml phosphatidylinositol phospholipase C (PI-PLC) before incubation with 
bacteria for 60min at 37`C. Graphs represent (A) ratio of bacteria associated 
per macrophage, from 200 cells counted (B) Internalisation (C) Percentage 
population of MDM with bacteria associated on surface. Data shown from 
four different donors, each experiment performed at least three times. 
Statistical significance denoted by *P<0.05 using Mann Whitney U test 
comparing pre-treated cells with untreated control cells. 
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The population of macrophages with adherent or internalised organisms fell 
dramatically at both time points; 73.75% at 30min and 36.52% by 60 min. 
5.2.1.4 Increased association of N. meningitidis to HeLa CD14- 
transfectants 
HeLa cells do not possess the necessary machinery for efficient phagocytosis of 
microbes, and as a result are not considered to be "professional" phagocytes. 
Transfecting HeLa cells with human CD14 confers the ability of these cells to 
express mCD 14, and this was confirmed by staining transfected cells with FITC- 
conjugated MY4. CD 14-transfected cells and control cells were incubated for lh 
at 4°C with N. meningitidis H44/76, and analysed for any changes in adherence 
alone. Control cells were HeLa cells which had been transfected with the 
plasmid vector which lacked CD 14 cDNA sequence. This model was used as a 
means of establishing the influence of CD14 in the absence of a number of 
macrophage receptors. 
Fig. 5.3 illustrates the difference in bacterial adherence between control cells 
(vector) and CD 14-transfected cells. A 60.24% increase in adherence to 
transfected cells was observed. There was a 65.48% increase in the proportion 
of CD 14-transfected HeLa cells with adherent meningococci present on the 
surface, and a 40.40% increase in total adherence (total bacteria/number of HeLa 
cells with adherent bacteria) (see Fig. 5.3B and Fig. 5.3C). 
Other possible receptors utilised by N. meningitidis may exist on HeLa cells that 
recognise OMP structures, such as pili, but these results suggest that their effects 
appear to be less prominent, as the presence/absence of CD 14 appears to have a 
profound effect on bacterial recognition. 
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Figure 5.3 
CD14-transfected HeLa cells 
Absence of CDI4 significantly impairs effective 
association of H44/76 to CDI4-transfected HeLa 
cells under non-opsonic conditions. Box-plots 
show (A) ratio of bacteria associated per HeLa 
cell, out of 200 (B) Percentage HeLa cells with 
bacteria associated (C) adherence index (total 
MC/100). Data based on two experiments, each 
done in triplicate. Statistical significance denoted 
by *P<0.05, **P<0.01 usilg Mann-Whitney U 
test. 
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Part II: Complement receptor 3 (CR3, CD11b/18) 
5.2.2.1 Blockade of CD11b/CD18 has no effect on binding or 
internalisation of N. meningitidis in the absence of serum opsonins 
Findings in Part I suggested that CD 14 is an important recognition receptor for 
N. meningitidis, but as CD I4 lacks transmembrane and cytoplasmic domains 
essential for bacterial phagocytosis, it was not considered to be a receptor 
directly involved in transduction of Neisseria internalisation. Therefore the role 
of complement receptor 3 (CR3 or CD 11 b/18) which does have phagocytic 
potential was examined. Two important binding sites, I-domain and lectin site, 
were inhibited using different reagents and effects on meningococcal processing 
observed. 
2LMP 19c is a murine anti-human mAb specific to an epitope found on the I- 
domain of CDI Ib subunit (Cywes, Godenir et al. 1996), a binding site of opsonic 
complement fragments such as C3b and iC3b. Studies carried out by Peyron and 
colleagues (Peyron, Bordier et al. 2000) also found that 2LMP19c mAb inhibited 
non-opsonic Mycobacterial internalisation by neutrophils, presumably by 
blocking the lectin site to which Mycobacierria are known to bind directly. A 
number of monoclonal antibodies known to be specific to the I-domain also 
block the lectin site. MDM were treated with 2LMP 19c, before cells were 
exposed to N. nteningitidis H44/76 in the presence/absence of serum opsonins. 
Macrophages were incubated with 2.5µg/ml of 2LMP 19c, isotype control IgG 1, 
or culture media as a control for 30min at 37°C, cells were then washed 
thoroughly to remove excess reagent. Mid-log phase N. meningitidis H44/76 
were used to infect cells at MOI of 50: 1. Non-opsonised N. meningilidis H44/76 
were incubated in the presence of antibody for all 37°C incubations. Fig. 5.4 
shows 2LMP19c-treated cells incubated with bacteria for lh at 4°C. No 
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significant difference between adherence of non-opsonised N. nzen1ngitidis 
H44/76 by pre-blocked MDM were observed (Fig 5.4); nor was any difference 
apparent at a range of concentrations (data not shown). 
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CD11b I-domain blockade 
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Anti-CDl lb/18 mAb 2LMP19c was used to block macrophages before inoculating 
with non-opsonised H44/76, incubating for 60min at 4°C. (A) Bacteria associated per 
macrophage (B) Percentage of macrophages with adherent bacteria on surface of cell. 
Results based on macrophages from four different donors, with each experiment done 
in triplicate. No significant difference was observed between antibody-treated and 
control macrophages using Mann-Whitney U test. (P>0.05) 
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5.2.2.2 Macrophages do not internalise opsonised N. meningitidis via 
CR3 
Previous observations in Chapter 1 indicated that non-Fcy macrophage receptors 
were involved in the opsonin-dependant internalisation of N. meningitidis, 
therefore the I-domain of CD! 1b was blocked using 2LMP19c monoclonal 
antibody. The I-domain is a known binding site of complement fragments such 
as iC3b and C3b. Macrophages were incubated with bacteria at 4°C and 37°C to 
ascertain if a direct relationship between opsonised N. meningitidis H44/76 and 
macrophage CR3 exists. 
Fig. 5.5 shows that no reduction was observed in serum opsonised bacterial 
adherence or internalisation of 2LMP19c-treated cells when compared with 
untreated control cells (P>0.05). The only significant effect of anti-CD I1b mAb 
under opsonic conditions occurred after 30min incubation at 37°C, when the 
percentage of macrophages with adherent or internalised bacteria (ie. DAPI 
positive organisms) notably fell by 32.98%. Although by 60min MDM appeared 
to return to levels comparable to untreated control levels. 
5.2.2.3 N-acetyl-D-glucosamine (NADG) treatment of lectin site of 
macrophage CR3 
The lectin-binding site of CD I1b is divalent cation independent and can be 
blocked by competing certain polysaccharides, including NADG, glucose and 
mannose all of which can bind to the lectin site (Thornton, Vetvicka et al. 1996). 
A number of integrins and GPI-anchored receptors associate with one another, as 
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Figure 5.5 
CD11b I-domain blockade in presence of immune serum 
Bacterial uptake examined by treating MDM with anti-CD1 lb mAb 2LMP19c 
for 15min at 37°C before inoculating with N. meningitidis H44/76 in the 
presence/absence of serum opsonins for 60 min at 37C. Control MDM were 
not treated with antibody. Graphs represent (A) bacteria per cell (B) 
Percentage of bound organisms internalised (C) Percentage population of 
macrophages interacting with bacteria. Data obtained from three donors with 
each experiment performed at least three times. Values represented as mean (f 
standard error of mean). Statistical significance calculated by Mann Whitney 
U test and denoted by *P<0.05. 
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GPI proteins, such as CD14, tend to be heavily glycosylated and previous studies 
using neutrophils have found NADG disrupts these interactions by competing for 
the binding site, and consequently preventing bacterial interactions on this region 
of the receptor (Zhou, van der Winkel et al. 1993; Galon, Gauchat et al. 1996). 
Work using NADG to block interactions between Mycobacteria strains and 
neutrophils found that the reagent appeared to disrupt the formation of CD 14- 
CR3 complexes and therefore inhibit bacterial association to the neutrophils 
(Peyron, Bordier et al. 2000). Such complexes are also known to form on 
macrophages, but no evidence of meningococcal involvement with CD 14-CR3 
has been published. Therefore, part of the non-opsonic studies of CR3 in this 
chapter involved the use of NADG at varying concentrations over time. MDM 
were incubated in the presence of NADG for 15min before infecting with N. 
meningitidis H44/76. Experiments were performed using at least three donors 
and each experiment repeated in triplicate. Fig . 5.6 shows that no difference 
was observed in the binding or internalisation of N. 1neningllldls H44/76 to 
control cells or NADG-treated cells under non-opsonic conditions. 
5.2.2.4 Inhibition of RGD-integrins does not influence interaction of N. 
meningitidis with macrophages 
Human MDM were treated with RGDS-containing peptides for 30min at 37°C 
prior to infection with N. meningitidis H44/76 at MOI of 50. MDM were 
incubated with bacteria at 4°C (Fig. 5.7) and 37°C (data not shown) for lh and no 
significant difference was found then compared with control cells (RGES-treated 
and untreated MDM). 
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Polysaccharide binding site blockade using NADG 
MDM incubated with a range of concentrations of N-acetyl D-glucosamine (NADG) 
before infecting with non-opsonised N. meningitidis H44/76 and incubating for 60min 
at 4C or 37°C. Graphs show (A) Numbers of adherent bacteria per cell after 
incubation at 4°C (B) Internalisation following 37 °C incubation. Graphs Data 
obtained from three donors and each experiment repeated at least three times. No 
significant difference in binding or uptake of meningococci using Mann-Whitney U 
test (P>0.05). 
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Integrin binding sites were blocked using RGDS-containing peptides (RGES used as 
control) before exposure to H44/76 in the absence of immune serum. (A) bacterial 
association (B) Percentage of macrophages with bacteria associated. Each value is 
mean (± standard error of mean) from four donors, each experiment done in 
triplicate. No difference shown under these conditions using Mann-Whitney U test 
(P>0.05). 
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Part III: Lipid rafts 
5.2.3 Role of macrophage lipid rafts in trafficking of N. meningitidis 
5.2.3.1 Cholesterol depletion of macrophages has no effect on bacterial 
phagocytosis 
Cholesterol-rich lipid rafts are used as a portal of entry by a number of 
organisms, and studies have attributed this trend to the high density of 
molecules, such as GPI-proteins, caveolin and heterotrimeric G-proteins, that 
tend to cluster at these sites (Brown and London 1998). 
Integrins are not only in high concentration, but are also in close proximity to 
signalling molecules on these specialised regions of the cell. Lipid rafts are 
areas on the plasma membrane that have more highly ordered lipids and are rich 
in sphingolipids and cholesterol. Chemical disruption of these rafts may give 
some insight into the preferred sites of entry of N. men1ngilidis, as we have 
observed in previous chapters that both CD 14 and CR3 are involved, in varying 
degrees, with macrophage recognition of meningococci. The only opsonic 
receptor so far reported to cluster on lipid rafts is CR3, therefore another way of 
studying the possible relationship between CD 14 and CR3 involved treating 
MDM with a cholesterol-scavenging antibiotic, nystatin, and cholesterol- 
depleting agent, ß-cyclodextrin, both of which disrupt lipid rafts structure which 
is dependent on the presence of cholesterol. 
Cells were treated with 25µg/ml of Nystatin or ß-cyclodextrin for 15 min at 37°C 
before incubating with N. meningitidis H44/76 and analysing by fluorescent 
microscopy or flow cytometry. Both opsonised and non-opsonised organisms 
were studied. The observations in the studies described in this chapter using an 
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anti-CR3 monoclonal antibody suggested that neither opson: sed nor non- 
opsonised meningococci were internalised via CR3 
Interestingly Fig. 5.8 demonstrates that following Nystatin treatment of MDM, 
opsonised meningococci adhered 38.91% less efficiently than untreated control 
cells (P<0.001), and the population of phagocytic macrophages increased by 
22.67% (P<0.05). Internalisation of organisms remained the same between 
untreated control and cholesterol-depleted cells to macrophages at 37°C. No 
differences were observed in the adherence or internalisation of non-opsonised 
meningococci by Nystatin-treated cells. This suggests that receptors that 
recognise opsonised N. meningitidis H44/76 may also be found in these lipid-rich 
domains. The numbers of organisms internalised have not been affected by 
treatment of the cells with Nystatin, but there appears to be an increase in the 
number of macrophages with less meningococci associated on their surface. It 
would seem that cholesterol-depletion increases the number of opsonic receptors 
available for binding meningococci, but fewer organisms actually bind to each 
macrophage (see discussion). 
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Figure 5.8 
Chemical disruption of lipid rafts using Nystatin 
Bacterial uptake examined by treating MDM with cholesterol-depleting agent 
Nystatin for 15min at 37°C before inoculating with N. meningitidis H44/76 in the 
presence/absence of serum opsonins at 37°C. Control MDM were not treated with 
Nystatin. Graphs represent (A) bacteria per cell (B) Percentage of bound organisms 
internalised (C) Percentage population of macrophages interacting with bacteria. 
Data obtained from four donors with each experiment performed at least three times. 
Values represented as mean (± standard error of mean). Statistical significance 
calculated by Mann Whitney U test and denoted by *P<0.05, **P<0.01, ***P<0.001 
when comparing Nystatin-treated cells with control cells under each condition. 
131 131 
A 
U 
U 
C) 
Ü 
c3 
opsonised non-opsonised 
B 
U 
C 
ü 
opsonised non-opsonised 
C 
u 
n 
0 Ü 
h 
O 
C 
O 
C, 
G 
O 
G 
opsonised non-opsonised 
132 
control Nystatin + control Nystatin + 
control Nystatin + control N ystatin + 
ýY ýýYý 
control Nystatin + control Nystatin + 
5.3 Summary and discussion 
Lipid rafts comprise dynamic assemblies of cholesterol and sphingolipids in 
plasma and endosomal membrane of eukaryotic cells (Simons and Ikonen 1997; 
Brown and London 1998; Brown and London 1998). Rats were originally 
reported to explain the lipid-based sorting properties of cell membranes, and 
were therefore implicated in cell membrane cholesterol-based micro- 
heterogeneity (Simmons and van Meer 1988). GPI-anchored receptors present on 
the surface of macrophages and neutrophils have been found to aggregate on 
distinct cholesterol-enriched lipid rafts, which appear to have a number of 
functions including signal transduction, cholesterol trafficking, endocytosis and 
transcytosis across epithelial cells (Anderson 1998; Okamoto, Schlegel et al. 
1998). CR3 and GPI-anchored proteins, including CD 14, were examined 
together in this chapter as previous studies have observed that CD 14 aggregate 
on lipid rafts and on activation CR3 also appear to translocate to lipid rafts 
(Petty and Todd 1996). 
Rafts are of current interest as they are unique micro-environments enriched with 
caveolae, signal transducing molecules and appear to be used by pathogenic 
organisms as a site of entry into cells. Organisms include C. jejuni, L. 
pneinnophila (Watarai, Derre et al. 2001), Plasmodium falcipar-urn, as well as 
LPS and Mycobacterium bovis BCG (Gatfield and Pieters 2000) where 
cholesterol aggregates at the site of bacterial entry and cholesterol depletion 
inhibits M. bovis uptake. Selective lipid recruitment has also been observed 
during HIV-1 or influenza virus budding from mammalian cells (Scheiffele, 
Rietveld et al. 1999; Ono and Freed 2001). 
Nystatin or ßCD treatment depletes cholesterol from membranes causing 
degradation of lipid rafts, dissociation of proteins attached and disappearance of 
caveolae from rafts. Nystatin treatment of macrophages before exposure to non- 
opsonised meningococci had no significant affect on macrophage-neisserial 
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interactions, but in the presence of immune serum bacterial adherence was 
impaired, suggesting that the presence of membrane rafts does appear to 
contribute significantly to the recognition of opsonised N. meningitidis H44/76 
by macrophages. Cholesterol-depletion increases the number of opsonic 
receptors available for binding meningococci, but fewer organisms actually bind 
to each macrophage. This may be due to Nystatin treatment resulting in release 
of receptors from these rafts, and their dispersal on the macrophage surface, 
making more available. 
Importance of these specialised microdomains is highlighted by the role of lipid 
rafts in signal transduction (Anderson 1998; Okamoto, Schlegel et al. 1998), and 
cross-linking of signalling receptors increases their affinity for rafts. A new 
microenvironment results from the partitioning of receptors into lipid rafts, 
where their state of phosphorylation can be adjusted by local kinases and 
phosphatases. Such compartmentalised signalling has been observed when 
antibodies or other ligands cross-link GPI-anchored proteins present in lipid 
rafts. Clustering of several lipid rafts may result in amplifying signal, and 
consequently affect signal transduction. Transmembrane and GPI-linked 
proteins present on rafts are solubilised and vesicles of rafts are released from 
the cell. The problem with the use of cholesterol-depleting or -scavenging 
reagents that disrupt the native structure of lipid rafts is that they are fairly crude 
tools as they are not specifically targeted to cholesterol present in lipid rafts 
alone, but will also deplete cholesterol from non-raft membrane. Results are also 
dependent on different modes of action, i. e. Cholesterol binding agents compared 
with those that inhibit cholesterol synthesis by the cell. Much more information 
on the properties is needed to understand the roles of lipid rafts in different cells. 
Little is known about the size, heterogeneity, dynamics or composition of lipid 
rafts, but it is apparent that a number of different types of lipid rafts can exist on 
a single cell distinguished by their lipid and protein compositions. Separation of 
lipid rafts from cell membrane can be done by density gradient ultra- 
centrifugation of detergent-solubilised membranes, and will produce a mixture of 
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different rafts that cannot be differentiated from one another; and it is likely that 
heavier rafts with higher lipid content will evade detection using these methods. 
PIPLC enzyme was used to cleave GPI-anchored proteins from the surface of the 
cell, consequently bacterial internalisation and recognition by macrophages was 
markedly impaired. As a prominent GPI-anchored receptor that recognises gram- 
negative bacteria, CD 14 receptors were then blocked using a monoclonal 
antibody (MY4), which again resulted in a significant decrease in meningococcal 
interactions with macrophages. As PIPLC and MY4 treatments reduce the 
availability of mCD14 receptors to meningococci, the contribution of alternative 
macrophage receptors able to associate and internalise N. meningitidis H44/76 
may become more prominent as neither treatment resulted in complete abolition 
of adherence or phagocytosis. These observations may be due to these 
alternative receptors binding N. ineningitidis, but not internalising them 
effectively. CD 14-independent uptake therefore appears to be less efficient than 
CD 14-dependent uptake. This suggests that GPI-anchored receptors, and 
specifically CD 14, have a role in trafficking of N. meningitidis H44/76 by human 
macrophages. This was subsequently confirmed using CD 14-transfected HeLa 
cells, and I found that bacterial adherence was enhanced in the presence of 
CD14. HeLa tranfects were a useful tool in attempting to isolate CD14 from a 
number of other macrophage receptors, and support the hypothesis that this 
receptor plays a significant role in non-opsonic meningococcal recognition. 
Previous studies have suggested that the effect of anti-CD 14 monoclonal 
antibodies, such as MY4, may in fact be a result of the antibody binding directly 
to the lectin binding site of CR3, thus inhibiting binding of CD 14 or bacteria to 
CR3, rather than blocking CD 14 directly. 
NADG has been used in previous studies to prevent CR3-GPI protein interactions 
or microbial binding to CR3 by occupying the lectin site, but this reagent 
appeared to have no significant effect on meningococcal recognition by 
macrophages, and may be due to mBSA binding to CR3 lectin site or 
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alternatively other serum components may can bind NADG. The anti-CD 11b 
monoclonal antibody 2LMP 19c is directed specifically at an epitope of the I- 
domain, which is a known binding region of complement components such as 
C3b and iC3b. MDM cells underwent treatment with this antibody but in the 
presence and absence of serum opsonins, no effect on adherence or phagocytosis 
of meningococci was apparent: except the observation that the percentage 
population of cells able to interact with serum opsonised organisms declined. 
This decrease at 30min following anti-I domain treatment was quickly recovered 
by 60min, and may have been due to an up-regulation in receptor expression by 
60min, or perhaps alternative receptors playing a more prominent role in the 
absence of CD I1b. It was also important to perform similar experiments in the 
absence of serum, as a number of monoclonal antibodies also directed 
specifically at the I-domain have been found to block lectin site activity, despite 
the fact that this binding site is located at the C-terminus; these include LM2/1, 
OKMI and MI/70 (Xia and Ross 1998; Xia, Vetvicka et al. 1999). Even though 
this antibody was bought in good faith, it may be that 2LMP 19c was not very 
effective due to a problem with antibody production by the company, 
consequently it is possible that CR3 receptors may not have all been blocked. 
As neither CD14 nor CR3 appear to internalise N. nleningit dis, alternative 
phagocytic receptors were examined in the following chapter, namely Class A 
scavenger receptors, mannose receptor and PAF receptors. 
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Chapter 6 
Non-opsonic receptor recognition of N. meningitidis 
Part I: Class A Scavenger receptor 
6.1.1 Introduction 
Work published by Hampton and colleagues (Hampton, Golenbock et al. 1991) 
first implicated the Class A scavenger receptor in lipid A binding, and it is now 
considered a prominent receptor on human macrophages that is able to directly 
bind an extensive range of ligands. Although the cytoplasmic tail of SR-A 
contains potential protein kinase C (PKC)-interaction sites, it lacks any known 
motifs associated with phagocytosis and yet a number of both gram-negative and 
gram-positive bacteria are internalised via SR-A, including E. coli, L. 
ionocytogenes, S. pyogenes, S. aureus and M. tuberculosis (Suzuki, Kurihara et 
al. 1997; Peiser, Gough et al. 2000; Thomas, Li et al. 2000). 
Direct interaction with LPS normally results in macrophage activation, and the 
initiation of a range of intracellular signalling events and cellular responses 
including production of nitric oxide and pro-inflammatory cytokines such as 
TNF-a and IL-6. A significant amount of evidence suggests that scavenger 
receptors play a role in the down-regulation of these inflammatory responses 
(van_Lenten and Fogelman 1992; Yang, Galeano et al. 1996; Matsuno, Aramaki 
et al. 1997), and the suppression of cellular responses that traditionally 
accompany macrophage activation, including transcriptional activation of NFKB, 
fluxes in intracellular Cat concentrations and hydrolysis of 
phosphatidylinositol-4,5-biphosphate (PIP2) (Schackelford, Misra et al. 1995). 
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The presence of SR-A on the surface of macrophages has therefore been 
associated with the protection of the host against endotoxic shock (Haworth, 
Platt et al. 1997). 
The use of SR-A"1- mice, rat anti-murine monoclonal antibody (2F8) and 
transfection using both murine SR-A isoforms (types I and II) has been the 
source of most microbe-SR-A relationship studies to date. Peiser and colleagues 
recently observed that murine macrophages recognise a range of gram-negative 
bacteria including N. meningitidis via SR-A, but to date little evidence of 
meningococcal processing through SR-A in human cells has been observed. The 
lack of available blocking antibodies to human SR-A meant that an alternative 
reagent was sought. Polyiniosinic acid (Poly I), a known SR-A ligand, binds to a 
lysine cluster present on the collagenous domain which acts as an LPS binding 
site (Yamamoto, Nishimura et al. 1997) and is effective in blocking ligand 
binding to this site. In order to establish that Poly I does indeed block the SRA 
ligand-binding site, I conducted a series of flow cytometry experiments using 
Dil-labelled acLDL, a fluorescently-labelled modified low-density lipoprotein 
that is bound and endocytosed specifically through SR-A. No distinction 
between the two SR-A isoforms can be made using Dil-labelled acLDL . 
As discussed in previous chapters, differentiation of THP-1 using the phorbol 
ester, PMA (phorbol myristate acetate) provokes the maturation of the cell into a 
more macrophage-like cell and induces the expression of a range of surface 
membrane receptors associated with terminally differentiated cells, including 
SR-A. PMA-treated THP-1 cells were the source of the first cDNA clones for 
human SR-Al and SR-All (Matsumoto, Naito et al. 1990). 
Following on from Chapter 4, this chapter continues the search for possible non- 
opsonic macrophage receptors utilized by serogroup B N. meningitidis. No 
previous studies have demonstrated that human macrophages phagocytose 
serogroup B N. meningitidis through SR-A. Previous results reported in this 
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thesis indicate that the individual blockade of a number of CR3 binding sites did 
not impair non-opsonic meningococcal uptake; and C1314 is involvedt in 
meningococcal uptake (see Chapter 5). 1 therefore incubated N. meningitidis 
H44/76 with Poly I-treated cells in order to establish whether SR-A plays any 
role in the adherence and phagocytosis of the organisms in human macrophages. 
Individually inhibiting binding to specific receptors offered some interesting 
results, in particular with respect to CD 14 and SRA involvement. 
Complimentary experiments were also carried out, where blocking reagents and 
antibodies were used to simultaneously block two or more receptors in order to 
give more insight into which non-blocked receptor(s) the organisms might utilise 
in the absence of others. CD 14, SRA and CR3 were all blocked. Two of these 
receptors appear to have a role in meningococcal trafficking in this study, and 
CR3, as a phagocytic receptor favoured by a number of pathogenic microbes, has 
been observed here to be involved in non-immunoglobulin-based interactions. 
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6.1.2 Results 
6.1.2.1 Poly I blocks SR-A ligand uptake 
1x106 MDM were cultured in 24-well tissue culture plates as described earlier, 
and incubated in the presence of 50µg/ml Poly I for 30min at 37°C. Wells were 
then washed three times and media replaced with RPMI 1640,2mM glutamine, 
10% HI FCS (heat-inactivated foetal calf serum) and 501tg/ml Poly I, to which 
Dil-labelled acLDL (DiI-acLDL) was added to the Poly I treated cells. Cells 
were incubated at 37°C, 5% CO2 for 2h and prepared for flow cytometry analysis 
(see Methods). MDM were checked for viability using a trypan blue exclusion 
assay. This assay demonstrated that Poly I was an effective SR-A blocking 
agent, as DiI-acLDL uptake of MDM was almost completely abolished following 
Poly I treatment, and the non-SRA ligand control reagent Poly C had no such 
affect (Fig. 6.1). This assay did not distinguish between binding and uptake of 
acLDL, but was used as a general marker of Poly I effectiveness. 
6.1.2.2 Neisseria meningitidis do not bind to human macrophages via 
Scavenger Receptor A 
Role of scavenger receptors in the direct binding of N. meningitidis H44/76 to 
the surface of MDM cells under non-opsonic conditions was examined. Poly I- 
treated MDM were incubated with N. nieningitidis H44/76 for Ih at 4°C, and Fig. 
6.2A demonstrates that no difference was observed in the number of bacteria 
adherent to each cell or in the percentage of macrophages with bacteria 
associated (Fig. 6.2C). 
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Figure 6.1 
Poly I inhibition of acLDL uptake 
MDM were incubated with Poly I before incubating with Dil-labelled acLDL 
(5ug/ml) for 120min at 37°C, before FACS analysis. Filled line represents Dil- 
acLDL fluorescence of control cells that were not treated with Poly I, dark line 
represents control DiI-acLDL fluorescence and unfilled line indicates DiI-acLDL 
fluorescence by Poly I-treated MDM. Experiments was performed in three human 
donors and repeated three times. Figure represents one experiment done in 
triplicate 
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Figure 6.2 
Phagocytosis inhibited by scavenger receptor blockade 
MDM were pre-treated with Poly I and inoculated with N. meningitidis H44/76 
strain (control cells were untreated MDM) and incubating at 4°C for 60min. 
Unbound organisms were washed off and cells underwent further incubation for 
30min at 37°C. (A) Ratio of adherent bacteria per macrophage after cold 
incubation (B) Population of MDM with bacteria bound or internalised after both 
cold and 37°C incubation (C) Percentage of bacteria internalised by MDM after 
incubation 4C and 30min at 37C. Results from six donors, values represent mean 
(± standard mean of error) and significance is denoted by *P<0.05, **P<0.01 
calculated by Mann Whitney U test. 
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6.1.2.3 Class A Scavenger Receptor enhances phagocytosis of Neisseria 
meningitidis 
MDM were incubated with 50µg/ml Poly I or non-SR-A ligand Poly C or 
untreated cells for 30 minutes at 37°C before inoculating with N. meningilidis 
H44/76 for one hour at 4°C to ensure binding was equal. Wells were then 
washed of any unbound organisms and incubated at 37°C for a further 30 
minutes, and analysed using fluorescent microscopy and 200 cells were counted 
per well. The internalisation of N. nteningitidis H44/76 by human MDM in the 
presence of the scavenger receptor inhibitor Poly I was reduced by 58% (P<0.01) 
when compared to untreated control cells(Fig 6.2B). 
6.1.2.4 Poly I influences uptake when cold step is omitted 
In order to establish whether the effect of Poly I, as described in 6.1.2.3, was 
temperature dependent, meningococcal response to Poly I-treated MDM were 
performed at 37°C, without the 4°C step. After 30min incubation with N. 
meningilidis H44/76 no difference in adherence was observed. By 60min there 
was a significant drop in the association, internalisation and recognition of 
meningococci by Poly I-blocked macrophages (Fig. 6.3). 
6.1.2.5 PMA-differentiated THP-1 internalised N. meningilidis more 
effectively 
Previous results (see Chapter 3) have shown that undifferentiated THP-l cells do 
not internalise N. meningitidis as effectively as human macrophages, which may, 
in part, be due to the absence of SR-A. As human SR-A monoclonal antibodies 
were not available, the THP-1 monocytic cells were incubated with PMA in order 
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Figure 6.3 
Class A Scavenger receptors and MDM 
Monocyte-derived macrophage cells were treated with Poly I before 
incubating for 60min at 37°C with N. meningitidis H44/76, in the 
presence of Poly I. Graphs represent (A) Ratio of bacteria per cell (B) 
Percentage of phagocytosis (C) Population of cells interacting with 
bacteria. Results were obtained from four separate donors, repeated at 
least three times. Values represent mean (± standard error of mean). 
Statistical significance indicated by *P<0.05, **P<0.01 using Mann 
Whitney U test comparing Poly I-treated cells with control cells at each 
time point. 
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to up-regulate SR expression. dTHP-1 cells were then treated with/without Poly 
I and inoculated with N. meningitidis H44/76 in order to examine whether dTHP- 
I cells expressed functional macrophage SR-A capable of internalising bacteria. 
This was tested by analysing whether treatment with Poly I would impair 
meningococcal uptake by dTHP-1, as was observed using primary human 
macrophages. 
Comparisons of Fig. 6.3 and Fig. 6.4 shows that PMA stimulation and therefore 
up-regulation in receptor expression, conferred in monocytes the capacity to 
internalise N. meningitidis more effectively than undifferentiated THP-l cells, to 
levels quite comparable to MDM cells; and Poly I treatment of these 
differentiated cells resulted in a 31.4% loss in meningococcal adherence and 
24.2% decrease in bacterial internalisation after 60 min incubation at 37°C. 
These findings imply SR-A does contributes to the non-opsonic phagocytosis of 
N. meningitidis H44/76. 
6.1.2.6 Population of phagocytic cells interacting with bacteria in the 
absence of SRA remains the same irrespective of Poly I treatment 
The marked reduction in bacterial internalisation due to SR-A blockade appeared 
to have no significant effect on the population of MDM or indeed dTHP-1 
binding and internalising organisms (Fig. 6.3C and 6.4C). Hence the same mean 
number of bacteria are binding to the same mean number of macrophages, but in 
the presence of Poly I internalisation is reduced by over half; although not 
completely abolished. Therefore, SR-A are likely to be key receptors involved in 
the non-opsonic internalisation of N. ineningilidis. As phagocytosis is not 
completely abolished following Poly I treatment, this suggests that in the 
presence of Poly I (and absence of available SR-A) meningococci uptake occurs 
through, as yet unknown, alternative macrophage receptors. Experiments 
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transfecting cell lines with human SR-A clones were not possible, as the relevant 
clones were not available. 
Figure 6.4 
SRA-mediated uptake in dTHP-1 inhibited by Poly I 
PMA-differentiated THP-1 (dTHP-1) cells treated with Poly I before 
incubating for 60min at 37°C with N. meningitidis H44/76, in the 
presence of Poly I. Graphs represent (A) Ratio of bacteria per cell 
(B) Percentage of phagocytosis (C) Population of cells interacting 
with bacteria. Results were obtained from four separate experiments, 
repeated at least three times. Values represent mean (± standard error 
of mean). Statistical significance indicated by *P<0.05, **P<0.01 
using Mann Whitney U test. 
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6.1.2.7 N. meningitidis is internalised in an actin-dependent manner 
To ensure that meningococcal uptake by MDM was an actin-dependent process, 
MDM were treated with Cytochalasin D for 30min before infecting cells with N. 
meningitidis H44/76 for 60min at 37°C. Figure 6.5 demonstrates that 
phagocytosis was reduced by over 70%. 
6.1.2.8 Blockade of phagocytosis by Poly I is dose-dependent 
MDM were incubated with Poly I at a range of concentrations (0-500µg/ml) 
before inoculating with N. meningitidis H44/76, incubating for lh at 4°C and 
30min at 37°C. Percentage of adherent bacteria internalised is demonstrated in 
Figure 6.6. By 25µg/ml Poly I-treatment of MDMs inhibited internalisation of 
meningococci to the point where maximal numbers of SR-As appear to have been 
blocked, and from 50 - 200µg/ml this appears to be reversed which may be due 
to alternative phagocytic receptor(s) playing more prominent roles in the absence 
of SR-A. 
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Figure 6.5 
Disruption of actin development inhibits phagocytosis 
MDM were incubated in the presence of 3µM Cytochalasin D for 30min 
before exposure to bacteria. Graph shows results from two experiments, 
based on mean values (±SEM). Statistical significance indicated by 
*P<0.05 using Mann Whitney U test. 
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Figure 6.6 
Effect of Poly I 
Range of Poly I concentrations used to block SR-A, and internalisation 
measured. MDM were incubated with N. rneningitidis H44/76 (MOl 50: 1) in 
the absence of serum for 60min at 4°C followed by 30min at 37°C. 
Observations were based on three human donors, each experiment repeated 
at least three times. Values represent mean (t standard error of mean) with 
statistical significance calculated using Mann Whitney U test to compare 
each concentration against untreated control cells. 
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6.1.2.9 Pro-inflammatory cytokine secretion not affected by SR 
blockade 
MDM were pre-incubated with Poly I to investigate whether the internalisation 
of N. nteningitidis H44/76 stimulates a pro-inflammatory cytokine response 
normally associated with LPS: macrophage interactions. MDM were incubated 
with Neissei"ia ineningilidis for 2h in the presence or absence of Poly I, after 
which supernates from each well were collected and frozen for further analysis to 
detect the levels of TNF-a. Enzyme-linked immunosorbent assays (ELISA) were 
carried out on the supernatants. Figure 6. shows that TNF-a secretion was not 
significantly altered in the presence/absence of increasing doses of Poly I up to 
50µg/ml. However Poly I at 100µg/ml did exhibit an attenuating effect. 
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Figure 6.7 
TNF-a secretion following scavenger receptor blockade 
MDM were treated with a range of concentrations of Poly I before incubation with 
N. meningitidis H44/76 for 120 min, and levels of TNF- a secreted into the 
surrounding media were measured. Observations were based on four human 
donors, each experiment repeated at least six times. Values represent mean (± 
standard error of mean) and significance denoted by *P<0.05 using Mann Whitney 
U test. 
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6.1.2.10 Examination of the effect of multiple receptor blockade on 
bacterial phagocytosis 
To examine if three of the macrophage receptors investigated individually in this 
study, namely CD 14, SRA and CR3, showed any differences in bacterial 
internalisation when more than one receptor was absent, combinations of the 
three blocking reagents/antibodies were used at same concentration as before 
(see Chapter 5); anti-CD 14 mAb ([MY4], 5µg/ml), anti-CD 1lb mAb 
([2LMP19c], 2µg/ml) and SR blocking agent ([Poly I], 50µg/ml). Combinations 
of reagents were incubated with MDM simultaneously for 30min, before washing 
three times and infecting with N. nieningitidis H44/76 (MOI 50: 1) and culture 
media containing blocking agents. Cells were then incubated for 60min before 
fixing, staining and microscopic analysis. 
Fig. 6.8A shows that after 60min incubation at 37°C the absence of CD14, 
through MY4 treatment, significantly impairs bacterial recognition by 
macrophages. This reduction is apparent in the total number of bacteria binding, 
the ratio of bacteria to each macrophage (23% reduction) and the proportion of 
macrophages interacting with bacteria. Moreover, this observation is repeated 
when CD 14 receptors are blocked in combination with either CR3 or SRA, where 
compared to control macrophages association is reduced by 18.3% and 23.7% 
respectively. These findings suggest again that macrophage CD 14 receptors are 
involved in bacterial capture at physiological temperature. 
Fig. 6.8B represents the differences in adherent meningococci phagocytosed by 
MDM. Only macrophages treated with Poly I and anti-CD14 reagents, both 
individually and together, showed a significant difference in bacterial 
internalisation; although not when co-incubated with anti-CR3 antibody, even 
though this combination of blocks significantly reduces adherence. Compared to 
control cells, anti-SRA treatment alone reduced internalisation by 26.5% and 
anti-CD 14/anti-SRA resulted in a 25% decrease. Similar patterns were observed 
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in number of organisms able to bind, and proportion of macrophages binding and 
internalising the bacteria. These findings suggests that CD 14 and SRA both 
contribute significantly to meningococcal uptake by macrophages, and may work 
in concert. Similar patterns were observed in Figure 6.8C and D. 
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Figure 6.8 
Multiple receptor blockade affects bacterial phagocytosis 
MDM were simultaneously exposed to combinations of blocking 
antibody/reagents before infecting macrophages with N. meningitidis H44/76 and 
incubating for 60min at 37°C. Anti-CR3 mAb is 2LMP19c, anti-CD14 mAb is 
MY4 and anti-SRA is Poly I. Graphs show (A) mean numbers of bacteria bound 
to each macrophage (B) mean percentage of total organisms internalised and (C) 
mean percentage population of macrophages interacting with bacteria and (D) total 
number of bacteria bound/ingested by 100 macrophages (filled bars) in the 
absence of serum., with bars representing mean (± standard error of mean). 
Results are based on three donors, each experiment repeated three times. 
Statistical significance is denoted by *P<0.05, **P<0.01 using Mann Whitney U 
test comparing treated cells with control. 
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6.1.2.11 Cholesterol depletion of macrophages does not inhibit SR-A 
ligand uptake 
ßCD is a carbohydrate that contains a cholesterol-binding pocket that depletes 
cholesterol, whereas nystatin sequesters cholesterol within the membranes. ßCD, 
extracts cholesterol from outside the rafts (not within) without binding to or 
inserting itself into the membrane. If CD14 and SRA do work in concert to 
internalise N. meningitidis they would need to be in close proximity, therefore as 
previous studies (see Chapter 1) have identified GPI-linked proteins such as 
CD14 tend to cluster on these lipid-rich microdomains disruption of these rafts 
might affect bacterial uptake. MDM were therefore treated separately with two 
different cholesterol disrupting agents used previously, Nystatin (data not shown) 
and ß-Cyclodextrin (3CD). Following raft disruption cells using a range of 
concentrations of ßCD for 15min at 37°C, cells were then incubated with a 
known SRA ligand, DiI-acLDL, for 2h before looking for any changes in SR-A 
ligand recognition by the macrophages; and these initial experiments show that 
no differences were observed Fig 6.9. 
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Figure 6.9 
ß-Cyclodextrin treatment of lipid rafts 
j3 CD 
IßCD 
IDCD 
DilacLDL uptake examined by treating MDM with a range of concentrations 
(1,10 and 50mM) of a cholesterol-depleting agent, ß-Cyclodextrin, for 
15min at 37°C before incubating with DiIacLDL for 2h. Control MDM 
were not treated with ß-Cyclodextrin. Figure shows one experiment 
representative of three, each experiment performed at least three times. 
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Part II: Mannose receptor and PAF receptor 
6.2.1 Introduction 
In previous chapters the possible roles of a number of macrophage receptors in 
non-immune opsonic phagocytosis were examined, and several lines of evidence 
have led us to suggest that CD 14 and scavenger receptors are likely to play a role 
in the recognition of N. meningitidis. In this chapter more receptors that could 
contribute to these processes are examined, specifically mannose receptor (MR) 
and platelet-activating factor receptor (PAF-R). 
Platelet-activating factor is an ether-linked acetylphosphorylcholine molecule, 
that functions through G-protein linked receptors as an inflammatory signal 
mediator (Snyder 1990). PAF, along with other phosphorylcholine-linked 
molecules, binds to the PAF receptor which is a non-opsonic receptor present on 
epithelial cells, endothelial cells and macrophages. Previous research has shown 
that strains of non-typeable H. influenzae invade human epithelial cells via a 
number of a pathways, including PAF receptor-mediated uptake (Swords, 
Buscher et al. 2000). S. pneumoniae also invade host cells through 
phosphorylcholine interactions with PAF receptors, as PAF receptor expression 
increases in inflamed airways, of individuals with asthma or chronic bronchitis 
(Cundell, Gerard et al. 1995). As a result of direct recognition through PAF 
receptors, pneumococci can invade host cells and subsequently migrate into the 
subarachnoid space by altering the permeability of the blood brain barrier 
(Cabellos, Maclntyre et al. 1998; Ring, Weiser et al. 1998). As no previous 
studies have implicated PAF-R in playing a role in meningococcal interactions 
here an effective PAF receptor antagonist was used to investigate whether the 
blockade of PAF-R would affect meningococcal entry into human macrophages. 
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is an integral membrane protein and a member of the lectin family of receptors 
that are expressed on tissue macrophages, but not circulating monocytes. 
Ligation of pathogens or mannose-rich glycoconjugates to the receptor results in 
the phagocytosis of the ligand accompanied by a pro-inflammatory response. A 
non-specific receptor involved in host defence, MR has been associated with 
uptake of yeasts (C. albicans, S. cerevisiae) (Ezekowitz, Sastry et al. 1990; 
Giamis, Lombard et al. 1993), parasites (P. carinii) (Ezekowitz, Williams et al. 
1991) and bacteria (E. coli) (Lefkowitz, Lincoln et al. 1997). A number of 
studies have observed that the phagocytosis of these particles can be inhibited 
with the treatment of mannose, yeast mannans and mannose-terminal 
glycoconjugates; therefore mannosylated BSA (mBSA) was used to act as a 
competitive ligand to the mannose receptor binding site, and observe the affect 
on meningococcal recognition. 
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6.2.2 Results 
6.2.2.1 Mannose receptors do not appear to have a role in 
meningococcal interaction in vitro 
Mannose receptors were blocked with mannosylated-BSA (mBSA; a-D- 
mannosylated albumin) in order to prevent bacterial interactions via the receptors 
known ligand-binding site. Macrophages were incubated with a range of 
concentrations of 0-100µg/ml, before infecting with N. ineningitidis H44/76. 
Fig. 6.10 shows adherence measured after 60min incubation with bacteria at 4°C, 
and no difference was observed. 
Internalisation was then measured over 60min at 37°C, mBSA was used at a 
concentration of 50µg/ml (see Fig6.11). When compared to untreated control 
cells, no significant difference in binding or internalisation of N. 1neningilidis 
H44/76 by mBSA-treated cells was observed. Experiments carried out using the 
same range of concentrations of mBSA (0-1001ig/ml) did not have any effect on 
bacterial ingestion at 37°C (data not shown). 
6.2.2.2 Involvement of platelet-activating receptor (PAF-R) in 
recognition of N. meningitidis 
PAF receptors were blocked using the PAF receptor antagonist, PAF-16, (1-0- 
hexadecyl-2-acetyl-sei-glycero-3-phospho-(N, N, N-trimethyl)hexanolamine) 
which is an analogue of PAF that can also inhibits phospholipid turnover and 
secretion, as well as PAF-induced platelet aggregation. MDM were incubated in 
final concentrations of PAF-16 that ranged from 1-l00nM final concentration, 
before cells were infected with N. meningitidis H44/76 and incubated at 4°C for 
an hour (see Fig. 6.12) or 37°C for up to an hour (data not shown). No difference 
164 
was observed between pre-blocked and control cells at 1 and IOnM, but a marked 
decrease in bacterial recognition was observed at lOOnM PAF-16. Cundell et al 
(Cundell, Gerard et al. 1995) observed a difference in Streptococcus pneumoniae 
recognition following receptor inhibition with this reagent. I observed that this 
high concentration of reagent appeared to have a detrimental affect on primary 
human macrophages, in terms of morphology the cells had reduced in size and 
taken on a different appearance, even though trypan blue exclusion indicated that 
these cells were still viable. Therefore even though the data indicate a 
significant difference at this concentration further experiments alternative 
inhibitors should be sought to gain a clearer perspective. 
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Figure 6.10 
Bacterial adherence following mannose receptor blockade 
MDM were exposed to different concentrations of mannosylated bovine 
serum albumin (mBSA) before infecting macrophages with N. meningitidis 
H44/76 and incubating for 60min at 4°C. Graphs shows numbers of bacteria 
bound to each macrophage, with bars representing mean (± standard error of 
mean). Results are based on four donors, each experiment repeated at least 
three times. No difference in bacterial adherence was observed (P>0.05). 
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Figure 6.11 
Mannose receptor blockade 
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(mBSA) before infecting macrophages with N. meningitidis 1144/76 and 
incubating for 60min at 37°C. Graphs shows numbers of bacteria bound to 
each macrophage, with bars representing mean (± standard error of mean). 
Results are based on four donors, each experiment repeated at least three 
times. No difference in bacterial adherence was observed (P>0.05). 
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Figure 6.12 
Platelet activating factor receptor inhibition 
Platelet activating factor receptor (PAF) on MDM blocked using a range of 
concentrations of receptor antagonist (PAF-Ra). Macrophages were 
inoculated with N. meningitidis H44/76, in the absence of serum, and 
incubated for 60min at 4°C. Vertical dotted line indicates point after which 
morphological deterioration of MDM is apparent. Data are mean values, and 
values in parenthesis are f standard mean of error. Results obtained from 
three donors and repeated three times. 
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6.3 Summary and discussion 
Observations thus far suggest that the two processes of binding and 
internalisation of P1. meningilidis H44/76 by MDM, under non-opsonic 
conditions, are governed by different groups of receptors. Blockade of 
macrophage SR-A, using Poly I, demonstrated that N. ineningitidis adhered to 
macrophages via specific binding receptors that were unaffected by Poly I 
treatment. It would also appear that blocking SR-A on the surface of the cells 
significantly impaired phagocytosis of N. meningilidis, but the percentage 
population of cells able to directly interact with meningococci remained the same 
irrespective of Poly I treatment. Differentiated THP-1(dTHP-1) cells were again 
found to be a useful tool, as PMA-treatment led to the scenario of bacterial 
binding and uptake that could be inhibited using Poly I. 
SR-A-dependent phagocytosis appeared to be affected by incubation time and 
concentration of Poly I, but interactions between meningococci and SR-A were 
quite specific as flow cytometry results identified Poly I as an effective inhibitor 
or SR-A ligand (DiI-acLDL) recognition. Differentiating between polyanionic 
sensitive receptors and SR-A of human macrophages using current methods is 
not easy. Results based on both primary macrophages and dTHP-1 cells revealed 
that phagocytosis of meningococci is inhibited to varying degrees by Poly I 
treatment. Bacterial internalisation by dTHP-1 cells was reduced by 24.2% 
whereas uptake by MDM fell by almost 60%. The differences between the cell 
types suggests that the contribution of SR-A in meningococcal phagocytosis 
varies (see Chapter 3), and the fact that Poly I did not abolish bacterial uptake 
implies that although SRA can be an important receptor for Neissei"ia, it is not an 
exclusive port of entry. The reduction in SRA-mediated inhibition by dTHP-1 
cells may be due to the action of PMA, which is thought to be effective in 
altering the expression of macrophage receptors, or may alternatively stimulate 
the over-expression of ion-phagocytic receptors that could compete and bind the 
bacteria. Differences in bacterial internalisation taken in conjunction with 
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changes in TNF-a production following a range of concentrations of Poly I (Fig 
6.6 & 6.7) allows us to suggest that levels of TNF-a play some part in the loss of 
effectiveness of Poly I at higher concentrations. 
Blocking of multiple receptors suggested that in the absence of CD 14 less 
organisms adhere to fewer macrophages, but are internalised effectively if SRA 
is available. In the absence of SRA bacteria can adhere to the macrophages well, 
but subsequent internalisation is impaired. Notably, incubation of MDM in the 
presence of anti-CR3 mAb (2LMP19c) Poly I has no effect on meningococcal 
internalisation, suggesting that in the absence of both SRA and CR3 binding sites 
another receptor is able to take over meningococcal internalisation. Perhaps- 
CD14 facilitates the transfer of organisms to another phagocytic receptor or a 
separate and available CR3 binding site is being utilised. Upregulation of CD14 
in response to endotoxin has been previously reported, (Marchant, Duchow et al. 
1992; Matsuura, Ishida et al. 1994) but upregulation of human SR-A in response 
to meningococcal LPS has not, and although the limited results in this chapter 
did not indicate this, further experiments should be carried out using a range of 
concentrations of LPS over time. Subsequent survival of internalised bacteria 
within macrophages, using established methods, was difficult to measure as 
relatively few meningococci were internalised under non-opsonic conditions. 
Previous observations showed that the numbers of bacteria bound per cell was 
self-limiting, as no more than approx 3 bacteria per cell bound to MDM in the 
absence of serum, even if the MOI was 200: 1 (data not shown). It has also been 
suggested that Poly I may interact with other members of the scavenger receptor 
family, CD36 and MARCO, but neither are known to play a role in bacterial 
phagocytosis, and no evidence exists to show CD36 binds bacteria, and MARCO 
is only expressed in a small subset of macrophages (Elomaa, Kangas et al. 1995). 
A number of factors may affect this data including, levels of SRA expression, 
recycling of receptor, clustering or limiting levels of bacteria or intracellular 
molecules. 
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It has been established that SRA could bind gram positive organisms (Thomas, 
Li et at. 2000) but it was not previously known that SRA could also recognise 
and ingest whole gram-negative bacteria. This in vitro study, and in vivo work 
carried out by Peiser et al (Peiser, de Winther et at. 2002) in mice have observed 
that SRA recognise N. meningitidis, but this study suggests that human SRA is 
not a significant binding receptor for meningococci, a role which this study 
suggest is filled by CD 14. Dual blockade of receptors also supported this 
hypothesis, but SRA-mediated uptake did not appear to take place on nystatin- or 
ß-cyclodextrin-depleted cholesterol-rich lipid rafts. 
Neither mannose or PAF receptors appeared to play a role in bacteria- 
macrophage interactions here; but as a general MR blocking agent mBSA may 
have bound to mannose receptors alone, but may have also adhered to the lectin- 
binding site of CR3, which recognises a wide range of saccharides. This study 
indicates that the initial recognition and subsequent phagocytosis of N. 
I Jeniizgitidls H44/76 are quite separate processes, governed by different 
receptors. If specific receptor(s) exist through which Neisseria can enter 
immune cells, such as macrophages or dendritic cells and subsequently remain or 
proliferate without alerting the necessary cytotoxic machinery, then inhibition of 
these receptors may leave the bacteria more susceptible to innate immune 
responses and inhibit bacterial invasion. Such avoidance of the cytotoxic 
machinery of immune cells is a tactic employed by certain facultative 
intracellular organisms, a number of which are known to "shelter" inside 
macrophages, and survival of particular microbial pathogens in macrophages is 
thought to be reliant on the selective exploitation of specific phagocytic 
receptors that do not induce signalling cascades or cytotoxic mechanisms, such 
as pro-inflammatory cytokine release and phagolysosome maturation. Therefore 
entry via SR-A could be viewed as a relatively "safe" portal of entry, as SR-A 
has been found to suppress rather than induce a range of pro-inflammatory 
cytokine and microbicidal signalling mechanisms. It is likely that further studies 
will reveal other microorganisms that interact with this receptor. 
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Chapter 7 
Summary of results and future work 
Macrophages are considered the first line of defence against invading Neisseria 
species in the upper respiratory tract, and it is therefore important to consider the 
question of how these distinctive organisms are able to overcome a number of 
innate defence systems present in their environment. Macrophages express an 
array of surface receptors; multiple receptors can be involved in the processing 
of single bacteria cells. These events are initiated by the crucial step of ligand 
recognition via specific receptors. The relationship between meningococci and 
specific receptors may contribute to host colonisation, therefore this study 
focused on receptor-mediated recognition of N. nienirrgitidis by uncoupling the 
sequential processes of adherence, internalisation and intracellular trafficking by 
macrophages. 
Once meningococci are in the bloodstream complement-mediated responses are 
the first line of defence, and are usually dependent on bacterial lysis by C5b to 
C9 complement components. If organisms can evade such an attack then they are 
able to proliferate relatively unhindered, and reach concentrations that activate a 
more pronounced complement-mediated response that can lead to tissue damage 
by neutrophil activation. Hence the contribution of complement and 
immunoglobulin G to macrophage recognition of meningococci was examined. 
Opsonisation of bacteria, using serum obtained from an late-complement 
deficient disease (LCCD) patient, resulted in a 2-fold increase in bacterial 
adherence to the surface of the macrophages, compared to control organisms. 
Adherence of organisms opsonised using serum deplete of IgG was significantly 
reduced to levels equivalent with non-opsonised control bacteria; suggesting that 
meningococcal adherence to primary human macrophages is a Fey receptor- 
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mediated process. Subsequent internalisation was also measured, and though 
opsonisation enhanced bacterial uptake, the presence or absence of 
immunoglobulin did not alter the levels of phagocytosis, implying that non-Fcy 
opsonic receptors, such as the complement receptors, are likely to play a more 
prominent role in opsonin-dependent meningococcal phagocytosis. A similar 
pattern of adherence and uptake had previously been observed in work carried 
out with S. pneumoniae and alveolar macrophages (Gordon, Irving et al. 2000). 
Subsequent experiments were carried out to further explore the involvement of 
complement receptor, specifically CR3, in bacterial phagocytosis in the presence 
of serum opsonins using an anti-CD] lb monoclonal antibody to block an epitope 
of the I domain. Previous studies with Mycobacteria (Peyron, Bordier et al. 
2000) had found this antibody successful in inhibiting bacterial uptake, but no 
difference in meningococcal adherence or internalisation was reported; the only 
reduction was in percentage population of macrophages directly interacting with 
bacteria. This may be due to the fact that I-domain of CR3 has many epitopes to 
different micro-organisms bind, and so future work might involve the use of a 
panel of anti-CD 1 lb monoclonal antibodies that recognise different epitopes on 
the I-domain; though some anti-I domain antibodies are also unsuitable as LPS 
Evas shown to displace the binding of M1/70, an anti-I domain mAb, to 
macrophages (Matsuno, Aramaki et at. 1998) and I domain mAbs do not inhibit 
binding of ß-glucans (Thornton, Vetvicka et al. 1996). Measurement of the 
concentration of other serum opsonins, such as MBL could also be performed as 
this may effect immune serum-mediated bacterial uptake; coupled with this the 
degree of opsonin deposition on meningococci would be useful information. 
Lipid raft disruption using Nystatin also appeared to reduce recognition of 
opsonised bacteria, which suggests that uptake takes place on these cholesterol- 
rich microdomains that are utilised by a number of invasive pathogenic 
microorganisms as a means of avoiding immune detection. This may be a 
strategy employed by N. meningitidis but at the moment the tools for studying 
lipid raft involvement are fairly crude (see Chapter 5). 
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Once in the nasopharynx, meningococci are likely to be exposed to resident 
macrophages and dendritic cells which are widely distributed extravascularly 
where opsonins may be low or absent, and in the liver, adrenal glands and 
choroid plexus they would be in direct contact with blood and CSF (Gordon, 
Lawson et al. 1992): therefore non-opsonic interactions of serogroup B N. 
rneningitidis were examined. The lectin-binding site of CR3, to which LPS can 
directly bind, was blocked using NADG, as well as monoclonal antibody. N. 
bf' ý'ýtý". SC. ý4ýilPSP., ýf2. b2ýr4Tih2,4PcJilr'L. tll c hinrlina 
site of CR3. Use of a wider range of monosaccharides and polysaccharides to 
block the lectin site may be helpful; and a number of anti-I domain antibodies 
have also been found to block the lectin site and could be utilised. It might also 
be of interest to prime macrophages with zymosan (contains ß-glucan) and 
observe if the affects on uptake of opsonised meningococci. Peripheral blood 
monocytes obtained from LAD patients may indicate if reduction or absence of 
complement receptors enhances susceptibility to meningococcal disease. 
By comparing meningococci with two other Neisser"ia species, N. lactamica and 
N. animalis, which are not known to be pathogenic in humans I observed that 
these two strains were bound and internalised by macrophages more efficiently 
than the pathogenic strains of N. meningitidis using this assay. The 
N. meningitidis strains used are capsulate and express both Opa and PiIC, whereas 
N. lactamica lacks Opa expression and N. animalis expresses neither Opa nor 
Pi1C. Of all three Neisseria species examined, N. aninialis was internalised most 
effectively by MDM, which is consistent with the fact that this strain has never 
been isolated in humans but is more usually found in mammals such as guinea 
pigs, and is consequently likely to be destroyed by the cell. N. lactamica was 
found to adhere most efficiently to macrophages, but internalisation was similar 
to that of N. , neningitidis. As N. lactamica is a non-pathogenic organism usually 
carried during early childhood, and this carriage is associated with an increase in 
antibody titres to pathogenic meningococci strains (Zorgani, James et al. 1996), 
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perhaps internalisation and degradation of the non-pathogen N. lactainica is 
beneficial to the host, by permitting the induction of an acquired immune 
response that is cross-reactive with N. meningilidis. 
Although a relatively rare occurrence, the fact meningococci are able to avoid 
the gauntlet of innate immune responses, suggests that either host cells fail to 
recognise and destroy the invasive bacteria, or that virulence determinants on the 
outer surface of the microbes are successful in preventing direct recognition. I 
therefore examined the role of meningococcal LPS in host cell recognition. The 
use of 1pxA mutant of N. meningitidis suggested that non-opsonic phagocytosis, 
but not adherence, was dependent to a large degree on the presence of LPS, as 
uptake of the mutant was reduced by 72.5%, and cytokine secretion was also 
reduced. The fact that uptake was not completely abolished and the mutant 
organisms stimulated lower levels of cytokine production suggests that other 
bacterial outer membrane components may play a role in meningococcal- 
macrophage interactions. Dissection of signal transduction pathways in 
macrophages could be used to investigate role of meningococcal LPS in greater 
detail, using LPS-deficient and truncated mutants. 
As a result of the findings using lpxA mutant in Chapter 4, a number of receptors 
known to bind LPS were examined in more detail. CD14 and SR-A appeared to 
contribute most to the non-opsonic adherence and phagocytosis of N. 
meningitidis. All GPI-linked proteins were initially removed from the surface of 
the cells using PIPL. C enzyme, and this resulted in a dramatic reduction in 
bacterial adherence. Attention was therefore directed at CD14, a GPI-linked 
pattern recognition receptor (PRR) that was known to bind LPS, but not whole 
gram-negative bacteria. Inhibition of CD 14 resulted in a marked reduction in 
bacterial association to macrophages that affected subsequent internalisation of 
bacteria. Human CD 14 was also examined in isolation of a number of other LPS 
receptors, to determine whether this receptor could enhance meningococcal 
binding to endothelial HeLa cells when transfected. Compared to control cells 
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over 60% increase in meningococcal binding to CD14-transfected HeLa cells was 
observed. As the functions of Toll-like receptors and CD 14 are intimately 
linked, and previous work has implicated TLR4/MD2 with CD14 in induction of 
a pro-inflammatory cytokine response using N. meningitidis (Pridmore, Wylie et 
al. 2001) blockade of macrophage TLRs may shed more light on this 
relationship; but as yet the relevant blocking monoclonals are not available. 
Attempts were made to obtain peripheral blood monocytes from PNH patients, as 
the cells would innately lack GPI-linked proteins to varying degrees depending 
on the severity of disease, but this proved difficult as it is a relatively rare 
condition. 
Study of bacterial interactions using primary human cells can be problematic, 
due to the high levels of variation between donors, therefore a suitable cell-line 
models for the use of N. meningitidis studies was sought. As permanent human 
mature cell lines do not exist, THP-1 cells were differentiated using phorbol 
myristate acetate (PMA), and numerous studies have shown that the in vitro 
differentiation of THP-1 are an appropriate model to study macrophage-pathogen 
interactions, as differentiation induces the cells to take on a more macrophage- 
like phenotype, resulting in the improved phagocytic capability of the cells 
compared to undifferentiated cells (Tsuchiya, Kobayashi et al. 1982). Following 
differentiation, THP-1 cells displayed an increased capacity to internalise 
meningococci was detected and was accompanied by a marked increase in 
numbers of bacteria adhering to the surface of the cells. Differentiation appears 
to result in the up-regulation of receptors essential for the capture N. 
meningitidis by macrophages. Observations using MDM cells blocked with Poly 
I, SRA inhibitor, suggest that phagocytosis of N. meningitidis is mediated, to a 
large degree, by class A scavenger receptors; and the use of PMA-differentiated 
THP-1 (dTHP-1) cells also supported the hypothesis that the phagocytosis of N. 
meningitidis is governed to a large part by the presence of specific macrophage 
receptors. The lack of available anti-human SR-A antibodies, meant Poly I was 
used to block bacterial interactions with class A scavenger receptors, and this 
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reagent was effective as phagocytosis was inhibited in both MDM and dTHP-1 
cells. At concentrations used in study, Poly I blockade had no significant effect 
on levels of cytokine secreted into the surrounding media suggesting that 
macrophage cytokine production is not dependent on numbers of bacteria being 
internalised and is SR-A-independent. It has also been suggested that Poly I may 
interact with other members of the scavenger receptor family, CD36 and 
MARCO, but neither are known to play a role in bacterial phagocytosis, and no 
evidence exists to show CD36 binds bacteria, and MARCO is only expressed in a 
small subset of macrophages (Elomaa, Kangas et al. 1995). A number of factors 
may affect this data including, levels of SRA expression, recycling of receptor, 
clustering or limiting levels of bacteria or intracellular molecules. Animal 
studies suggest that scavenger receptors are important in bacterial infections, 
including Neisseria (Suzuki, Kurihara et al. 1997; Thomas, Li et al. 2000; Peiser 
and Gordon 2001), as complement components are widely distributed in vivo, it 
is less problematic to assess the contribution of non-opsonic receptors in vitro. 
Resident macrophages have reduced microbicidal mechanisms available than 
activated macrophages, and uptake of N. meningitidis by these cells via SR-A 
might provide some protection against complement, IgA or clearance. CD 14 
expression is reduced on these tissue macrophages (Landmann.. Muller et al. 
2000) but SR-A expression is high (Gough, Greaves et al. 1999), which suggests 
these cells might be less sensitive to endotoxin than monocytes or activated 
macrophages and might help prevent immune activation by scavenging less LPS 
in a CD 14-independent manner via SR-A. 
Targeting molecules for SR-mediated internalisation is followed by the display 
of modified specific antigens to T-cells by MHC class I (Abraham, Singh et al. 
1995; Bansal, Mukherjee et al. 1999). Cultured dendritic cells can express SR-A 
and phagocytic cells, capable of antigen presentation and stimulation of nave T 
cells (Platt, da_Silva et al. 1999). Further study with these cells should help 
determine if SR-A are involved in these processes. Further examination of 
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receptor signalling and cell biology is required to shed more light on role of SR- 
A in host defence. 
Mucosal damage may alter invasion and colonisation of meningococci and 
activities such as smoking are associated with increased risk of invasive disease. 
Activated macrophages are also more likely to be recruited to sites of mucosal 
damage, and could help explain the increased risk of infection to smokers 
(Brandtzaeg 1995) and if they internalise N. meningitidis could traffic the 
organisms to the parts of the body. Dendritic cells, which may also express SR- 
A (Platt, da_Silva et al. 1999), may also be used as a vehicle for bacteria to move 
to other parts of the body, so interactions of meningococci with these cells 
should also be examined. Further work to identify whether other Neisseria 
species and strains, such as N. lactainica, are also internalised via SR-A would 
help determine if indeed the ligand recognised is conserved across species and 
thus a general receptor for colonisation. If this were the case, diseases caused by 
pathogenic Neisseria may be a result of other virulence mechanisms. Following 
immune activation of macrophages their role in meningococcal pathogenesis may 
become more protective, as scavenger receptors may function in macrophage 
control of inflammation, (reviewed in Chapter 1) as high levels of LPS are 
correlated with disease severity and are characteristic of MCD (Brandtzaeg 
1995). Excess meningococcal LPS would also be in contact with Kupffer cells 
and marginal spleen zone macrophages in the spleen, which express high levels 
of SR-A (Hughes, Fraser et al. 1995) but not CD14. These macrophages would 
be well placed to clear excess LPS from the circulation without release of pro- 
inflammatory molecules and help prevent septicaemia. 
Further experiments that could be undertaken, includes the use of FRET analysis 
to study the molecular proximity of CD 14 and SR-A on the surface of 
macrophages, and explore the possibility that SR-A may exist as part of a more 
complex signalling complex. Also studies carried out by Yamamoto and 
colleagues (Yamamoto, Ebe et al. 1999) suggested that CD 14 and SR-A receptor 
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expression of alveolar macrophages were upregulated in response to endotoxin 
exposure. Specifically, a significant number of CD14 single positive and SR-A 
single positive cells were observed over time; and a minor population of 
CD 14/SR-A double positive cells were also noted. As this thesis indicates the 
possible involvement of both CDI4 and SR-A in macrophage interactions with 
meningococci, I performed preliminary experiments by exposing MDM cells to 
purified LPS of N. rneningitidis H44/76 before incubating with SR-A ligand Dil- 
acLDL or labelled CD 14 mAb, and analysing by flow cytometry for increases in 
receptor expression: unfortunately this set of experiments was unsuccessful. It 
would also be of interest to attempt to characterise events governing signal 
transduction for SR-A receptors in response to meningococcal LPS. 
Measurement of nitric oxide production of Poly I treated cells to further examine 
the role of SR-A in host cytotoxic responses. Initial genetic studies linking SR- 
A with disease, by studying polymorphisms in human receptor gene to determine 
a link with meningococcal infection has yet to be completed, and this work could 
be expanded to include CD 14. 
Many aspects of macrophage-meningococcal interactions have yet to be clarified, 
including the roles of SR-A, CD14 and CR3 on activated macrophages and 
dendritic cells, and the role of lipid-rich rafts in these interactions should also be 
studies in more detail. 
181 
Chapter 8 
References 
Abraham, R., N. Singh, et at. (1995). Modulation of immunogenicity and antigenicity of 
proteins by maleylation to target scavenger receptors on macrophages. Journal of 
Immunology. UNITED STATES. 154: 1-8. 
Aderem, A. and D. Underhill (1999). "Mechanisms of phagocytosis in macrophages. " 
Annu. Rev. Immunol. 17: 593-623. 
Agramonte-Heva, J., A. Gonzalez-Arenas, et at. (2002). Gram-negative bacteria an 
phagocytic cell interaction mediated by complement receptor 3. FEMS 
Immunology and Medical Microbiology. 34: 255-266. 
Ahmed, S., D. Brown, et al. (1997). On the oriin of sphingolipid/cholesterol-rich 
detergent-insoluble cell membranes: physiological concentration of cholesterol 
and sphingolipid induce formation of a detergent-insoluble liquid-ordered lipid 
phase in model membranes. Biochemistry. 36: 8056-8063. 
Albiger, B., L. Johansson, et at. (2003). Lipooligosaccharide-deficient Neisseria 
meningitidis shows altered pilus-associated characteristics. Infect. Immun. 71: 
155-62. 
Allen, L. and A. Aderem (1996). "Molecular definition of distinct cytoskeletal structures 
involved in complement- and Fc receptor-mediated phagocytosis in 
macrophages. " Journal of Experimental Medicine 184: 627-637. 
Altieri, D. and D. Edington (1988). The saturable high affinity association of Factor X to 
ADP-stimulated monocytes defines a novel function of Mac-I receptor. J. Biol. 
Chem. 263: 7007-7015. 
Amino, M., R. Noguchi, et al. (1983). Studies on the effect of letinan on human immune 
system. II. In vivo effect of NK activity, MLR induced killer activity and PHA 
induced blastic response of lymphocytes in cancer patients. Jpn. J. Cancer 
Chemother. 10: 2000. 
Anderson, R. (1998). "The caveolae membrane system. " Annual Review of Biochemistry 
67: 199-225. 
Andersson, L. and M. Freeman (1998). Functionl changes in scavenger receptor binding 
conformation are induced by charge mutants spanning the entire collagen domain. 
J. Biol. Chem. 273: 19592-19601. 
Antal-Szalmas, P., J. Van Strijp, et al. (1997). Quantitation of surface CD14 on human 
monocytes and neutrophils. J Leuk. Biol. 61: 721-728. 
Ashkenas, J., M. Penman, et al. (1993). Structures and high and low affinity Iiagnd 
binding properties of murine type I and type II macrophage scavenger receptors. 
J. Lipid Res. 34: 983-1000. 
Astiz, M., D. Saha, et al. (1996). Monocyte response to bacterial toxins, expression of 
cell surface recptors and release of anti-inflammatory cytokines during sepsis. J. 
Lab. Clin. Med. 128: 594-600. 
182 
Bansal, P., P. Mukherjee, et al. (1999). MHC class I-restricted presentation of maleylated 
protein binding to scavenger receptors. Journal of Immunology. UNITED 
STATES. 162: 4430-7. 
Bazil, V., V. Horejsi, et al. (1986). Biochemical characterisation of soluble forms of the 
53-kDa monocyte surface antigen. Eur. J Immunol. 16: 1583. 
Beaty, C., T. Franklin, et al. (1994). Lipopolysaccharide-induced cytokine production in 
human monocytes: role of tyrosine phosphorylation in transmembrane signal 
transduction. Eur. J. Immunol. 24: 1278-1284. 
Bernard, A., L. Boumsell, et al. (1984). Joint report of the first international workshop on 
human leukocyte differentiation antigens by investigations of the participating 
laboratories. New York, Springer-Verlag. 
Bessler, M. and J. Fehr (1991). fe-gamma-III receptors (FcRIII) on granulocytes: a new 
specific and sensitive test for paroxysmal nocturnal haemoglobinuria. Eur J 
Haematol. 47: 179. 
Bessler, M., P. Hillmen, et al. (1994). Genomic organisation of X-linked gene (PIG-A) 
that is mutated in paroxysmal nocturnal haemoglobinuria and of a related 
pseudogene mapped to 12g21. Hum Mol Genet. 3: 751. 
Bessler, M., P. Mason, et al. (1994). Paroxysmal nocturnal haemoglobinuria (PNH) is 
caused by somatic mutations in the PIG-A gene. EMBO J. 13: 110-117. 
Beutler, B. (2000). Toll-like receptor 4 and the afferent limb of innate immunity. Curr. 
Opin. Microbiol. 3: 23-28. 
Bone, R., C. Grodzin, et al. (1997). "Sepsis: a new hypothesis for pathogenesis of the 
disease process. " Chest 112: 235-243. 
Bouhlal, H., J. Galon, et al. (2001). Soluble CD 16 inhibits CR3 (CD I1 b/CD 18)-mediated 
infection of monocytes/macrophages by opsonized primary R5 HIV-1. Journal of 
Immunology. United States. 166: 3377-83. 
Brandtzaeg, P. (1995). Pathogenesis of meningococal infections. Meningococcal Disease. 
K. Cartwright, John Wiley and Sons Ltd. 
Brandtzaeg, P. (1995). Pathogenesis of meningococcal infections. Meningococcal 
Disease. K. Cartwright, John Wiley and Sons Ltd. 
Brandtzaeg, P. (1995). Pathogenesis ofineningococcal infections. Meningococcal 
disease. K. Cartwright. US, John Wiley & Sons Ltd. 
Brandtzaeg, P. (1996). Systemic meningococcal disease: clinical pictures and 
pathophysiological background. Rev. Med. Micro. 7: 63-72. 
Brandtzaeg, P., P. Kierulf, et al. (1989). Plasma endotoxin as a predictor of multiple 
organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159: 
195-204. 
Brandtzaeg, P., P. Kierulf, et al. (1989). Plasma endotoxin as predictor of multiple organn 
failure and death in systemic meningococcal disease. J. Infect. Dis. 159: 195-204. 
Brown, D. (1993). The tyrosine kinase connection: how GPI-anchored proteins activate T 
cells. Current Opinions in Immunology. 5: 349-354. 
Brown, D. and E. London (1997). Structure of detergent-resistant membrane domains: 
Does phase seperation occur in bioogical membranes? Biochem. Biophys. Res. 
Commun. 240: 1-7. 
Brown, D. and E. London (1998). Function of lipid rafts in biological membranes. Annu. 
Rev. Cell Dev. Biol. 14: 111-136. 
183 
Brown, D. and J. Rose (1992). Sorting of GPI-anchored proteins to glycolipid-enriched 
membrane subdomains during transport to the apical cell surface. Cell. 68: 533- 
544. 
Brown, D. A. and E. London (1998). "Structure and origin of ordered lipid domains and 
biological membranes. " J. Membr. Biol. 164(2): 103-114. 
Brown, M. S., S. K. Basu, et al. (1980). 13: 67-8 1. 
Brown, M. S. and J. L. Goldstein (1983). Lipoprotein metabolism in the macrophage: 
implicatios for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 
2230-2261. 
Bufler, P., G. Stiegler, et al. (1995). Soluble lipopolysaccharide receptor (CD14) is 
released via two different mechanisms from human monocytes and CDI4 
transfectants. Eur. J Immunol. 25: 604-6 10. 
Cabellos, C., D. Maclntyre, et al. (1998). "Differing roles for platelet-activating factor 
during inflammation of the lung and subarachnoid space. " J. Clin. Invest. 90: 612- 
618. 
Cain, J., S. L. Newman, et al. (1987). Role of complement receptor type 3 and serum 
opsonins in the neutrophil response to yeast. Complement Inflamm. 4: 75. 
Capel, P., O. Groeneboer, et al. (1978). The binding of activated C3 to polysaccharides 
and immunoglobins. J. Immunol. 121: 2566-2572. 
Caron, E. and A. Hall (1995). "Identification of two distinct mechanisms of phagocytosis 
controlled by different Rho GTPases. " Science 282: 1717-1721. 
Castellano, F., P. Montcourrier, et al. (2000). "Membrane recruitment of racl triggers 
phagocytosis. " Journal of Cell Science 113: 2955-2961. 
Castellano, F., P. Montcourrier, et al. (1999). "Inducible recruitment of cdc42 or WASP 
to a cell surface receptor triggers actin polymerisation and filopodium formation. " 
Curr. Biol. 9: 351-360. 
Chen, W., U. Syldath, et al. (1999). Human 60-kDa heat-shock protein: a danger signal to 
the innate immune system. J. Immunol. 162: 3212. 
Chow, J., D. Young, et al. (1999). "Toll-like receptor 4 mediates lipopolysaccahride 
induced signal transduction. " J. Biol. Chem. 274: 10689-10692. 
Christie, R., M. Freeman, et al. (1996). Expression of the macrophage scavenger receptor, 
a multifunctional lipoprotein receptor, in microglia associated with senile plaques 
in Alzheimer's disease. Am. J. Pathol. 148: 399-403. 
Connolly, M. and N. Noah (1999). Is group C meningococcal disease increasing in 
Europe? A report of surveillance of meningococcal infection in Europe 1993-6. 
European Meningitis Surveillance Group. Epiderniol. Infect. 122: 41-49. 
Cook, J., D. Taylor, et al. (1978). Comparative evaluation of the role of macrophages and 
lymphocytes in mediating the antitumour action of glucan. Piog. Cancer Res. 
Tlrer". 7: 183. 
Couturier, C., G. Jahns, et at. (1992). Membrane molecules which trigger the production 
of IL-I and TNF alpha by LPS-stimulated human monocytes. Eur. J Immunol. 22: 
1461-1466. 
Cox, D., P. Chang, et al. (1997). "Requirements for both racl and cdc42 in membrane 
ruffling and phagocytosis in leukocytes. " Journal of Experimental Medicine 186: 
1487-1494. 
184 
Cox, D., C. Tseng, et al. (1999). "A requirement for phophatidylinositol 3-kinase in 
pseudopod extension. " Journal of Biological Chemistry 274: 1240-1247. 
Criado, M., C. Ferreiros, et al. (1985). Adherence and hydrophobicity in Neisseria 
meningitidis and their relationship with surface charge. Med. Microbiol. Immunol. 
174: 151-156. 
Cundel1, D., N. Gerard, et al. (1995). "Streptococcus pnetononiae anchor to activated 
human cells by the receptor for platelet-acivating factor. " Nature 377: 435-438. 
Cundell, D., N. Gerard, et al. (1995). Streptococcus pneinnoniae anchor to activated 
human cells by the receptor for platelet-acivating factor. Nature. 377: 435-438. 
Cunningham, M., B. J., et al. (1999). "Eschei"ichia coli and Poiphyomonas ginivalis 
lipopolysaccharide interction with CD14: implications for myeloid and non- 
myeloid cell actiation. " Clin. Infect. Dis 28: 497-504. 
Cywes, C., N. Godenir, et al. (1996). Non-opsonic binding of Mycobacter"ia tuberculosis 
to human complement receptor type 3 expressed in Chinese Hamster Ovary cells. 
Infection and Immunity. 64: 5373. 
De_Winther, M. P., M. J. Gijbels, et al. (2000). Transgenic mouse models to study the 
role of the macrophage scavenger receptor class A in atherosclerosis. International 
Journal of Tissue Reactions. SWITZERLAND. 22: 85-91. 
Dehio, C., S. Gray-Owen, et al. (2000). Host cell invasion by pathogenic Neisseriae. 
Subcellular Biochemistry. 33: 61-96. 
Devitt, D., O. Moffat, et al. (1998). "Human CD 14 mediates recognition and 
phagocytosis of apoptotic cells. " Nature 392: 505-509. 
Diamond, M., J. Garcia-Aguilar, et al. (1993). The I-domain is a major recognition site on 
the leukocyte integrin Mac-1 (CD I1 b/CD 18) for four distinct adhesion ligands. J. 
Cell Biol. 120: 1031. 
Diamond, M., D. Staunton, et al. (1990). ICAM-1 (CD54): a counter receptor for Mac-! 
(CD 1l b/CD 18). J. Cell Biol. 111: 3129-3139. 
Doi, T., K. Higashino, et al. (1993). Charged collagen structure mediates the recognition 
of negatively charged macromolecules by macrophage scavenger receptors. 
Journal of Biological Chemistry. UNITED STATES. 268: 2126-33. 
Doita, M., L. Rasmussen, et al. (1991). Effect of soluble aminated b-1,3-D-polyglucose o 
human monocytes: stimulation of cytokine and prostaglandin E2 production but 
not antigen presenting function. J. Leukoc. Biol. 49: 342. 
Donaldson, L., Y. Moores, et al. (1999). Introduction of immunisation against group C 
meningococcal infection. London, Department of Health. 
Dransfield, I., D. Corcoran, et al. (1988). "Comparison of human monocytes isolated by 
elutriation and adherence suggests that heterogeneity may reflect a continuum of 
maturation/activation states. " Immunol. 63: 491-498. 
Drevets, D. A., P. J. Leenen, et al. (1996). Complement receptor type 3 mediates 
phagocytosis and killing of Listeria monocytogenes by a TNF-alpha- and IFN- 
gamma-stimulated macrophage precursor hybrid. Cellular Immunology. UNITED 
STATES. 169: 1-6. 
Edwards, J., E. Brown, et al. (2002). A co-operative interaction between Neisseria 
gonorrhoeae and complement receptor 3 mediates infection of primary cervical 
epithelial cells. Cell. Microbiol. 4: 571-584. 
185 
Edwards, J., E. J. Brown, et al. (2001). The role of complement receptor 3 (CR3) in 
Neisseria gonor-rhoeae infection of human cervical epithelia. Cell. Microbiol. 3: 
611-622. 
El Ahmer, 0., S. Essery, et al. (1999). The effect of cigarette smoke on adherence of 
respiratory pathogens to buccal epithelial cells. FEMS Immunol. Med. Microbiol. 
23: 27-36. 
el-Khoury, J., S. E. Hickman, et al. (1996). Scavenger receptor-mediated adhesion of 
microglia to B-amyloid fibrils and secretion of reactive oxygen species. Nature. 
382: 716-719. 
Elomaa, 0., M. Kangas, et al. (1995). Cloning of a novel bacteria-binding receptor 
structurally related to scavenger receptors and expressed in a subset of 
macrophages. Cell. UNITED STATES. 80: 603-9. 
Esser, A. (1994). The membrane attack complex of complement. 
Ezekowitz, R., K. Sastry, et al. (1990). "Molecular characterisation of the human 
macrophage mannose receptor: demonstration of multiple carbohydrate domains 
and phagocytosis of yeast in Cos-1 cells. " J. Exp. Med. 172: 1785-1794. 
Ezekowitz, R., D. Williams, et at. (1991). "Upatke of Pneumocystis car-inii mediated by 
macrophage mannose receptor. " Nature 351: 155-158. 
Ezekowitz, R., D. Williams, et al. (1991). Upatke ofPneaunocystis carinii mediated by 
macrophage mannose receptor. Nature. 351: 155-158. 
Fadok, V., D. Bratton, et al. (1998). Macrophages that have... J Clin. Invest. 101: 890- 
898. 
Fell, E. (1999). The relative contributions of recombination and mutation to the 
divergence of clones of Neisser-ia meningitidis. Mol. Biol. Evol. 16: 1496-1502. 
Figdor, C., A. to Velde, et al. (1986). Leukocytes in host defence; progress in leukocyte 
biology. D. Jacobs. New York, Alan R Liss. 5: 301-306. 
Figueroa, J. and P. Densen (1991). Infectious diseases associated with complement 
deficiencies. Clin. Microbiol. Rev. 4: 359-395. 
Forster, P. and M. Landy (1981). Hetero eg neity of mononuclear phagocytes. New York, 
Academic Press. 
Fra, A., E. Williamson, et at. (1995). Proc. Natl. Acad. Sci. USA. 92: 8655-8659. 
Frank, S., A. Lustig, et al. (2000). A distinct seven-residue trigger sequence is 
indispensable for proper coiled-coil formation of the human macrophage 
scavenger receptor oligomerization domain. J. Biol. Chem. UNITED STATES. 
275: 11672-7. 
Fraser and Ezekowitz (1998). The serum mannose binding protein and the macrohage 
mannose receptor. Seminars in Immunology. 10: 363-372. 
Freeman, M., J. Ashkenas, et al. (1990). An ancient, highly conserved family of cysteine- 
rich protein domains revealed by cloning type I and type II murine macrophage 
scavenger receptors. Proc. Natl. Acad. Sci. USA. UNITED STATES. 87: 8810-4. 
Frey, E., D. Miller, et al. (1992). Soluble CD14 participates in the response of cells to 
lipopolysaccharide. J. Exp. Med. 176: 1665-1671. 
Fridriksson, E., P. Shipkova, et at. (1999). Quantative analysis of phospholipids in 
functionally important membrane domains from RBL-2H3 mast cells using 
tandem high resolution mass spectrometry. Biochemistry. 38: 569-572. 
186 
Fusco, P., F. Michon, et al. (1997). Pre-clinical evaluation of a novel group B 
meningococcal conjugate vaccine that elicits bactericidal activity in both mice and 
non-human primates. J. Infect. Dis. 175: 364-372. 
Gallay, P., C. Jongeneel, et al. (1993). Short time exposure to lipopolysaccharide is 
sufficient to activate human monocytes. J Immunol. 150: 5086-5093. 
Galon, J., J. Gauchat, et al. (1996). Soluble Fc-gamma receptor type III (Fc-gamma-RIII, 
CD 16) triggers cell activation through interaction with complement receptors. J. 
Immunol. 157: 1184. 
Gatfield, J. and J. Pieters (2000). "Essential role for cholesterol in the entry of 
mycobacteria into macrophages. " Science 288(1647-50). 
Giamis, J., Y. Lombard, et al. (1993). Both mannose and b-glucan receptors are involved 
in phagocytosis of unopsonized, heat-killed Sacchromyces cer"evisiae by murine 
macrophages. J. Leukoc. Biol. 54: 564. 
Giancotti, F. and E. Ruoslahti (1999). Integrin signalling. Science. 285: 1028-1032. 
Gilbert, M., A. Cunningham, et al. (1997). Characterisation of a recombinant Neisseria 
meningitidis alpha-2,3-sialyltransferase and its acceptor specificity. Eur. J. 
Biochem. 249: 187-194. 
Goldman, R. (1988). Characteristics of the B-glucan receptor of murine macrophages. 
Exp. Cell Res. 174: 48 1. 
Goldman, R. (1988). Induction of b-1,3-glucan receptor in P388D I cells treated with 
retinoic acid or 1,25-dihydroxyvitamin D3. Immunology. 63: 319. 
Goldschneider, I., E. Gotschlich, et al. (1969). Human immunity to the meningococcus. 
II. Development of natural immunity. Journal of Experimental Medicine. 129: 
1327-1348. 
Goldstein, J. L., Y. K. Ho, et al. (1979). Binding site on macrophages that mediates 
uptake and degradation of acetylated low density lipoprotein, producing massive 
cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337. 
Gomez-Mouton, C., J. Abad, et at. (2001). Proc. Natl. Acad. Sei. USA. 98: 9642-9647. 
Goodrum, K. J., L. L. McCormick, et at., Eds. (1994). Group B streptococcus-induced 
nitric oxide production in murine macrophages is CR3 (CD II b/CD 18) dependent. 
Infection and Immunity. UNITED STATES. 
Gordon, S., G. Irving, et al. (2000). "Intracellular trafficking and killing of Streptococcus 
pneumoniae by human alveolar macrophages is influenced by opsonins. " Infect. 
Immun. 68(4): 1-7. 
Gordon, S., L. Lawson, et at. (1992). Antigen markers of macrophage differentiation in 
murine tissues. Macrophage biology and activation. S. Gordon. Berlin, Germany, 
Springer-Verlag: 1-37. 
Gough, P. J. and S. Gordon (2000). The role of scavenger receptor in the inate immune 
system. Microbes and Infection. 2: 305-311. 
Gough, P. J., D. R. Greaves, et at. (1998). A naturally occurring isoform of the human 
macrophage scavenger receptor (SR-A) gene generated by alternative splicing 
blocks modified LDL uptake. Journal of Lipid Research. UNITED STATES. 39: 
531-43. 
Gough, P. J., D. R. Greaves, et al. (1999). Analysis of macrophage scavenger receptor 
(SR-A) expression in human aortic atherosclerotic lesions. Arteriosclerosis, 
Thrombosis, and Vascular Biology. UNITED STATES. 19: 461-71. 
187 
Greenberg, S., P. Chang, et at. (1993). "Tyrosine phosphorylation is required for Fc 
receptor mediated phagocytosis in mouse macrophages. " Journal of Experimental 
Medicine 177: 529-534. 
Greenberg, S., P. Chang, et al. (1996). "Clustered syk tyrosine kinase domains trigger 
phagocytosis. " Prot. Natl. Acad. Sci. USA 93: 1103-1107. 
Griffiss, J., B. Brandt, et al. (1984). Immune response of infants and children to 
disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150: 71-79. 
Grilli, M., J. Chiu, et al. (1993). NFkappaB and Rel: participants in a multiform 
transcriptional regulatory system. Int. Rev. Qjol. 143: 1-62. 
Grunwald, U., X. Fan, et al. (1996). "Monocytes can phagocytose gram negative bacteria 
by a mechanism dependent on CD14. " J Immunol. 157: 4119-4125. 
Hailman, E., H. Lichenstein, et at. (1994). Lipopolysaccharide (LPS)-binding protein 
accelerates the binding of LPS to CD 14. J Exp Med. 179: 269. 
Hampton, R. Y., D. T. Golenbock, et al. (1991). Recognition and plasma clearance of 
endotoxin by scavenger receptors. Nature. ENGLAND. 352: 342-4. 
Hampton, R. Y., D. T. Golenbock, et al. (1991). Recognition and plasma clearance of 
endotoxin by scavenger receptors. Nature. 352: 342-34. 
Hassall, D. (1992). Three probe flow cytometry of a human foam cell forming 
macrophage. Cytometry. 13: 381-388. 
Haworth, R., N. Platt, et al. (1997). The macrophage scavenger receptor type A is 
expressed by activated macrophages and protects the host against lethal endotoxic 
shock. Journal of Experimental Medicine. 186: 1431-1439. 
Haziot, A., S. Chen, et al. (1988). The monocyte diffrentiation antigen. CD 14, is 
anchored to the cell mambrane by a phosphatidylinositol linkage. Journal of 
Immunology. 
Heale, J. P., A. J. Pollard, et al. (2001). Two distinct receptors mediate nonopsonic 
phagocytosis of different strains of Pseudomonas aeruginosa. Journal of 
Infectious Diseases. United States. 183: 1214-20. 
Heist, G., S. Solis-Cohen, et al. (1922). A study of the virulence of meningococci for man 
and of human susceptibility to meningococcic infection. Journal of Immunology. 
VII: 1-33. 
Hobbs, A. and S. Moncada (1999). Inducible enzymes in the inflammatory response. 
Inducible nitric oxide synthase and inflammation. D. Willoughby. Basel, 
Switzerland, Birkhauser: 31-55. 
Holten, E. (1979). Serotypes of N. meningitidis isolated from patients in Norway during 
the first 6 months of 1978. J. Clin. Microbiol. 9: 186-188. 
---Honda; VHd Id, dl: (1998). -1friiiw ohisioeiielilieal evidence fur- a Illae Upilage 
scavenger receptor in Mato cells and reactive microglia of ischemia and 
Alzheimer's disease. Biochemical and Biophysical Research Communications. 
UNITED STATES. 245: 734-40. 
Huang, E., A. Nocka, et al. (1990). "The haemopoietic growth factor KL is encoded by 
the SL locus and is the ligand of the c-kit receptor, the gen product of the W 
locus. " Cell 63: 225-233. 
Hughes, D. A., I. P. Fraser, et al. (1995). Murine macrophage scavenger receptor: in vivo 
expression and function as receptor for macrophage adhesion in lymphoid and 
non-lymphoid organs. Eur. J. Immunol. GERMANY. 25: 466-73. 
188 
Ikezu, T., B. Trapp, et al. (1998). Caveolae, plsma membrane microdomains for alpha 
secretase-mediated processing of the amyloid precursor protein. Journal of 
Biological Chemistry. 273: 10485-10495. 
Isakov, N. (1997). Immunoreceptor tyrosine-based activation motif (ITAM), a unique 
module linking antigen and Fc receptors to their signalling cascades. Journal of 
Leukocyte Biology. 61: 6-16. 
Jack, D., N. Klein, et al. (2001). Mannose-binding lectin: targetin the microbial world for 
complement attack and opsonophagocytosis. Immunological Reviews. 180: 86- 
99. 
Janeway, C. (1992). "The immune system evolved to discriminate infectious non-self 
from non-infectious self. " Immunol. Today 13: 11-16. 
Jiang, Q., S. Akashi, et al. (2000). "Cutting Edge: Lipopolysaccharide Induces Physical 
Proximity Between CD 14 and Toll-Like Receptor 4 (TLR4) Prior to Nuclear 
Translocation ofNF-{kappa}B. " J Immunol 165(7): 3541-3544. 
Johnston Jr., C. (1988). "Monocytes and macrophages. " New Eng. J. Med. 318: 747-752. 
Jonas, L., C. Schutt, et al. (1990). Electron microscopy study of receptor mediated 
endocytosis of a monoclonal antibody (Rollo-1) against the surface marker CD14 
of human monocytes. Acta Histochemica Suppl. 39: 339-344. 
Joseph, C., S. Wright, et al. (1994). Bacterial lipopolysaccharide has strutural similarity 
to ceramide and stimulate ceramide-activated prtein kinase in myeloid cells. J 
Biol. Chem. 269: 17606-10. 
Juan, T., E. Hailman, et al. (1995). "Identification of lipopolysaccharide binding domain 
in CD 14 between amino acids 57-64. " JBC 270: 5219-5224. 
Kabha, K., L. Nissimov, et al. (1995). "Relationship mong capsular structure, 
phagocytosis, mouse virulence in Klebsiella pneunioniae. " Infect. Immun. 
63(847-852). 
Kahler, C., L. Martin, et al. (1998). The (alpha 2-8)-linked polysialic acis capsule and 
lipooligosaccharide structure both contribute to the ability of serogroup B 
Neisseria rneningitidis to resis the bactericidal activity of normal human serum. 
Infect. Immun. 66: 5939-5947. 
Kahler, C. and D. Stephens (1998). Crit. Rev. Microbiol. 24: 281-334. 
Kaplan, G. (1977). "Differences in the mode of phagocytosis with Fc and C3 receptors in 
macrophages. " Scand. J. Immunol. 6: 797-807. 
Karin, N. and Y. Ben-Neriah (2000). Phosphorylation meets ubiquitination: the control of 
NFkB activity. Ann. Rev. Immunol. 18: 621-663. 
Kodama, T., M. Freeman, et al. (1990). Type I macrophage scavenger receptor contains 
helical and collagen-like coiled coils. Nature. 343: 531-535. 
Kodama, T., M. Freeman, et al. (1990). Type I macrophage scavenger receptor contains 
alpha-helical and collagen-like coiled coils. Nature. ENGLAND. 343: 531-5. 
Konopski, Z., B. Smedsrod, et al. (1994). A novel immunomodulator soluble aminated b- 
1,3-D-glucan binding characteristics to mouse peritoneal macrophages. Biochem. 
Biophys. Acta Mol. Cell Res. 61: 1221. 
Kop, E. and R. Medzhitov (1999). The Toll-receptor family and control of innate 
immunity. Current Opinions in Immunology. 11: 13-18. 
Kopp, E. and R. Medzhitov (1999). "The Toll-receptor family and control of innate 
immunity. " Current Opinions in Immunology 11: 13-18. 
189 
Landmann, C., C. Ludwig, et al. (1991). Effect of cytokines and LPS on CD14 antigen 
expression on human monocytes and macrophages. Journal of cell biochemistry. 
47: 317-329. 
Landmann, R., B. Muller, et al. (2000). "CD 14, new aspects of ligand and signal 
diversity. " Microb. Infect. 2: 295-304. 
Larson, R. and T. Springer (1990). Structure and function of leukocyte integrins. 
Immunol. Rev. 114: 181-217. 
Lauener, R., R. Geha, et al. (1990). "Engagement of the monocyte surface antigen CD 14 
induces lymphocyte-function associated antigen-1/intercellular adhesion 
molecule-1 -dependent homotypic adhesion. " J. Immunol_ 145: 1390-4. 
Le_Cabec, V., C. Cols, et at. (2000). Nonopsonic phagocytosis of zymosan and 
Mycobacterium kansasii by CR3 (CD 1I b/CD 18) involves distinct molecular 
determinants and is or is not coupled with NADPH oxidase activation. Infection 
and Immunity. UNITED STATES. 68: 4736-45. 
Lefkowitz, D., J. Lincoln, et al. (1997). Enhancement of macrophage-mediated 
bactericidal activity by macropahge-mannose receptor ligand interactions. 
Immunol. Cell. Biol. 75: 136-141. 
Legler, D., 0. Micheau, et at. (2003). "Recruitment of TNF receptor I to lipid rafts is 
essential for TNFalpha-mediated NF-kappaB activation. " Immunity 18(5): 655- 
64. 
Leininger, E., M. Roberts, et al. (1991). Pertactin, an Arg-Gly-Asp conatining Bodatella 
pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. 
Acad. Sei. USA. 88: 345-349. 
Levin, B. and J. Bull (1994). Short-sighted evolution and the virulence of pathogenic 
microorganisms. Trends Microbiol. 2: 76-81. 
Levitz, S. M., A. Tabuni, et al. (1997). Binding of Cryptococcus neoformans to 
heterologously expressed human complement receptors. Infection and Immunity. 
UNITED STATES. 65: 931-5. 
Linehan, S. A., L. Martinez_Pomares, et al. (2000). Macrophage lectins in host defence. 
FRANCE. 2: 279-88. 
Ljungman, A., P. Leanderson, et al. (1998). (1-3)-b-D-glucan stimulates nitric oxide 
generation and cytokine mRNA expression in macrophages. Environ. Toxicol. 
Pharmacol. 5: 273. 
Lorenzi, R., P. Brickell, et al. (2000). "Wiskott-Aldrich Syndrome Protein is necessary 
for efficient IgG-mediated phagocytosis. " Blood 95: 2943-2946. 
Lue, K., R. Lauener, et al. (1991). "Engagement of CD 14 on human monocytes 
terminates T-cell proliferation by delivering a negative signal to T-cells. " J. 
Immunol. 147: 1134-1138. 
Machesky, L. and R. Insall (1998). "Scarl and the related Wiskott-Aldrich syndrome 
protein, WASP, regulate the actin cytoskelton through Arp2/3 complex. " Curr. 
Biol. 8: 1347-1356. 
Mandrell, R., A. Lesse, et al. (1990). In vitro and in vivo modification ofNeisseria 
gonnorhoeae lipooligosaccharideepitope structure by sialylation. J. Exp. Med. 
171: 1649-1664. 
190 
Marchant, A., J. Duchow, et al. (1992). "Lipopolysaccharide induces up-regulation of 
CD 14 molecules on monocytes in human whole blood. " Eur. J. Immunol. 22: 
1663. 
Marshall, J., J. Booth, et al. (2001). "Restricted accumilation of phaphatidylinositol S- 
kinase products in a plasmalemmal subdomain during Fc gamma receptor- 
mediated phagocytosis. " Journal of Cell Biioloey 153: 1369-1380. 
Martin, T., J. Mathison, et al. (1992). Lipopolysaccharide binding protein enhances 
responsiveness of alveolar macrophages to bacterial LPS. J Clin. Invest. 90: 2209- 
2219. 
Martinez-Pomares, L., M. Kosco-Vilbois, et al. (1996). "Fe chimeric protein containing 
the cysteine-rich domain of the murine mannose receptor binds to macrophages 
from spleenic marginal zone and lymph node subcapsular sinus and to germinal 
centres. " J. Exp. Med. 184: 1927-1937. 
Martinez-Pomares, L., J. Mahoney, et al. (1998). "A functional slouble form of the 
murine mannose receptor is produced by macrophages in vitro and is present in 
mouse serum. " J. Biol. Chem. 273: 23376-23380. 
Mary, R., E. Caron, et al. (2000). "Involvement of the Arp2/3 complex in the 
phagocytosis mediated by FcgammaR or CR3. " Nature Cell Biology. 
Massol, P., P. Montcourrier, et al. (1998). "Fe-receptor mediated phagocytosis requires 
CDC42 and Rae I. " EMBO J. 17: 6219-6229. 
Matsumoto, A., M. Naito, et al. (1990). Human macrophage scavenger receptors: primary 
structure, expression, and localization in atherosclerotic lesions. Proceedings of 
the National Academy of Sciences of the United States of America. UNITED 
STATES. 87: 9133-7. 
Matsuno, R., Y. Aramaki, et al. (1998). Contribution of CR3 to nitric oxide production 
from macrophages stimulated with high-dose of LPS. Biochemical and 
Biophysical Research Communications. UNITED STATES. 244: 115-9. 
Matsuno, R., Y. Aramaki, et al. (1997). Scavenger receptors may regulate nitric oxide 
production from macrophages stimulated by LPS. Biochemical and Biophysical 
Research Communications. UNITED STATES. 237: 601-5. 
Matsuura, K., T. Ishida, et al. (1994). "Upregulation of mouse CD14 expression in 
Kupffer cells by lipopolysaccharide. " J. Exp. Med. 179: 1671. 
Matzinger, P. (1994). Tolerance, danger and the extended family. Annu. Rev. Immunol. 
12: 991. 
Matzinger, P. (1998). "An innate sense of danger. " Sem. Immunol. 10: 399-415. 
Maynard, Y. and J. Baenziger (1987). Profi. Clin. Biol. Res. 247: 243-257. 
McConville, M. and M. Ferguson (1993). The structure, biosynthesis and function of 
glyco lay ted phosphatidylinositols in the parasitic protozoa and higher eukaryotes. 
Biochem. J. 
McGinley, M. D., L. O. Narhi, et al. (1995). "CD 14: Physical Properties and 
Identification of an exposed site that is protected by lipopolysaccharide. " J. Biol. 
Chem. 270(10): 5213-5218. 
McLeod Griffis, J. (1995). Mechanism of host immunity. Menineococcal Disease. K. 
Cartwright, John Wiley and Sons Ltd. 
Medzhitov, R. and C. Janeway (1997). "Innate Immunity: the virtues of a non-clonal 
system of recognition. " Cell 91: 295-298. 
191 
Medzhitov, R., P. Preston Hurlburt, et al. (1997). "A human homologue of Drosophila 
Toll protein signals activation of adapive immunity. " Nature 388: 394-397. 
Meyer, T. (1999). Pathogenic Neisseriae: Complexity of pathogen-host cell interplay. 
Clin. Infect. Dis. 28: 433-441. 
Mielewczyk, S., K. Breslauer, et al. (1996). Binding studies of a triple helical peptide 
model of macrophage scavenger receptor to tetraplex nucleic acids. Biochemistry. 
35: 11396-11402. 
Morikawa, M., R. Noguchi, et al. (1986). Calcium-dependent and independent 
tumouricidal activities of polymorphonuclear leukocytes induced by linear b-1,3- 
D-glucan and phorbol myristate acetate in mice. Cancer Res. 46: 66. 
Morisato, D. and K. Anderson (194). "The spatzle gene encodes a component of the 
extracellular signalling pathway establishing the dorsal-ventral pattern of the 
Drosophila embryo. " Cell 76: 677-688. 
Mosser, D. (1994). Receptors on phagocytic cells involved in microbial recognition. 
Macrophage-pathogen interactions. T. Eisenstein. NY, Marcel Dekker Inc. 
Nafa, K., P. Mason, et al. (1995). Mutations in the PIG-A gene causing paroxysmal 
nocturnal haemoglobinuria (PNH) are mainly of the frameshift type. Blood. 
CHECK. 
Naito, M., T. Kodama, et al. (1991). Tissue distribution, intracellular localization, and in 
vitro expression of bovine macrophage scavenger receptors. American Journal of 
Pathology. UNITED STATES. 139: 1411-23. 
Naito, M., H. Suzuki, et al. (1992). Coexpression of type I and type II human macrophage 
scavenger receptors in macrophages of various organs and foam cells in 
atherosclerotic lesions. American Journal of Pathology. UNITED STATES. 141: 
591-9. 
Nicholson, A. and I. Lepow (1979). Host against against Neisseria meningitidis requires a 
complement-dependent bactericidal activity. Science. 205: 298-299. 
Ohno, N., K. Saito, et al. (1993). Immunopharmacological characterisation of a highly 
branched fungal (1-3)-b-D-glucan, OL-2 isolated from Omphalia lapidescens. 
Biol. Pharm. Bull. 16: 414. 
Okamoto, T., A. Schlegel, et al. (1998). J Biol. Chem. 273: 5419-5422. 
Olcen, P., J. Kjellander, et al. (1979). Culture diagnosis of meningococcal carriers: yield 
from different sites and influence of storage in transport medium. J. Clin. Pathol. 
32: 1222-1225. 
Oliferenko, S., K. Paiha, et al. (1999). Journal of Cell Biology. 146: 843-854. 
Ono, A. and E. Freed (2001). "Plasma membrane rafts play a critical role in HIV-1 
assembly and release. " Proc. Natl. Acad. Sei. USA 98: 13925-30. 
Paresce, D. M., R. N. Ghosh, et al. (1996). Microglial cells internalise aggregates of the 
Alzheimer's disease amyloid B-protein via a scavemger receptor. 17: 553-565. 
Peiser, L., M. de Winther, et al. (2002). The class A macrophage scavenger receptor is a 
major pattern receognition receptor for Neisseria meningitidis which is 
independent of lipopolysaccharide and not required for secretory responses. 
Infect. Immun. 70: 5346-5354. 
Peiser, L. and S. Gordon (2001). The function of scavenger receptors expressed by 
macrophages and their role in the regulation of inflammation. France. 3: 149-59. 
192 
Peiser, L., P. J. Gough, et at. (2000). Macrophage class A scavenger mirobial strain and 
cuture conditions in vitro. Infect. Immun. 68: 1953-1963. 
Peiser, L., P. J. Gough, et al. (2000). Macrophage class A scavenger receptor-mediated 
phagocyotsis of Escherichia coli: role of cell heterogeneity, microbial strain and 
culture conditions in vitro. Infection and Immunity. 68: 1953-1963. 
Perdomo, J., J. Cavaillon, et al. (1994). "Acute inflammation causes epithelial invasion 
and mucosal destruction in experimental shigellosis. " J. Exp. Med. 180: 1307- 
1319. 
Petty, H. and R. Todd (1996). Integrins as promiscuous signal transduction devices. 
Immunol. Today. 17: 209-211. 
Petty, H. and R. Todd, Eds. (1996). Integrins as promiscuous signal transduction devices. 
Immunol. Today. 
Petty, H. and R. Todds III (1996). Integrins as promiscuous signal transduction devices. 
Trends Immunol. 17: 209-212. 
Peyron, P., C. Bordier, et al. (2000). Nonopsonic phagocytosis of Mycobacterium 
tuberculosis by human neutrophils depends on cholesterol and is mediated by 
CR3 associated with glycosylphosphatidylinositol-anchored proteins. J. Immunol. 
165: 5186-5191. 
Pierini, L. M. and F. R. Maxfield (2001). Flotillas of lipid rafts fore and aft. PNAS. 98: 
9471-9473. 
Platanov, A., V. Beloborodov, et at. (1993). Meningococcal disease in patients with late 
complement component deficiency: studies in USSR. Med. (Baltimore). 
Platt, N., R. P. da Silva, et al. (1999). Class A scavenger receptors and the phagocytosis 
of apoptotic cells. Immunology Lam. NETHERLANDS. 65: 15-9. 
Platt, N. and S. Gordon (1998). Scavenger receptors: diverse activities and promiscuous 
binding of polyanionic ligands. Chemistry and Biology. 5: R193-203. 
Platt, N., H. Suzuki, et at. (1996). Role for the class A macrophage scavenger receptor in 
the phagocytosis of apoptotic thymocytes in vitro. Proceedings of the National 
Academy of Science USA. 93: 12456-12460. 
Pollard, A. and C. Frasch (2001). Development of natural immunity to Neisseria 
meningitidis. Vaccine. 19: 1327-1346. 
Pontow, S., V. Kery, et at. (1992). Mannose receptor. Int. Rev. Cytol. 137: 221-245. 
Popovic, T. (2000). Neisseria ineningitidis serogroup W135 isolates from US travellers 
returning from Hajj are associated with ET-37 complex. Emerg. Infect. Dis. 6: 10- 
11. 
Pralle, A., P. Keller, et at. (2000). Sphingolipid-cholesterol rafts diffuse as small entities 
in the plasma membrane of mammalian cells. Journal of Cell Biology. 148: 997- 
1007. 
Pridmore, A., D. Wylie, et al. (2001). "A lipopolysaccharide-deficient mutant of N. 
meningitidis elicits attenuated cytokine release by human macrophages and 
signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. " J. Infect. Dis. 183: 
89-96. 
Pugin, J., D. Neumann, et a). (1994). "CDJ 4 is a patter recognition receptor. " Immunity 
1: 509-516. 
Pujol, C. e. a. (1997). Interactions of N. meningitidis with polarized layer of epithelial 
cells. Infect. Immun. 65: 4836-4842. 
193 
Rabehi, L., T. Irinopoulou, et al. (2001). "Gram-Positive and Gram-Negative Bacteria Do 
Not Trigger Monocytic Cytokine Production through Similar Intracellular 
Pathways. " Infect. Immun. 69(7): 4590-4599. 
Rabinovitch, M. (1995). "Professional and non-professional phagocytes: an introduction. " 
Trends Cell Biol. 5: 85-87. 
Rabinovitch, M. and M. de Stefano (1976). Proc. Natl. Acad. Sci. USA 85: 2805. 
Ram, S., F. Mackinnon, et al. (1999). The contrasting mechanisms of serum resistance of 
Neisseria gonnorhoeae and group B Neisselria ineningitidis. Mol. Immunol. 36: 
915-928. 
Ravetch, J. (1994). "Fe receptors:. " Cell 78: 553-560. 
Read, R., A. Fox, et al. (1995). Experimental infection of human nasal mucosal explants 
with Neisseria meningitidis. J. Med. Micro. 42: 353-361. 
Read, R. and L. Goodwin (2001). Experimental nasopharygeal colonisation by Neisseria 
nleningitidis using explant organ culture. Meningococcal disease, Methods and 
Protocols, Methods in Molecular Medicine Series. M. Maiden. Totowa, NJ, 
Humana: 621-634. 
Read, R., S. Zimmerli, et al. (1996). "The alpha (2-8)-linked polysialic acid capsule of 
group B Neisseria ineningitidis modifies multiple steps during interactions with 
human macrophages. " Infect. Immun. 64: 3210-3217. 
Read, R., S. Zimmerli, et al. (1996). The (alpha 2-8)-linked polysialic acid capsule of 
group B Neisseria meningitidis modifies multiple steps during interaction with 
human macrophages. Infect. Immun. 64: 3210-3217. 
Reller, L., R. MacGregor, et al. (1973). Bactericidal antibody after colonisation with 
Neisseria ineningltldls. Journal of Infectious Disease. 127: 56-62. 
Ridley, A. and A. Hall (1994). "Signal transduction pathways regulating Rho-mediated 
stress fibre formation: requirement for a tyrosine kinase. " EMBO J. 13: 2600- 
2610. 
Riedo, F., B. Plikaytis, et al. (1995). Epidemiology and preention of meningococcal 
disease. Pediatr. Infect. Dis. J. 14: 643-647. 
Ring, A., J. Weiser, et al. (1998). "Pneumococcal trafficking across the blood-brain- 
barrier. Molecular analysis of a novel bidirectional pathway. " J. Clin. Invest. 102: 
347-360. 
Riordan, T., K. Cartwright, et at. (1998). Acquisition and carriage of meningococci in 
marine commando recruits. Epidemiol. Infect. 121: 495-505. 
Rohrer, L., M. Freeman, et al. (1990). Coiled-coil fibrous domains mediate ligand 
binding by macrophage scavenger receptor type II. Nature. 343: 570-572. 
Roper, K., D. Corbeil, et al. (2000). Nat. Cell Biol. 2: 582-592. 
Ross, G. D., J. Cain, et al. (1987). Specificity of membrane complement receptor type 
three (CR3) for b-glucans. Complement Inflamm. 4: 61. 
Ross, S. and P. Densen (1984). Complement deficiency states and infection: 
epidemiology, pathogenesis and consequences of neisserial and other infections in 
an immune deficiency. Medicine (Baltimore). 63: 243-273. 
Rosse, W. (1990). Phosphatidylinositol-linked proteins and paroxysmal nocturnal 
haemoglobinuria. Blood. 75: 1595. 
Rothberg, K., J. Heuser, et al. (1992). Caveolin, a protein component of caveolae 
membrane coats. Cell. 68: 673-682. 
194 
Rotoli, B., M. Bessler, et al. (1993). Membrane proteins in paroxysmal nocturnal 
haemoglobinuria. Blood Reviews. 7: 75. 
Ruoslahti, E. (1996). RGD and other recognition sequences for integrins. Annu. Rev. Cell 
Dev. Biol. 12: 697-715. 
Savedra, R. J., R. Delude, et al. (1996). Mycobacterial lipoarabinomannan recognition 
requires a receptor that shares components of the endotoxin siganiling system. J. 
Immunol. 157: 2549. 
Savill, J. (1998). Phagocytic docking without shocking. Nature. 392: 442-443. 
Schackelford, R. E., U. K. Misra, et al. (1995). Oxidized low density lipoprotein 
suppresses activation of NF kappa B in macrophages via a pertussis toxin- 
sensitive signaling mechanism. Journal of Biological Chemistry. UNITED 
STATES. 270: 3475-8. 
Scheiffele, P., A. Rietveld, et al. (1999). "Influenza viruses select ordered lipid domains 
during budding from the plasma membrane. " J Biol. Chem. 274: 2038-2044. 
Scherer, P., Z. Tang, et al. (1995). Caveolin isoforms differ in theirN-terminal protein 
sequence and subcellular distribution. Identification and epitope mapping of an 
isoform-specific monoclonal antibody probe. Journal of Biological Chemistry. 
270: 16395-16401. 
Schlesinger, P. (1994). "Binding of the terminal mannosyl units of lipoaribinomannan 
from a virulent strain of Mycobateria tuberculosis to human macrophages. " J. 
Immunol. 152: 4070-4078. 
Schroeder, R., E. London, et al. (1994). Interactions between saturated acyl chains confer 
detergent resistance on lipids and GPI-anchored proteins: GPI-proteins in 
lipososmes and cells show similar behaviour. Proc. Natl. Acad. Sci. USA. 91: 
12130-12134. 
Schubert, J., P. Uchiechowski, et al. (1990). The PIG anchoring effect in NK 
lymphocytes of PNH patients. Blood. 76: 118. 
Schumann, R., S. Leong, et al. (1990). Structure and function of lipolysaccharide binding 
protein. Science. 249: 1429-1431. 
Schutt, C., B. Ringel, et al. (1988). Human monocyte activation induced by anti-CD 14 
monoclonal antibody. Immunol. Lett. 19: 321-328. 
Schwende, H., E. Fitzke, et al. (1996). Differences in the state of differentiation of THP-1 
cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. 
Seljelid, R. (1986). A water-soluble animated betal-3D-glucan derivative causes 
regression of solid tumours in mice. Biosci. Rep. 6: 845. 
Seljelid, R., J. Bogwald, et al. (1984). A soluble b-1,3-D-glucan derivative potentiates the 
cytostatic and cytolytic capacity of mouse peritoneal macrophages in vitro. 
Immunop/zarmacoloQy. 7: 69. 
Seljelid, R., L. Rasmussen, et al. (1987). The protective effect of bl-3-D-glucan- 
derivatized plastic beads against Escherichia coli infection in mice. Scand. J. 
Immunol. 25: 55. 
Shang, X. and A. Issekutz (1998). Contribution of CD 11 a/CD 18, CD I1 b/CD 18, ICAM-1 
(CD54) and -2 (CD102) to human monocyte migration through endothelium and 
connective tissue fibroblast barriers. Eur. J. Immunol. 28: 1970-1979. 
Shepherd, V., E. Campbell, et al. (1982). J. Ret. Soc. 32: 423-431. 
Shepherd, V., M. Konish, et al. (1985). J. Biol. Chem. 260: 160-164. 
195 
Sherwood, E., D. Williams, et al. (1987). In vitro tumouricidal activity of resting and 
glucan-activated Kupffer cells. J. Leukoc. Biol. 42: 69. 
Shimazu, R., S. Akashi, et al. (1999). MD-2, a molecule that confers lipopolysaccharide 
responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782. 
Simmons, D., S. Tan, et al. (1989). Monocyte antigen CD14 is a phospholipid-anchored 
membrane protein. Blood. 73: 284-289. 
Simmons, D., S. Tan, et al. (1989). "Monocyte antigen CD14 is a phospholipid-anchored 
membrane protein. " Blood 73: 284-289. 
Simmons, K. and G. van Meer (1988). "Lipid sorting in epithelial cells. " Biochemistry 
27: 6197-6202. 
Simonet, M., S. Richard, et al. (1990). "Electron microscopic evidence for il: vivo 
extracellular localisation of Yersirnia pseudotuberculosis harboring the pYV 
plasmid. " Infection and Immunity 58: 841. 
Simons, K. and E. Ikonen (1997). Nature 387: 569-572. 
Simons, K. and E. Ikonen (1997). Functional rafts in cell membranes. Nature. 387: 569- 
572. 
Simons, K. and D. Toomre (2000). Lipid rafts and signal transduction. Nature Reviews 
Molecular Cell Biology. 1: 31-39. 
Smart, E., G. Graf, et al. (1999). Caveolins, liquid-ordered domains, and signal 
transduction. Mol. Cell. Biol. 19: 7289-7304. 
Smart, E., Y. Ying, et al. (1996). Journal of Biological Chemistry. 271: 29427-29435. 
Smiley, S., J. King, et al. (2001). "Fibronectin stimulates macrophage chemokine 
secretion through Toll-like receptor 4. " J. Immunol. 167: 2887-2894. 
Smith, H., N. Parsons, et al. (1995). Sialylation of neisserial lipopolysaccharide: a major 
influence on pathogenecity. Microb. Pathos. 19: 365-377. 
Snyder, F. (1990). "Platelet-activating factor and related acetyl lipids as potent 
biologically active cellular mediators. " Am. J. Physiol. 259: C697-C708. 
Speert, D. P., S. Y. Wong, et al. (1997). "Modulation of macrophage function for defence 
of the lung against Pseudomonas aeruginosa. " Behring Institute Mitteilungen(98): 
274-82. 
Springer, T. (1995). Traffic signals on endothelium for lymphocyterecirculation and 
leukocyte emigration. Annu. Rev. Physiol. 57: 827-872. 
Stahl, P. and S. Gordon (1982). J. Cell Biol. 93: 49-56. 
Stahl, P., J. Rodman, et al. (1978). "Evidence for receptor-mediatd binding of 
glycoproteins, glycoconjugates lysosomal glycosidases by alveolar macrophages. " 
Proc. Natl. Acad. Sei. USA 75: 1399-1403. 
Steeghs, L., H. de Cock, et al. (2001). Outer membrane composition of a 
lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J. 20: 6937- 
45. 
Steeghs, L., R. den Hartog, et al. (1998). Meningitis bacterium is viable without 
endotoxin. Nature. 392: 449-450. 
Stelter, F., M. Bernheiden, et al. (1997). "Mutation of amino acids 31-44 of human CD 14 
abrogates binding of LPS and Escherichia coll. " Eur. J Biochem. 243(100-109). 
Stephens, D. and M. Farley (1991). Pathological events during the infection of human 
nasopharynx with N. meningitidis and H. it jluenzae. Rev. Infect. Dis. 13: 22-33. 
196 
Stites, D., A. Terr, et al. (1997). Medical Immunology. Stamford, Conn., Appleton and 
Lang. 
Stites, D., A. Terr, et al. (1997). Medical Immunology. Stamford, Conn., Appleton & 
Lang. 
Stokes, R. W., I. D. Haidl, et al. (1993). Mycobacteria-macrophage interactions. 
Macrophage phenotype determines the nonopsonic binding of Mycobacterium 
tuberculosis to murine macrophages. Journal of Immunology. UNITED STATES. 
151: 7067-76. 
Strausbaugh, L. J. Meningitis, antimicrobial agents and the blood-brain barrier. 
Sugawara, I., K. Lee, et al. (1984). Schizophyllan (SPG)-treated macrophages and and 
anti-tumour activities against syngeneic and allogenc tumour cells. I. 
Characteristics of SPG-treated macrophages. Cancer Immunol. Immunother. 16: 
137. 
Sugiyama, T. and S. Wright (2001). Soluble CD14 mediates efflux of phospholipids from 
cells. J. Immunol. 166: 826-83 1. 
Suzuki, H., Y. Kurihara, et al. (1997). The multiple roles of macrophage scavenger 
receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to 
infection in MSR knockout mice. Journal of Atherosclerosis and Thrombosis. 
JAPAN. 4: 1-11. 
Suzuki, H., Y. Kurihara, et al. (1997). A role for macrophage savenger receptors in 
atherosclerosis and susceptibility to infection. Nature. 386: 292-296. 
Sweet, M. and D. Hume (1996). Endotoxin signal transduction in macrophages. J Leuk. 
Biol. 60: 8-26. 
Swords, W., B. Buscher, et al. (2000). "Non-typpeale Haemophilus in fiuenzae adhere to 
and invade human bronchial epithelial cells via interaction of lipooligosaccharide 
with the PAF receptor. " Mol. Microbiol. 37(1): 13-27. 
Taha, M. -K. (2000). Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 
356: 2159. 
Takeda, J., T. Miyata, et al. (1993). Deficiency of PIG-A gene in paroxysmal nocturnal 
haemoglobinuria. Cell. 73: 703. 
Tapping, R., Akashi, et al. (2000). "Toll-like receptor 4, but not toll-like receptor 2, is a 
signalling receptor for Escherichia and Salmonella lipopolysaccharides. " J. 
Immunol. 165: 5780-5787. 
Taylor, M., K. Bezouska, et at. (1992). "Contribution to ligand binding by multiple 
carbohydrate-recognition domains in macrophage mannose receptor. " J. Biol. 
Chem. 267: 1719-1726. 
Terpstra, V. and T. J. van_Berkel (2000). Scavenger receptors on liver Kupffer cells 
mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood. 
UNITED STATES. 95: 2157-63. 
Thomas, C. A., Y. Li, et al. (2000). Protection from lethal gram positive infection by 
macrophage scavenger receptor-dependant phagocytosis. Journal of Experimental 
Medicine. 191: 147-156. 
Thomas, C. A., Y. Li, et al. (2000). Protection from lethal gram-positive infection by 
macrophage scavenger receptor-dependent phagocytosis. Journal of Experimental 
Medicine. UNITED STATES. 191: 147-56. 
197 
Thompson, T. and T. Tillack (1985). Organisation of glycosphingolipids in bilayers and 
plasma membranes of mammalian cells. Ann. Rev. Biophys. Chem. 14: 361-386. 
Thornton, B., V. Vetvicka, et al. (1996). Analysis of the sugar specificity and molecular 
location of the b-glucan binding lectin site of complement receptor type 3 
(CD Il b/CD 18). J. Immunol. 156: 1235. 
Thorson, L. M., D. Doxsee, et al. (2001). Effect of mycobacterial phospholipids on 
interaction of Mycobacterium tuberculosis with macrophages. Infection and 
Immunity. United States. 69: 2172-9. 
Tobias, P., K. Soldau, et al. (1995). Lipopolysaccharide binding protein-mediated 
complexation of LPS with soluble CD 14. Journal of biological chemistry. 270: 
10482-10488. 
Todd, R., A. Bhan, et al. (1984). Human myelomonocytic differentiation antigens defined 
by monoclonal antibodies. Leukocyte Typing. Human leukocyte differentiation 
antigens detected by monoclonal antibodies. S. Schlossman. New York, Springer- 
Verlag: 424-433. 
Todds III, R. (1996). The continuing saga of complement receptor type 3 (CR3). J. Clin. 
Invest. 98: 1-2. 
Townsend, R., L. Goodwin, et al. (2002). Invasion by Neisseria meningitidis varies 
widely between clones and among nasopharyngeal mucosae derived from adult 
human hosts. Microbiology. 148: 1467-1474. 
Tsuchiya, S., Y. Kobayashi, et al. (1982). Induction of maturation in culture human 
monocytic leukaemia cells by phorbol diester. Cancer Res. 42: 1530-1536. 
Tzeng, Y. -L. and D. Stephens (2000). Microbe Infect. 6: 686-700. 
Ukeki, K., K. Tabeta, et al. (2002). Self-heat shock protein 60 induces tumour necrosis 
factor-alpha in monocyte-derived macrophage: possible role in chronic 
inflammatory peridontal disease. Clin. Exp. Immunol. 127: 72-77. 
Valledor, A., F. Borras, et al. (1998). Transcription factors that regulate monocyte 
macrophage differentiation. J. Leukoc. Biol. 63: 405-417. 
Van Deuren, M., J. van der Ven-Jongekrijg, et al. (1995). Correlation between pro- 
inflammatory cytokines and anti-inflammatory mediators and the severity of 
disease in meningococcal infections. J. Infect. Dis. 172: 433-439. 
van Furth, R. (1985). Mononuclear phagocytes: characteristics, physiology and function. 
Dordrecht, Netherlands, Martinus Nijhoff. 
Van Nhieu, G. and R. Isberg (1991). The Yersinia pseudotuber"culosis invasion protein 
and human fibronectin bind to mutually exclusive sites on the alpha5betal 
integrin receptor. J. Biol. Chem. 266: 24367-24375. 
van_Lenten, B. J. and A. M. Fogelman (1992). Lipopolysaccharide-induced inhibition of 
scavenger receptor expression in human monocyte-macrophages is mediated 
through tumor necrosis factor-alpha. Journal of Immunology. UNITED STATES. 
148: 112-6. 
Vetvicka, V., B. Thornton, et al. (1996). Soluble b-glucan polysaccharide binding to the 
lectin site of neutrophil or NK cell complement receptor type 3 (CD I1 b/CD 18) 
generates a primed state of the receptor capable of mediating ytotoxicity of iC3b- 
opsonized target cells. J. Clin. Invest. 98: 50. 
198 
Vetvicka, V., B. Thornton, et al. (1997). Targeting of NK cells to mammary carcinoma 
via naturally occurring tumour cell-bound iC3b and b-glucan- primed CR3 
(CD 11 b/CD 18). J. Immunol. 159: 599. 
Virji, M., H. Kaughty, et al. (1991). The role of pili in interactions of pathogenic 
Neisser"ia with cultured human endothelial cells. Mol. Microbiol. 5: 1831-41. 
Virji, M., K. Makepeace, et al. (1995). Opc- and pilus-dependent interactions of 
meningococci with human endothelial cells: molecular mechanisms and 
modulation by surface polysaccharides. Mol. Microbiol. 18: 741-754. 
Vogel, U., H. Claus, et al. (1999). Role of lipooligosaccharide sialylation in serum 
resistance of serogroup B and C meningococcal disease isolates. Infect. Immun. 
67: 954-957. 
Wagner, C., G. Hansch, et al. (2001). The complement receptor 3, CR3 (CD II b/CD 18), 
on T-lymphoctes: activation-dependent up-regulation and regulatory function. 
Eur. J. Immunoff. 31: 1173-1180. 
Walker, E., N. Warner, et al. (1985). "Characterisation of subsets of bone-marrow 
derived macrophages by flow cytometry analysis. " J. Leukoc. Biol. 37: 121-136. 
Wang, P., R. Kitchens, et al. (1998). "Phosphatidylinositides bind to plasma membrane 
CDI4 and can prevent monocyte activation by bacterial lipopolysaccharide. " J 
Biol. Chem. 273: 24309. 
Wang, P. and R. Munford (1999). "CD14-dependent internalisation and metabolism of 
extracelluar phophatidylinositol by monocytes. " J Biol. Chem. 274: 23235. 
Ware, R., W. Rosse, et al. (1994). Mutations within the PIG-A in patients with 
paroxysmal nocturnal haemoglobinuria. Blood. 83: 2418. 
Watanabe, A., A. Takeshita, et al. (1996). CD14-mediated signal pathway of 
Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. 
Infect. Immun. 64: 4488-4494. 
Watarai, M., I. Derre, et al. (2001). "Legionella pneamnophila is internalised by a 
macropinocytic uptake pathway controlled by the Dot/lcm system and the mouse 
Lgn 1 locus. " Infection and Immunity 64: 2585-94. 
Wonduly, R., A. Ghaffar, et al. (1996). LPS-induced suppression of phagocytosis and 
effects on the phagocytic machinery. Immunopharmacol. Immunotoxicol. 18: 
267-289. 
Wooten, R., T. Morrison, et al. (1998). The role of CD 14 in signalling mediated by outer 
membrane lipoproteins of Borrelia barrgdo, fef"i. J. Immunol. 160: 5485. 
Wright, S. (1999). Innate recognition of microbial lipids. Inflammation: Basic principles 
and clinical corelates. R. Snyderman. New York, Raven Press: 525. 
Wright, S. D., L. Craigmyle, et al. (1983). "Fibronectin and serum amyloid P component 
stimulate C3b- and Obi-mediated phagocytosis in cultured human monocytes. " J. 
Exp. Med. 158: 1338-1343. 
Wright, S. D., R. A. Ramos, et al. (1990). "CD 14, a receptor for lipopolysaccharide (LPS) 
and LBP binding protein. " Science 249: 1431-33. 
Wright, S. D., J. Weitz, et al. (1988). Complement receptor type 3 (CD Il b/CD 18) of 
human polymorphonuclear leukocytes recognises fibrinogen. Proc. Natl. Acad. 
Sci. USA. 85: 7734-7738. 
Xia, Y. and G. D. Ross (1998). Mapping the b-glucan lectin site of human CR3 
(CD II b/CD 18) with recombinant fragments of CD I1b. FASEB J. 12: A907. 
199 
Xia, Y., V. Vetvicka, et al. (1999). The beta-alucan-binding lectin site of mouse CR3 
(CD II b/CD 18) and its function in generating a primed state of the receptor that 
mediates c otoxic activation in response to iC3b-opsonized target cells. UNITED 
STATES. 
Yalamanchili, P., C. Lu, et al. (2000). Folding and function of I-domain deleted Mac-I 
and lymphocyte function-associated antigen-1. J. Biol. Chem. 275: 21877-21882. 
Yamada, E. (1955). The fine structure of the gall bladder epithelium of the mouse. J. 
Biophys. Biochem. Cyto. 1: 445-458. 
Yamada, N., T. Miyata, et al. (1995). Somatic mutations in the PIG-A gene found in 
Japanese patients with paroxysmal nocturnal haemoglobinuria. Blood. CHECK. 
Yamamoto, K., N. Nishimura, et al. (1997). The lysine cluster in the collagen-like 
domain of the scavenger receptor provides for its ligand binding and ligand 
specificity. Febs Letters. NETHERLANDS. 414: 182-6. 
Yamamoto, T., Y. Ebe, et al. (1999). Expression of scavenger receptor class A and CD14 
in lipopolysaccharide-induced lung injury. Pathology International. 
AUSTRALIA. 49: 983-92. 
Yamashina, N., E. Ueda, et at. (1990). Inherited complete deficiency of 20kD 
homologous restriction factor (CD59) as a cause of paroxysmal nocturnal 
haemoglobinuria. N Eng] J Med. 323: 1184. 
Yang, X., N. Galeano, et al. (1996). Oxidised low density lipoproteins alter macrophage 
lipid uptake, apooptosis, viability and nitric oxide synthesis. J. Nutr. 126: 1072. 
Yu, B., E. Hailman, et al. (1997). Lipopolysaccharide binding protein and soluble CD14 
catalyze exchange of phospholipids. J Clin. Invest. 99: 315. 
Zhou, M., J. van der Winkel, et al. (1993). Co-capping of the leukoadhesion molecules 
complement receptor type 3 and lymphocyte function-associated antigen-I with 
Fc receptor III on human neutrophils: possible role of lectin-like interactions. J. 
Immunol. 150: 3030. 
Zhu, P. (2001). Fit genotypes and escape variants of subgroup III Neissel7a 1ne111ngitidis 
during three pandemics of epidemic meningitis. Proc. Nat. Acad. Sei. USA. 98: 
5234-5239. 
Zimmerli, S., S. Edwards, et al. (1996). Selective receptor blockade during phagocytosis 
does not alter the survival and growth of Mycobacterium tuberculosis in human 
macrophages. American Journal of Respiratory Cell and Molecular Biology. 
UNITED STATES. 15: 760-70. 
Zisch, A., L. D'Alessandri, et al. (1995). The glypiated neuronal cell adhesion molecule 
contactin/FI I complexes with Src-family protein tyrosine kinase Fyn. Mol. Cell. 
Neurosci. 6: 263-279. 
Zorgani, A., V. James, et at. (1996). Serum bactericidal activity in a secondary school 
population following an outbreak of meningococcal disease: effects of carriage 
and secretor status. FEMS Immunol. Med. Microbiol. 14: 73-81. 
200 
PUBLICATIONS 
Pridmore AC, Wyllie DH, Abdillahi F, Steeghs L, van der Ley P, Dower SK, 
Read RC 
A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated 
cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but 
not via TLR4/MD2. JI fett Dis. 2001 Jan 1; 183 (1): 89-96 
Abdillahi F, Klein N, Steeghs L, van der Ley P, Read RC. 
Role of human Class A scavenger receptor in phagocytosis of Neisseria meningitidis. 
(In preparation) 
CONFERENCES 
Poster 
12`h International Pathogenic Neisseria Conference 
Galveston, Texas, USA - 12-17`h Nov 2000 
Poster and short presentation 
11th International Congress on Immunology 
Stockholm, Sweden - 22-27 July 2001 
